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ABSTRACT
EXPLORING THE ACCESSIBILITY, AFFORDABILITY, AND EQUITABILITY OF
TELECONTRACEPTION PLATFORMS AND THEIR IMPLICATIONS FOR
REPRODUCTIVE HEALTH CARE
by
Jenna Nitkowski

The University of Wisconsin-Milwaukee, 2021
Under the Supervision of Professor Noelle Chesley

Telemedicine has skyrocketed to national attention with the COVID-19 crisis, raising
questions about how to best use virtual tools to support public health. One emerging sector of
telemedicine is the rise of telecontraception platforms, such as Nurx, Pill Club, and Planned
Parenthood Direct. Known as “the Uber for birth control”, these platforms represent a growing
market and innovative approach that aim to address barriers to obtaining birth control such as
geography, cost, time, and gatekeeping by providing contraception and other sexual and
reproductive healthcare services directly to consumers (Sundstrom et al. 2019; Grindlay and
Grossman 2016; Chuck 2017; Stormo et al. 2011). Contraception historically was and currently
is riddled with red tape for women trying to access critical care they need to make decisions
about their own bodies and lives. Telecontraception represents an important potential solution to
these long-standing issues, yet its impact on women and health care has not yet been studied in
depth. What are telecontraception platforms adding to the current landscape of reproductive
health care? What problems are they solving and where are they falling short? Using mixed
methods, this research aims to address this gap by exploring the accessibility, affordability, and
equitability of these growing platforms.

ii

Findings illustrate telecontraception alleviates many existing access barriers. Yet there
are mixed findings regarding affordability and equitability. Cost, insurance, and state availability
limit the scope of telecontraception and mirror existing systemic challenges women face on the
ground. This carries important implications because this research also found that the majority of
women across the United States expressed strong pregnancy avoidance attitudes regardless of
subgroup. Having a large presence of women legislators alongside other state conditions was
linked to telecontraception availability in Republican and Democrat politically controlled states,
suggesting that gender and having women in positions of power, in combination with other
political, social, and economic state-level factors, is another growing and important factor to
consider in advocating for issues related to women such as reproductive rights and policy.
Overall, this project identifies areas of progress and opportunities for improvement not only for
telecontraception but for health apps and telemedicine more broadly.
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INTRODUCTION
Telemedicine is a rapidly growing area of healthcare with the potential to cut costs and
increase access, particularly for underserved and rural populations (Centers for Disease Control
and Prevention 2020). The current COVID-19 crisis has brought telemedicine into the national
spotlight. Rates of telehealth visits have increased during the pandemic, expanding access to
services and improving reimbursement policies (Koonin et al. 2020; Campos-Castillo and
Anthony 2021). One emerging sector of telemedicine is telecontraception platforms, such as
Nurx, Pill Club, and Planned Parenthood Direct. Known as “the Uber for birth control”, these
platforms provide birth control and sexual and reproductive healthcare services directly to
consumers and aim to address barriers to obtaining contraception, particularly in the United
States (Chuck 2017). The United States is unique in requiring a doctor’s prescription for birth
control, compared to other countries where it is often free or sold over the counter without a
prescription (Drum 2012; Khosla 2015). Furthermore, legislation and orders can also vary across
different states, adding another layer of complexity to access (Nash et al. 2020).
Nearly one-third of women report difficulties obtaining prescription contraception, with
the most common barriers related to access and affordability (Grindlay and Grossman 2016).
Moreover, the COVID-19 pandemic has impacted in-person access to contraception due to
economic and logistic barriers (Lindberg et al. 2020). Requests for contraception from Nurx have
increased by fifty percent since the beginning of the COVID-19 pandemic (St-Esprit 2021).
Telecontraception serves as a potential avenue to help increase access to contraception and
sexual and reproductive healthcare services by alleviating obstacles related to geography, cost,
and time (Sundstrom et al. 2019; Weigel et al. 2019; Grindlay and Grossman 2016; Rodler et al.
2020; Jain and Mehrotra 2020). Research has demonstrated both family planning provider and
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patient support for telecontraception services (Stifani, Avila, and Levi 2021; Sundstrom et al.
2019). However, currently it is unknown whether telecontraception increases access for those
who face barriers or whether they provide convenience for those who already have access
(Dorland, Fowler, and Morain 2019; Zuniga et al. 2020).
Despite recent media coverage of telecontraception platforms (Rinker 2021; Shieber
2020; Landi 2020; Chuck 2017), research has not yet examined their impact on women in depth
or how women experience and evaluate these platforms. By examining how existing inequalities
shape contraception access and user evaluations of telecontraception platforms, this research can
inform both virtual and in-person healthcare systems. Telemedicine can save time, money, and is
linked with high patient and provider satisfaction (Hanson et al. 2019), yet it not known whether
these same findings carry over to telecontraception. Users may have positive or negative
evaluations of telecontraception, and uptake of these platforms may be patterned by existing
systemic disparities such as socioeconomic status. Highlighting user perspectives and
evaluations of telecontraception platforms can uncover reasons for using the platform, delineate
the pros and cons of using the platforms, and illuminate needs gaps in the traditional in-person
healthcare system.
Informed by the ecosocial model of health (Krieger 1994; Krieger 2001), this dissertation
examines the multiple, overlapping processes at work in reproductive healthcare and
telecontraception ranging from individual attitudes to state-level conditions. The research design
uses mixed methods to investigate both micro and macro factors shaping reproductive healthcare
access, affordability, and equity with an emphasis on priority populations such as racial and
ethnic minority and uninsured women. Using national population analyses, state-level data, and
user reviews, I map the state of reproductive health care for a national aggregate sample of
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women as well as subsets of women such as priority populations and telecontraception platform
users. Together, these findings provide a more comprehensive view of the current landscape and
highlight opportunities for improved service delivery in both virtual and in-person healthcare
spaces. This dissertation has three aims and is structured sequentially according to these aims.
Aim #1: The Current Landscape of Reproductive Healthcare
The goal of the first aim is to better understand sources of reproductive healthcare access,
affordability, and equitability issues. This section of the dissertation aims to provide a picture of
the current landscape of reproductive healthcare services, paying particular attention to
subgroups of women such as racial and ethnic minority women, uninsured women, low-income
women, and women living in metro versus nonmetro areas. Over ten percent of women in the
United States are uninsured, and there are still significant racial and ethnic disparities in
insurance coverage despite passage of the Affordable Care Act (Kaiser Family Foundation 2021;
Shane and Ayyagari 2014; Breslau et al. 2018; Smith and Medalia 2014; O’Hara and Brault
2013). This analysis builds on previous research by simultaneously examining multiple aspects
of reproductive health such as individual attitudes, interpersonal influences, and institutional
policy factors post-Affordable Care Act for key subgroups using a national survey of women.
Doing so allows for a more in-depth look into the factors behind reproductive healthcare
disparities and whether different levels (individual, interpersonal, institutional) matter more than
others to identify areas and opportunities for improvement.
Aim #2: Understanding State-Level Variation in Telecontraception Access
The second aim investigates the state-level conditions that pattern accessibility and
availability of telecontraception platforms across the United States. Although telecontraception
platforms claim to provide contraception and sexual and reproductive healthcare services directly

3

to patients, policy and legislation can affect the reach of telecontraception across states by
dictating a platform’s ability to prescribe and/or dispense medications. Therefore, patients may
not be able to access these services if their state has not granted telecontraception platforms the
prescribing and dispensing authority. Recent research mapping out telecontraception platform
characteristics has identified differences in cost, age requirements, and state availability across
platforms (Zuniga et al. 2020; Dorland, Fowler, and Morain 2019). However, it is unknown what
affects these different factors. The political, economic, or social conditions within a state can all
interact to impact telecontraception platform availability. Using an original dataset constructed
from public-use websites, these analyses identify specific combinations of state-level conditions
that pattern access and availability of telecontraception platforms across the United States and
illustrate the social shaping of technological innovations.
Aim #3: Understanding the Experiences of Telecontraception Users
The goal of Aim #3 is to illuminate user evaluations of telecontraception platforms to
gain access to contraception and sexual and reproductive healthcare services. Doing so allows for
an on-the-ground perspective of what women experience accessing contraception and
reproductive healthcare services both in the virtual and in-person healthcare spheres. Research
examining user motivations, experiences, and evaluations of telecontraception platforms is
lacking. While there has been research on health and wellness app users as well as informational
reproductive health app users (Carroll et al. 2017; Whitfield, Welti, and Manlove 2019; Gressel
et al. 2014; Akinola et al. 2019), little research exists on telecontraception platform users and
research on their experiences using these platforms. Knowing more about how women
experience and evaluate these platforms is important to delineating what telecontraception is
adding to the landscape of reproductive healthcare services, specifically whether and how it is
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addressing existing barriers to obtain contraception and other sexual and reproductive health
services. This is important because it can identify areas where telecontraception may be helping
women as well as areas for improvement, and this knowledge can be used to improve both
virtual and traditional in-person healthcare spaces. This section of the dissertation aims to
address this knowledge gap by analyzing publicly available user reviews for two major
telecontraception platforms, Nurx and Planned Parenthood Direct, which represent opposites in
terms of size, development stage, and user orientation. Findings from this qualitative analysis
illustrate that telecontraception addresses many barriers present in the traditional healthcare
system by providing timely access to contraception and connecting patients with on-demand
access to supportive, knowledgeable providers and information about birth control options.
Support and gratitude for the idea of telecontraception and its services uncover a long-standing
need for these types of services for women. Findings also demonstrate that while users share
similar motivations for accessing telecontraception platforms, their experiences can differ
depending on existing systemic issues such as cost and insurance.
Dissertation Significance and Impact
More informed understandings of reproductive healthcare accessibility, affordability, and
equitability on the individual, state, and national levels will allow for more nuanced, targeted
refinement of reproductive healthcare service delivery and policy. This can provide more
openings for intervention and improvement of reproductive health care for all women across the
United States. Providing a current snapshot of telecontraception, an emerging area of
telemedicine, and the specific factors patterning its availability and impacting user experiences
can also inform and improve broader telehealth measures, interventions, and policy.
Telecontraception platforms are a rapidly growing area of telemedicine that have the potential to
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improve access, affordability, and equitability of reproductive healthcare. While research is
beginning to examine these platforms (Zuniga et al. 2020; Dorland, Fowler, and Morain 2019),
this study is the first to assess the accessibility, affordability, and equity of these innovative
platforms and their impact on women and healthcare in depth.
Findings from this dissertation demonstrate multiple, overlapping influences on
contraception access and how these influences are patterned by existing social, economic, and
political conditions. Health apps and telemedicine are growing in numbers and demand (Lupton
2018; Carroll et al. 2017; Payne et al. 2015). As these new platforms enter our world, new
research will be needed to analyze how they shape and are shaped by current institutions. This
dissertation answers this call by examining the specific case of telecontraception. Technological
innovations operate within specific contexts, so research is needed to illuminate how emerging
technologies such as telecontraception impact, and are impacted by, society. Using a sociological
lens to examine these technological innovations allows for a more holistic way of investigating
their accessibility and delivery because it encompasses the broader social, economic, and
political conditions and context from which these platforms are born and in which they operate.
This dissertation analyzes the promises and pitfalls of telecontraception platforms, illuminating
areas for improvement in both the virtual and traditional in-person healthcare systems. Findings
can help inform legislators, policymakers, stakeholders, researchers, and health practitioners
involved with reproductive healthcare and telemedicine, as well as those focused on
understanding how emerging technological innovation and change both shapes and is shaped by
society.
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AIM #1: Individual, Interpersonal, or Institutional Influences? Using Ecosocial Theory to
Examine Disparities in Women’s Healthcare Visits
Just over one in ten, or 11.1 million women, in the United States did not have insurance
in 2019 (Kaiser Family Foundation 2021). Although the Affordable Care Act (ACA) has
increased insurance coverage rates, disparities persist by race and ethnicity (Shane and Ayyagari
2014; Breslau et al. 2018; Smith and Medalia 2014; O’Hara and Brault 2013). Insurance
coverage carries implications for health outcomes and disparities, especially for women’s access
to reproductive healthcare visits. Previous research indicates that healthcare visits are a critical
element contributing to health (Antonisse et al. 2018; Collins et al. 2016; Baicker et al. 2013),
and quality of women’s health care visits can vary by insurance type (Ranji, Gomez, and
Salganicoff 2019). Despite the vast amount of literature demonstrating racial/ethnic and
socioeconomic disparities in unintended pregnancy (Kim et al. 2016; Finer and Zolna 2016), less
is known about the specific factors which contribute towards broader disparities in women’s
reproductive health, specifically their access to office visits.
Moreover, influences at multiple levels, from attitudes to policy, can affect women’s
access and experiences of reproductive healthcare. Recent research using the social ecological
model (SEM) to investigate factors associated with unintended pregnancy found that
intrapersonal, interpersonal, institutional, and policy factors all contributed to racial and ethnic
disparities in unintended pregnancy (Kim et al. 2016). In addition to cost and access issues,
research on rural reproductive health disparities point to other barriers such as generational
habits and attitudes toward health (Smith, Sundstrom, and DeMaria 2019), illustrating that
interpersonal influences and individual attitudes may also play a role in health disparities.
Higher numbers of low-income women, immigrant women, and women of color are
uninsured compared to white women (Kaiser Family Foundation 2021; Eliason 2019). What
11

implications does this have for reproductive health disparities? While previous research has
examined reproductive healthcare access and affordability before and after ACA (Finer,
Sonfield, and Jones 2014; Sonfield et al. 2015), less is known about reproductive healthcare
services post-ACA for key population subgroups, such as race/ethnicity, income, and insurance
status, and the specific factors which influence women’s reproductive healthcare experiences and
visits. Recent studies have begun to look into this: Eliason (2019) compared the use of sexual
and reproductive health services before and after ACA, and Hammond (2019) examined
contraception access by subgroup post-ACA. In addition to access and affordability, women’s
feelings and attitudes toward contraception and pregnancy are an integral part of reproductive
healthcare, since they can drive behavior (Jones 2017). More research is needed on which factors
drive reproductive healthcare visits and whether different levels (individual, interpersonal,
institutional) matter more than others so that healthcare providers, professionals, and
policymakers can better serve the reproductive healthcare needs of all women.
This study builds on previous research by simultaneously examining multiple factors of
reproductive health, such as individual attitudes, interpersonal variables, and institutional policy
factors, post-ACA for key population subgroups using a national survey of women. Moreover,
data for this study allows us to go beyond insurance coverage to investigate multiple
reproductive healthcare factors, from individual to policy, and how they are patterned across
women. Examining the state of in-person reproductive healthcare services for different
populations of women can illuminate the accessibility and equitability of reproductive healthcare
services as well as individual attitudes and feelings toward pregnancy and contraception,
providing a more in-depth look into the factors behind reproductive healthcare disparities. Doing
so can help inform researchers, policymakers, and stakeholders about the factors driving
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women’s reproductive healthcare visits, allowing for more nuanced, targeted refinement of
public messaging and education, medical protocols, and reproductive healthcare policy.
LITERATURE REVIEW
Women’s Healthcare Visits: An Overview
The Affordable Care Act expanded coverage of preventative healthcare services for
women, such as cancer and mental health screenings, prenatal care, and contraceptive method
counseling (Health Resources & Services Administration 2019). However, research focused on
access to sexual and reproductive health service visits shows that increased access under ACA
only tells part of the story. Eliason (2019) looked at racial and ethnic differences in making a
sexual or reproductive healthcare visit before and after the dependent care provision of the ACA
was passed, which allowed young people to stay on a parent’s health insurance plan until their
26th birthday. The young adult population under the age of 26 is disproportionately non-white in
the United States (Schaeffer 2019), meaning that this provision of the ACA has the potential to
address racial disparities. Although lacking health insurance coverage decreased during this time
period, utilization of sexual and reproductive health services did not change for non-Hispanic
black women and non-Hispanic white women (Eliason 2019). However, there was an increase in
receiving birth control methods or prescriptions for Hispanic women before and after this
provision (Eliason 2019). Another study found that although rates of uninsured women declined
post-ACA, they did not change for Latinas, either U.S.-born or foreign-born (Jones and Sonfield
2016).
Taken together, the above research illustrates how making a women’s healthcare visit can
vary depending on many factors ranging from attitudes to access. Research shows that
preventative healthcare visits are a critical point of contact that influences healthcare disparities
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(Antonisse et al. 2018; Collins et al. 2016; Baicker et al. 2013; Benard et al. 2014). More
research is needed to untangle what drives making a visit and whether certain factors matter
more than others. Moreover, the type of visit may also matter if there are different influences at
play depending on the type of healthcare visit, such as whether it is a preventative visit or a
sexual health visit.
Ecosocial Model of Health Theory
Nancy Krieger’s (1994) ecosocial framework posits a theory of health that recognizes the
dynamic, intertwined nature of individuals and societal structures (Krieger 2014). This theory
seeks to explain patterns of health disparities by illustrating particular time-period and contextspecific combinations of norms, social structures, policies, institutions, and individual agency as
well as the dynamic interrelationships among them. It seeks to move beyond biological causes of
health by incorporating social explanations to provide a fuller picture of “‘who and what drives
current and changing patterns of social inequalities in health’” (Krieger 2001, p. 672). Central to
Krieger’s theory is the image of a “web” of pathways linking together at multiple levels, and the
individual as the embodiment of both their biological and social world; their lived experience
(Krieger 2014; Krieger 1994). Both biology and society structure the pathways of embodiment; it
is not one or the other because they are interlinked. This framework recognizes the dynamic,
multilevel, overlapping processes at work in health outcomes, challenging the separation
between an “exogenous” environment and a biological “organism” (Krieger 1994, p. 899). The
following review of the literature examines aspects of reproductive healthcare on multiple levels
(individual/intrapersonal, interpersonal and institutional), while recognizing that these levels are
fundamentally intertwined.
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Individual. One important component of the reproductive healthcare “web” of pathways
concerns individual attitudes, feelings, and knowledge about contraceptive use and pregnancy.
Pregnancy attitudes are often divided into two distinct dimensions: cognitive (intentions) and
affective (feelings) (Jones 2017). Cognitive attitudes towards pregnancy consist of an
individual’s intention to avoid pregnancy, while affective attitudes consist of an individual’s
feelings towards possible pregnancy (Jones 2017). Research has found that these are two
different concepts, and that cognitive attitudes are associated with consistent contraceptive use
more than affective attitudes (Jones 2017). Having a strong pregnancy avoidance attitude was
associated with ten times higher odds of using contraceptives consistently compared to those
who had a weak pregnancy avoidance attitude (Jones et al. 2015). Measures of pregnancy
attitudes can change over time, illustrating the need for longitudinal data (Vaisanen and Jones
2015). Knowledge of birth control is another factor in contraceptive use and behavior. Research
has found that misinformation and misperceptions about birth control, such as needing to take a
break from it or not getting pregnant after stopping a shot, affected contraception use (Kendall et
al. 2005; Reed et al. 2014). This misinformation can be particularly risky because it can result in
unintended pregnancy. Qualitative research has found that women using contraception
inconsistently or not at all had false beliefs about their likelihood of pregnancy, viewing
themselves as “safe” from pregnancy since they did not get pregnant after unprotected sex (Reed
et al. 2014).
Pregnancy attitudes and feelings can also differ by race/ethnicity, education, and age.
One study found that although cognitive attitudes toward pregnancy avoidance were not
associated with race/ethnicity, affective attitudes (feelings about experiencing an unplanned
pregnancy) were associated with race/ethnicity (Hayford and Guzzo 2013). Another study found
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that Hispanic women and white women were more likely to start trying to get pregnant than
other racial and ethnic groups, and higher-educated women had a higher likelihood of weaker
pregnancy avoidance attitudes (Vaisanen and Jones 2015). These findings illustrate how social
structures may impact individual attitudes, such as having more resources to support a
pregnancy. Age is also associated with differences in pregnancy avoidance attitudes. One study
found that attitudes changed more among older than younger (18 to 24 years) women (Vaisanen
and Jones 2015). Research has shown that teens prefer to go to family planning clinics for sexual
and reproductive health services (Oglesby 2014; Sugerman et al. 2000), regardless of insurance
status: approximately half of teens visiting a Planned Parenthood clinic had health insurance
(Sugerman et al. 2000). While cost and confidentiality were cited as important preferences in that
study, another study found that patients rated Planned Parenthood highly on additional
dimensions of care, such as ease of getting care and medical staff treatment (Oglesby 2014). On
the other hand, another study found that Latinas and black women preferred receiving
reproductive healthcare at a general health care site (Becker and Tsui 2008). Women’s
preferences for where to go may be based on the specific context of the facility in which they
receive their services. These findings indicate that preferences and attitudes at the individual
level do not exist in isolation but rather are shaped by interpersonal and community factors, such
as staff interaction with patients and facility type characteristics.
Interpersonal. Interactions between an individual and the people around them, and how
they exert a reciprocal influence upon one another, illustrate the interpersonal level of the
ecosocial theory (Rimer and Glanz 2005). Patient-provider communication is one example of
this reciprocal interaction, and there is an extensive literature devoted to this topic. Doctors and
patients influence one another through their interactions, and these interactions can influence
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health behavior and outcomes. Research on patient-provider communication during reproductive
and sexual health visits illustrate how these interactions can result in different outcomes based on
patient characteristics such as sexual orientation (Agénor et al. 2015; Everett et al. 2019) or
gender (Emmers-Sommer et al. 2009). Ashton et al. (2003) argue that racial/ethnic health
disparities occur as a result of doctor-patient interactions rather than obtaining access to a doctor.
Poor communication is posited as the main driver behind racial/ethnic health disparities, more so
than provider racial bias or patient preferences, and the authors provide suggestions for how this
can be remedied (Ashton et al. 2003).
Research on racial and ethnic disparities in reproductive healthcare specifically has
uncovered differences in service delivery preferences and service quality perceptions among
black, Latina, and white women (Becker and Tsui 2008). Preferences and perceptions do not
exist in a vacuum but are shaped by individual, interpersonal, and institutional factors. Historical
abuses and systemic control, surveillance, and sterilization of women of color (Roberts 1999;
Salas 2019) may impact their trust and experiences of reproductive healthcare interactions.
Research has found that blacks were more likely than whites to report pressure to use
contraceptives by a provider (Becker and Tsui 2008), pressure that can be implicit such as
through provider tone of voice or imbalanced information favoring certain methods (Gomez and
Wapman 2017). Other research did not find differences in contraceptive counseling by
race/ethnicity and socioeconomic status of the patient but found that providers largely did not
assess patient pregnancy intention, birth control preferences, or allow patients an opportunity to
ask questions (Dehlendorf et al. 2017). Educational, interactive decision tools for patients to
choose birth control and a printout given to the provider about their preferences prior to a
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healthcare visit have been effective in patient-provider communication by allowing patient
concerns and preferences to enter the discussion (Holt et al. 2020).
Patient-provider interactions can influence patient behavior such as contraceptive use and
pregnancy planning. One study found that contraceptive use was associated with the quality of
care from a family planning service provider, with higher predicted probabilities of contraceptive
use increasing as the quality of care increased from low, to medium, to high (RamaRao et al.
2003). Having a women’s health care visit is linked with consistent contraceptive use (Jones et
al. 2015). Another study found that women were less uncertain about their current plan to have a
(another) baby if they discussed it with a healthcare provider in the last six months (Jones 2017).
Taken together, the research on patient-provider interaction illustrates an important aspect of the
ecosocial theory: interactions between women and their doctors can influence feelings and
behaviors, and thus health outcomes.
Other interactions and relationships in a woman’s life can also influence contraceptive
use. Research on African American mother-daughter relationships illustrated that motherdaughter closeness and communication influenced reproductive health care and behavior, with
more open communication between mothers and daughters facilitating better communication
between daughters and their health care providers (Warren-Jeanpiere 2006). Relationship status
and satisfaction has also been linked with sexual health behavior. Relationship status and past
use of contraception was significantly associated with contraception use intention (Campo et al.
2012). Choice of method also differed depending on relationship status, with condoms associated
with short-term relationships and hormonal methods used during longer-term relationships (Reed
et al. 2014). Interestingly, while communication with a sexual partner was positively associated
with contraceptive use intention, talking with friends was negatively associated with intention to
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use birth control (Campo et al. 2012). Many different relationships and interactions can thus
influence women’s health behavior and outcomes, ranging from mothers, to friends, to sexual
partners.
Institutional and Policy. Larger systematic and policy changes can also affect health
behavior and outcomes. Insurance coverage and type of health insurance (for example, public or
private) is a key factor associated with health outcomes. Women who are uninsured or have
Medicaid insurance have more advanced breast cancer when diagnosed compared to privately
insured women and also had higher risk of death and worse survival outcomes (Ayanian et al.
1993), particularly for black and Hispanic women (Halpern et al. 2007). Lacking health
insurance or having fee-for-service insurance was associated with lack of breast, colorectal, and
cervical cancer screening (Hsia et al. 2000; Garfield, Orgera, Damico 2019). One explanation is
that uninsured individuals do not have a regular place to go to for medical care (Garfield, Orgera,
Damico 2019; Hsia et al. 2000). A recent Kaiser Family Foundation report found that 50 percent
of uninsured individuals did not have a usual source of care, compared to just 11 percent of
employer or privately insured individuals (Garfield, Orgera, Damico 2019). Expanding coverage
to the uninsured can result in improved healthcare access and outcomes. An enormous body of
research on Medicaid expansion under ACA (see Antonisse et al. 2018) illustrates how gaining
coverage is associated with a myriad of improved outcomes, such as receipt of preventive care
services (Baicker et al. 2013), contraceptive prescriptions (Ghosh, Simon, and Sommers 2017),
improved access to doctor visits and prescriptions (Collins et al. 2016), decreased probability of
positive depression screening (Baicker et al. 2013), and better physical and mental self-reported
health compared to a control group which did not receive the expanded Medicaid access
(Finkelstein et al. 2011).
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Insurance status carries important consequences for reproductive healthcare costs. While
preventive screenings and care are now covered under the ACA, racial and ethnic disparities
persist in insurance coverage rates (Shane and Ayyagari 2014; Breslau et al. 2018; O’Hara and
Brault 2013) as well as sexual and reproductive health services uptake (Hall, Moreau, and
Trussell 2012; Eliason 2019). Higher numbers of low-income women, immigrant women, and
women of color are uninsured compared to white women (KFF 2021; Eliason 2019). Another
study found that Medicaid expansion and subsidized marketplace coverage under the ACA
starting in 2014 decreased the percentage of uninsured women in states that expanded Medicaid,
but not for women in states that opted out nor for U.S. and foreign-born Latinas (Jones and
Sonfield 2016). Taken together, this research illustrates that policy matters both for health
outcomes and disparities. Breslau et al. (2018) argues that these findings illustrate how
researchers need to look at both current and historical causes for these disparities and that health
equity cannot simply be achieved through policy, such as ACA. This illustrates the importance of
looking at multiple levels, such as individual attitudes, patient-provider interactions, and
institutional policy factors, because this may illuminate whether some levels impact healthcare
disparities more than others.
Significance
As this literature review shows, research on health outcomes and disparities occurs on the
individual, interpersonal, and institutional levels. Do all levels matter equally for all types of
women, or are some levels more important than others? This study builds on previous work by
simultaneously examining reproductive healthcare access, affordability, and attitudes post-ACA
for important population subgroups using a national survey of women to better understand the
relative importance of these different factors (see Figure 1). Specifically, this study looks at
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individual, interpersonal, and institutional influences on making a birth control visit and a
preventative reproductive healthcare visit using the 2012-2014 Continuity and Change in
Contraceptive Use Study (CCCU), a national survey of 4,634 women between the ages of 18 and
39 containing questions surrounding reproductive health attitudes, access, and affordability
(Jones 2018).

Figure 1. Ecosocial Model of Health: Individual, Interpersonal, and Institutional Influences
Previous research has used the CCCU to examine out-of-pocket contraceptive costs for
privately insured women before and after the ACA (Finer, Sonfield, and Jones 2014; Sonfield et
al. 2015), reproductive health access by demographic subgroups at Wave 2 in spring 2013
(Hammond 2019), as well as contraceptive use, methods, and attitudes (Jones et al. 2015;
Vaisanen and Jones 2015; Jones 2017; Jones 2017; Jones 2018; Jones, Lindberg, and Higgins
2014; Lindberg, Jones, and Higgins 2014). Using the most recent wave of the CCCU (Wave 4,
conducted in spring 2014) provides a national picture of reproductive healthcare across groups,
allowing for a glimpse into both individual and policy factors that affect reproductive healthcare
access and affordability. Moreover, previous research conducted by Jones and Sonfield (2016)
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using the CCCU examined whether insurance coverage expanded for women living in states that
expanded Medicaid under ACA. This study builds on this research by looking in greater detail at
the breakdown of subgroups living in these states and whether women living in these states made
a visit for reproductive healthcare due to this expansion. This study also addresses a gap in the
literature raised by Hammond (2019) by looking at access and attitudes for women with
Medicaid insurance and uninsured women.
METHODS
Sample
Data for this project comes from the 2012-2014 Continuity and Change in Contraceptive
Use Study (CCCU), a national survey of 4,634 women between the ages of 18 and 39 containing
questions surrounding reproductive health attitudes, access, and affordability (Jones 2018). The
CCCU administered four waves of online surveys to the sample every six months. Wave 1 of the
study had a response rate of 59% (N=4,634). Retention rates for Waves 2 through 4 were 69%
(N=3,207), 75% (N=2,398), and 77% (N=1,842), respectively. The survey contains measures
about reproductive access, affordability, and attitudes on a national level and allows for analyses
by key subgroup, such as race/ethnicity, socioeconomic status, and insurance status. Moreover,
this study uses data from 2014 (Wave 4), a year in which additional policy changes led to some
states expanding Medicaid under ACA as well as the creation of the health insurance
marketplace. This study builds on previous literature by examining attitudes, interpersonal
variables, and access simultaneously in the same national sample of women to provide a
comprehensive understanding of reproductive healthcare access and experiences that can inform
health education and policy in this area. Informed by the ecosocial model of health theory
(Krieger 1994; Krieger 2001; Krieger 2014), the framework for this study recognizes the
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multilevel processes at work in reproductive healthcare access, affordability, and equity, from
individual attitudes to state and federal-level policies.
Analytic Sample. Data for this study comes from Wave 1 and Wave 4 of the CCCU
(N=1,842). Women were asked if they made a women’s health care visit for any of the following
three reasons in the last six months: visit for birth control or contraception, annual gyn visit or
pap smear, or other women’s health care (pregnancy-related care, STDs, breast or other exams).
A filter variable was created to assess whether a woman made a women’s health care (WHC)
visit for any of the three reasons in the last six months, or did not make any women’s health care
visit in the last six months. Out of the total 1,842 Wave 4 women, 1,020 (55.4%) made a WHC
visit while 797 (43.3%) did not. I exclude women who did not have a visit (N = 797) as well as
cases with missing data on any included variables (N = 63), resulting in a final analytic sample of
982 women.
Analyses of the 797 women who did not make any WHC visit in the last six months
illustrated that they were very similar in their demographic characteristics (race/ethnicity,
education, employment, marital status, living in a Medicaid expansion state) to those in the final
analytic sample, but had higher percentages of using a long-acting reversible contraceptive at the
last wave, not dating anyone, and were older. The main differences were that they had higher
percentages of not being insured (16.73%, compared to 6.31%) and not having a regular place to
go for medical care (29.54%, compared to 12.73%). While these are important differences, the
aim of this study is to look at individual, interpersonal, and institutional influences on making a
WHC visit, specifically the predictors of making a birth control visit and the predictors of
making an annual gynecological or pap smear visit. Since the 797 sample of women did not
make any WHC visit in the last six months, we cannot look at visit-specific variables, such as
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patient-provider communication or payment type, which may have influenced making a visit.
Therefore, we exclude these women because the goal is to uncover information about which
factors influence making a birth control visit as well as a preventative reproductive healthcare
visit.
Missing Data. Missing data accounted for 6.03 percent (N = 63) of the eligible sample.
Robustness checks were conducted to analyze findings with and without the missing data.
Although there is no formal rule for when to impute data, low rates of missing data ranging from
one to five percent generally do not require imputation models (Little et al. 2014; Social Science
Computing Cooperative 2013). Data analyses of the 63 cases with missing data did not indicate
concentration of missingness on one variable. The variable with the largest amount of missing
data was the birth control visit dependent variable, with 12 cases missing data on that variable.
However, since the amount of missing data was over five percent, multiple imputation was
conducted in Stata as a robustness check to compare results with listwise deletion results. While
there has been a long history of debate regarding imputing values on the dependent variable,
research has demonstrated that the values of the dependent variable can be used to give
information about the independent variables and the associations among all variables (not just
those associated with missing data) and therefore should be included in analyses (Young and
Johnson 2010; Allison 2000; Social Science Computing Cooperative 2015). Using imputed data
can result in less biased data than dropping all cases with missing data (Horton and Kleinman
2007). Findings using imputed data were similar to those using listwise deletion, so listwise
deletion results are presented. Additionally, findings comparing results excluding pregnant
women were compared to results including pregnant women since being pregnant could
influence whether a woman has made a visit for birth control in the last six months. Results are
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similar, so pregnant women are retained in all analyses. Supplementary analyses comparing
estimation samples are available in Appendix A.
Statistical Analyses
Quantitative data analyses are two-fold. First, cross-tabulations, chi-square tests, and oneway analysis of variance (ANOVA) tests were conducted to test for statistically significant
relationships between reproductive health variables and key subgroups of women (race and
ethnicity, socioeconomic status, and insurance status) in order to investigate which factors may
be influencing disparities in healthcare visits. Second, logistic regression models predicting two
different types of visits (birth control visit and women’s preventative reproductive healthcare
visit) were conducted to better understand which level(s) may be driving reproductive health
disparities. All statistical analyses were conducted in SPSS 25.0 (IBM Corp. 2017) and Stata IC
15.1 (StataCorp. 2017). This study was approved by the University of Wisconsin-Milwaukee
Institutional Review Board (IRB #20.339).
Measures
Dependent Variables. Reproductive healthcare visit type was measured using two
variables, one for a birth control or contraception visit and one for preventive services (annual
gynecological visit or pap smear). Despite the expansion of women’s healthcare services under
ACA, disparities in making a visit persist by race/ethnicity, age, and geographic location (Benard
et al. 2014; Shomo 2019; Nardi, Sandhu, and Selix 2016; Eliason 2019). To assess healthcare
utilization of preventive and sexual health services, respondents were asked “Did you make a
visit for any of the following medical services in the last 6 months?” with the option of
responding “yes” or “no” (Jones 2018). The two dependent variables of interest in this study are
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whether a respondent made a visit for “an annual gyn visit or pap smear” or “a visit for birth
control or contraception” in the last six months (Jones 2018).
Individual Attitudes, Knowledge, and Contraception Use. Cognitive attitude toward
pregnancy was used as a measure for pregnancy avoidance attitude, following previous research
(Jones et al. 2015; Jones 2017). Women were asked “How important is it to you to AVOID
becoming pregnant now?” and could respond on a six-point scale ranging from 1 “not at all
important” to 6 “very important” (Jones 2018). Birth control methods knowledge was asked
about at Wave 1 (“How much do you know about birth control methods?” (Jones 2018)) and
respondents could answer on a scale from 1 “I know nothing” to 6 “I know everything”.
Knowledge of birth control methods was treated as a continuous rather than categorical variable
in all analyses due to problems with small cell sizes when used in the logit analyses. Hormonal
contraception use utilized a recoded variable from GfK, the company that administered the
survey, indicating whether the respondent used the birth control pill at any of the previous survey
waves, as well as whether they used an implant or IUD at Wave 3 (six months prior to Wave 4).
Interpersonal Variables. Patient-provider communication was assessed using two
variables. Discussions with a healthcare provider about pregnancy intention was measured using
the question “At your last visit for women's health care, did a doctor or nurse spend time talking
with you about your future plans for having or not having children (or more children)?”
Contraceptive counseling was measured by using the question “At your last visit for women's
health care, did you get information about birth control and pregnancy prevention?” (Jones
2018). Although these questions cannot assess whether the respondent wanted to talk about these
subjects during their last women’s health care visit, they still provide valuable information on
whether providers actually discussed these topics with their patients and whether this differed by
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subgroup. Previous research did not find differences in contraceptive counseling by
race/ethnicity and socioeconomic status of the patient but found that providers largely did not
assess patient pregnancy intention or birth control preferences (Dehlendorf et al. 2017). The last
interpersonal variable is relationship status, since previous research demonstrated its link with
contraceptive method and use (Reed et al. 2014; Campo et al. 2012). Respondents were asked
whether they have been with their current partner for six months or longer, and response options
consisted of: “yes”, “no”, and “yes, though we have broken up and gotten back together during
that time” (Jones 2018). A fourth category was coded as “N/A, not in a relationship” if the
respondent was not currently dating someone on a regular basis.
Institutional Policy Factors. Having a regular place to go for medical care, living in a
state that expanded Medicaid as of December 2013, facility type, and payment method all
measure structural, systemic access to reproductive healthcare. Regular place for medical care
was measured using the question “Do you have a regular place you go to for medical care?” (yes
or no) (Jones 2018). Living in a state that expanded Medicaid was measured as a dichotomous
variables (yes or no), and was constructed using a list of states that expanded Medicaid as of
December 2013, the time period before Wave 4 of the CCCU was conducted in 2014. Facility
type was measured using responses to the question “Thinking about your last visit where you
received women’s health care, what type of place did you go to?” (Jones 2018). Responses
options consisted of: private doctor’s office or group practice; Planned Parenthood or other
family planning clinic; public health department or community health clinic; student health
clinic; or some other type of health care facility (Jones 2018). Responses for student health clinic
and some other type of health care facility were combined into one category due to low cell
count sizes. Payment method was measured by the question “How did you pay for your last
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women’s healthcare visit?” with possible responses of: paying some or all of the costs including
co-pays myself, insurance paying some or all of the costs, reduced fee, or free services (Jones
2018). Reduced fee and free services were combined into one category due to low cell count
sizes.
Key Subgroups. Important population subgroups of the national sample of women were
measured using three categorical variables: race and ethnicity, socioeconomic status, and
insurance status. Race and ethnicity consisted of five mutually exclusive response options: nonHispanic white women, non-Hispanic black women, non-Hispanic other women, non-Hispanic
multiracial (2 or more races) women, and Hispanic women. Socioeconomic status utilized a
recoded variable from GfK, the company that administered the survey, which calculated poverty
status based on household income and size. Household income and size were only asked about at
Wave 1 in 2012. Insurance status consisted of the following categories: private insurance,
Medicaid, marketplace, and uninsured.
Control Variables. Control variables include age, education (less than high school, high
school, some college no degree, associate’s degree, bachelor’s degree, master’s degree, or
professional or doctorate degree; master’s and professional and doctorate degree were combined
into one category due to low cell count sizes), employment status (full-time, part-time, or
unemployed), marital status (never married, living with partner, married, divorced, or separated;
divorced and separated were combined into one category due to low cell count sizes), and
nativity status (born in the U.S. or not). Nativity status is an important factor to include in health
disparities research because lumping together these two groups can obscure the findings (Krieger
2012). Analyses were run with age as both a continuous and categorical variable, and results
were statistically significant with either coding decision. In order to illuminate possible policy
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effects of the dependent care coverage provision and based on the histogram cutoffs, the
categorical coding of age was retained in analyses (18 to 26, 27 to 30, 31 to 36, and 37 to 39).
RESULTS
Overall Sample Characteristics
Table 1 illustrates descriptive statistics for all study variables. Approximately half of
women made a visit for birth control while over 75% of women made a visit for an annual
gynecological visit. Just over 45 percent of women indicated that it is very important to avoid
becoming pregnant now, and most of the sample indicated moderately high knowledge of birth
control methods. Past use of the pill was the most popular method, with smaller percentages for
long-acting reversible contraceptives. For those who made a WHC visit in the last six months,
just under half (49%) said their doctor talked to them about their plans for children and 41% got
information about birth control and pregnancy prevention. Nearly 82% had been with a partner
for six months or longer, and just over 10% were not currently dating anyone. The majority of
the sample (83%) went to a private doctor’s office or group practice for their last WHC visit, and
nearly 75% used insurance to pay for some or all of the costs of the visit. Just over 87% had a
regular place for medical care and 65% lived in a state that expanded Medicaid under ACA.
Regarding the key subgroups, over two-thirds of the sample (69%) was non-Hispanic
white and 65% were at 200% or above the federal poverty level. Just over 15% of the sample
was below the federal poverty level. Approximately 72% had private health insurance, 16% had
Medicaid insurance, 6% had marketplace insurance, and just over 6% were uninsured. Almost
half (49%) were married, 35% had a bachelor’s degree, and 55% were employed full-time.
Almost a third (32%) were unemployed. Approximately 10% were foreign-born and 40% were
in the age group of 18 to 26 years old, with an overall mean age of 29 years.
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Comparing the sample characteristics to 2014-2018 U.S. Census Data on females 16
years and older, black or African American respondents are underrepresented in our sample (9%
of our sample, versus national estimate of 13%) as well as white respondents, who represent 69%
of our sample versus a national estimate of 76% (United States Census Bureau N.d.). The sample
also has slightly higher levels of education, with 35 percent of the sample having a bachelor’s
degree compared to 32% of women age 25 years and older (U.S. Census Bureau N.d.). Foreignborn women represent nearly 10 percent of our sample compared to national estimates of 14%
(U.S. Census Bureau N.d.).
Individual, Interpersonal, and Institutional Reproductive Health Variables by Key Subgroup
Individual Attitudes, Knowledge, and Contraception Use. Table 2 shows individual
attitudes, knowledge, and contraception use by key subgroup. The majority of women both
within and across all key subgroups reported a strong pregnancy avoidance attitude, with no
statistically significant difference among the subgroups. Knowledge of birth control methods
differed significantly only among socioeconomic status, although when looking at pairwise
comparisons of these means none of the comparisons were statistically significant. The average
score for birth control methods knowledge was 4.30 for those at 200% or above the federal
poverty level, compared to 4.16 for those below the federal poverty level.
Hormonal contraception use also differed significantly by key subgroup. There were
significant racial and ethnic differences in past use of the pill and long-acting reversible
contraceptive (LARC; either an implant or IUD). Over half of non-Hispanic white women had
used the pill, compared to 36 percent of Hispanic women. Use of a LARC method was highest
among Hispanic and multiracial women, and lowest among black and other race women. There
were also significant differences in past use of the pill (but not LARC) by socioeconomic status
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and insurance type. Higher proportions of high-SES women had used the pill compared to lower
SES women. Women with Medicaid insurance had the lowest proportions of past pill use
compared to all other insurance types, and privately insured women had the highest proportion of
past pill use. Hispanic women reported the highest percentages of past LARC use (17%).
Approximately 10% of women in all socioeconomic groups had used a LARC method in the
past. Past LARC use was highest for women with private insurance (11%), and lowest for those
without insurance (6%).
Interpersonal Variables. Discussions between a patient and provider about future plans
for children did not differ significantly by race/ethnicity, socioeconomic status, or insurance
status (see Table 3). Approximately half of women reported that their doctor or nurse spent time
talking with them about their future plans for having or not having children (or more children)
during their last women’s health care visit, with other race, low-income, and uninsured women
reporting lower rates. On the other hand, contraceptive counseling differed significantly by
socioeconomic status and insurance status. As socioeconomic status increased, the percentage of
women responding that they got information about birth control and pregnancy prevention
decreased. Higher percentages of uninsured women and women with marketplace insurance
reported receiving birth control and pregnancy prevention information compared to women with
Medicaid or private insurance. The majority of women had been with the same partner for six
months or longer, although relationship status differed significantly by subgroup. Over 80
percent of white, Hispanic, and other race/ethnicity women reported being with the same partner
for six months or longer uninterrupted. Non-Hispanic black and multiracial women reported the
largest percentages of not dating anyone or breaking up and getting back together with their
partner in the last six months. The percentage of women reporting being with a partner for six
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months or longer was higher for higher-SES women compared to low-SES women. Women with
private insurance and uninsured women reported the highest proportions of being with a partner
for six months or longer.
Institutional Policy Factors. There were significant differences by subgroup for nearly all
the systemic access variables (see Table 4). Hispanic women had the highest rates of being
uninsured (18%), compared to all other racial groups which had single-digit rates of no
insurance. Rates of private insurance increased as socioeconomic status increased. Low-SES
women reported higher proportions of not having a regular place to go for medical care
compared to high-SES women. Uninsured women had three to four times the rate of not having a
regular place to go for medical care compared to all other insurance types. For those women who
did make a women’s health care visit in the last six months, there were significant differences in
facility type by race, socioeconomic status, and insurance type. While most women went to a
private doctor’s office or group practice (with the exception of uninsured women), these
proportions were highest for white, high-SES, and privately insured women. Just over one in ten
black women and one in ten Hispanic women went to Planned Parenthood for their last women’s
health care visit. The proportion of women going to Planned Parenthood or a public health
department or community health clinic were highest among low-SES women. Nearly one in four
women with marketplace insurance went to Planned Parenthood or another family planning
clinic, compared to 2% of privately insured women.
Most women made a women’s healthcare visit, with higher percentages of an annual
gynecological visit compared to a visit for birth control or contraception, although none of the
differences were statistically significant by subgroup. Women’s healthcare visit payment differed
significantly by race, socioeconomic status, and insurance type. Approximately one in five non-
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Hispanic black, non-Hispanic other, and Hispanic women received free or reduced fee services,
compared to 8% of non-Hispanic white and multiracial women. One in four low-income women,
and nearly half of uninsured women received free or reduced fee services. Most women (with the
exception of uninsured women1) paid for their women’s health care visit with insurance. Just
over 35 percent of uninsured women paid for the visit themselves, compared to approximately 14
percent of privately insured and marketplace-insured women. The majority of women lived in a
state that expanded Medicaid under ACA, with the exception of non-Hispanic black women.
Uninsured women reported the lowest proportions of living in a state that expanded Medicaid
under ACA compared to all other insurance types.
Predictors of Making a Visit for Birth Control or Contraception
Overall Model Fit. Table 5 contains the results of four nested logistic regression models
examining individual, interpersonal, and institutional policy factors influencing making a visit
for birth control or contraception in the last six months. Likelihood ratio tests comparing model
fit indicated that each subsequent model was better fitting than the previous model in which it
was nested (Model 2 was a better fit than Model 1, Model 3 was a better fit than Model 2),
except when comparing Model 3 and Model 4. The likelihood ratio test favored Model 3 over
Model 4, which indicates that adding additional variables did not significantly improve the
model fit. This could be due to statistically significant correlations between insurance status and
three out of the four institutional policy variables (facility type, visit payment, and regular place
for medical care). However, the pairwise correlation coefficients between insurance status and
each institutional policy variable ranged from 0.03 to 0.27, indicating that these correlations were

1

Another survey question asked whether a respondent had insurance during any of the last six months, and 15
uninsured women responded “yes”. So the 10 uninsured women in Table 4 who used insurance to pay for their last
women’s healthcare visit most likely had insurance at the time of the visit (within the last six months).

33

small. Overall, summary goodness-of-fit statistics give an overall picture of model fit but cannot
provide information about model components (Hosmer and Lemeshow 2000). While results of
the likelihood ratio tests indicate that Model 4 does not provide a significantly improved fit
compared to Model 3, the reason for this finding is most likely not due to collinearity issues
between insurance status and institutional policy variables.
Birth Control Visit: Model 1. Results shown in Model 1 (health disparities model)
indicate that insurance status had a significant influence on making a visit for birth control or
contraception. Women with Medicaid insurance had lower odds of making a birth control visit
compared to women with private insurance (OR=.55; p<.05). Compared to privately insured
women, the odds of making a birth control visit are reduced by 45% for women with Medicaid
insurance.
Birth Control Visit: Model 2. Model 2 adds individual pregnancy attitudes, knowledge,
and contraception use to the base model. Results show that stronger pregnancy avoidance
attitudes were significantly associated with greater odds of making a visit for birth control
compared to those with weaker pregnancy avoidance attitudes. Women who indicated that it is
very important for them to avoid pregnancy right now had 6.22 higher odds of making a birth
control visit compared to women who responded that it was not at all important for them to avoid
pregnancy right now (p<.001). Knowledge of birth control methods did not have a statistically
significant influence on making a birth control visit. Past use of the pill was significantly
associated with higher odds (OR=5.71; p<.001) of making a visit for birth control compared to
those who did not use the pill in the past, controlling for other variables. Using a LARC method
at the last survey wave did not have a significant effect on making a birth control visit in the last
six months.
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Birth Control Visit: Model 3. Adding in the interpersonal variables, the odds of making a
visit for birth control were over three times larger (OR=3.87) for women who got information
about birth control and pregnancy prevention during their last visit, compared to those who did
not get this information during their last visit (p<.001). Women who were not dating anyone on a
regular basis had lower odds of making a visit for birth control compared to women who had
been with their partner for six months or longer (OR=.41; p<.01). Compared to women who had
been with a partner for six months or longer, the odds of making a birth control visit were
reduced by 59% for women who were not dating anyone.
Birth Control Visit: Model 4. Adding in the institutional policy factors, women who went
to Planned Parenthood or another family planning clinic for a women’s health care visit in the
last six months had 2.71 higher odds of making a visit for birth control compared to those who
went to a private doctor for a women’s health care visit (p<.05). Visit payment method, having a
regular place to go for medical care, and living in a state that expanded Medicaid under ACA did
not have a significant effect on making a birth control visit, controlling for other variables.
Uninsured women had lower odds of making a visit for birth control compared to privately
insured women (OR=.32; p<.01). Compared to privately insured women, the odds of making a
birth control visit were reduced by 68% for uninsured women. Age had a significant impact on
making a birth control visit in all four models, with higher odds for younger women compared to
older women.
Predictors of Making an Annual Gynecological or Pap Smear Visit
Overall Model Fit. Table 6 contains the results of four nested logistic regression models
examining individual, interpersonal, and institutional policy factors influencing making an
annual gynecological or pap smear visit in the last six months. Likelihood ratio tests yielded
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mixed findings regarding model fit. Overall, the likelihood ratio tests favored the fuller models
with one exception. Results of likelihood ratio tests indicated that adding individual attitudes,
knowledge, and contraception use variables (Model 2) significantly improved model fit
compared to the base model (Model 1). However, adding interpersonal variables (Model 3) did
not significantly improve the model fit compared to Model 2. Adding in institutional policy
factors in Model 4 significantly improved model fit compared to Model 3.
Annual Gynecological Visit: Model 1. In Model 1 on Table 6, the base health disparities
model, there were significant subgroup differences by race. Non-Hispanic black women had two
times higher odds of making an annual gynecological visit compared to white women,
controlling for other variables (OR=2.01; p<.05). There were no statistically significant
differences in making an annual gynecological visit by socioeconomic status or insurance status.
Annual Gynecological Visit: Model 2. Adding in individual pregnancy attitudes,
knowledge, and contraception use in Model 2, women with strong pregnancy avoidance attitudes
had lower odds of making an annual gynecological visit compared to those with weaker
pregnancy avoidance attitudes. Compared to women with weaker pregnancy avoidance attitudes,
the odds of making an annual gynecological visit were reduced by 54% for women with strong
pregnancy avoidance attitudes (OR=.46; p<.05). Knowledge of birth control methods and past
use of the pill did not have a significant influence on making an annual gynecological visit,
controlling for other variables. The odds of making an annual gynecological visit were nearly
twice as high for women who had used a LARC method at the last wave, compared to women
who did not (OR=1.86; p<.05). Model 2 also illustrates that race remains significant.
Annual Gynecological Visit: Model 3. Model 3 on Table 6 adds in interpersonal variables
and demonstrates that women whose doctor or nurse talked about future plans for children at
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their last women’s health care visit had 1.50 higher odds of making an annual gynecological visit
compared to women whose doctors did not discuss this with them (p<.05). Contraceptive
counseling and relationship status did not have a significant effect on making an annual
gynecological visit.
Annual Gynecological Visit: Model 4. Looking at the full model (Model 4), the patterns
are similar to Model 3 but facility type has a statistically significant effect on the odds of making
an annual gynecological visit. Women who went to Planned Parenthood or another family
planning clinic, or a student health clinic/some other type of health care facility in the last six
months for a women’s health care visit had lower odds of making an annual gynecological visit
compared to those who went to a private doctor’s office. Compared to women who went to a
private doctor’s office for their last women’s healthcare visit, the odds of making an annual
gynecological visit were reduced by 71% for women who went to Planned Parenthood or another
family planning clinic for their last women’s healthcare visit (OR=.29; p<.001). The odds of
making an annual gynecological visit were reduced by 56% for women who went to a student
health clinic or some other type of healthcare facility for their last WHC visit, compared to those
who went to a private doctor’s office (OR=.44; p<.05).
Visit payment method, having a regular place to go for medical care, and living in a
Medicaid expansion state did not have a significant effect on the odds of making an annual
gynecological visit, controlling for other variables. However, race and insurance status did have
a significant effect on making an annual gynecological visit in Model 4. Non-Hispanic black
women had 2.44 higher odds of making an annual gynecological visit compared to non-Hispanic
white women (p<.05). Women with marketplace insurance had 2.43 higher odds of making an
annual gynecological visit compared to women with private insurance (p<.05). Age also had a
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significant effect on making an annual gynecological visit in all four models, with younger
women having significantly lower odds of making a visit compared to older women.
DISCUSSION
This study utilized a nationwide survey of women to examine reproductive healthcare by
incorporating information about individual attitudes, interpersonal variables, and institutional
policy structures to provide a more holistic view on which elements are most or least influential
in making a women’s reproductive healthcare visit. Previous research has investigated these
issues separately, but this study looks at all these factors together and for key subgroups. Results
indicate that while some aspects are shared by all women, such as the majority of women having
strong pregnancy avoidance attitudes regardless of subgroup, there are other significant
differences patterned by systemic access factors such as race and ethnicity, insurance, and
socioeconomic status. These findings illustrate the importance of examining reproductive
healthcare both on an aggregate and subgroup level, because they may yield opposite findings. It
also demonstrates how focusing solely on individual attitudes or institutional factors can tell
different stories, so examining all three levels is important. As the literature review
demonstrated, law and policy may not play out the same for all groups of women (Ross et al.
2016; Shane and Ayyagari 2014; Breslau et al. 2018; Smith and Medalia 2014; O’Hara and
Brault 2013). This is important because despite shared pregnancy avoidance attitudes, the ability
of women to access reproductive healthcare is patterned by existing systemic access inequalities.
Overall, findings from this study indicate that context matters when it comes to
reproductive healthcare visits. Many of the patterns which operated in the birth control visit
context were the opposite for the annual gynecological visit context. Individual attitudes,
interpersonal variables, and institutional policy factors were all important and significant
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influences on making a birth control visit, but institutional factors were the main factors driving
making an annual gynecological visit. This illustrates that the drivers of sexual/reproductive
healthcare visits are different from those of preventative reproductive healthcare visits.
Moreover, interpersonal variables were particularly significant in the birth control visit context
but not in the annual gynecological visit context. This aligns with previous research which links
contraceptive use with relationship status (Campo et al. 2012; Reed et al. 2014). In addition, race
was a significant predictor of making an annual gynecological visit but not a birth control visit.
Black women had nearly two and a half times the odds of making an annual gynecological visit
compared to white women. This could reflect the influence of interpersonal relationships, such as
Warren-Jeanpiere’s (2006) research on African American mother-daughter relationships and
how mothers can strongly influence their daughters to get an annual gynecological visit. It could
also reflect more pressure on African American women to get annual checkups or pap smears
due to higher incidence and death rates of cervical cancer among minority women compared to
white women (Benard et al. 2014; Shomo 2019). More research is needed to illuminate the
reasons behind this racial difference in making an annual gynecological visit or pap smear.
Facility type played an important role in both types of women’s reproductive healthcare
visits. Women who went to Planned Parenthood or another family planning clinic for their last
women’s healthcare visit had nearly three times higher odds of making a birth control visit than
women who went to a private doctor’s office, while the opposite was true for preventative
reproductive healthcare visits. Moreover, younger women (ages 18 to 26) had three times higher
odds of making a visit for birth control or contraception compared to older women, but again the
opposite was true for annual gynecological preventative healthcare visits. These findings mirror
that of previous research which has shown teens prefer to go to family planning clinics for sexual
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and reproductive health services (Oglesby 2014; Sugerman et al. 2000). This may explain why
previous research did not find an increase in sexual and reproductive health service utilization
due to the dependent coverage of the ACA (Eliason 2019). Teens or other groups of women may
prefer to utilize Planned Parenthood for cost and confidentiality (Sugerman et al. 2000), or for
additional dimensions of care, such as ease of getting care and medical staff treatment (Oglesby
2014). These findings may also explain why Eliason (2019) did not find an increase in utilization
of sexual and reproductive health services after the dependent coverage provision of the ACA
passed. Young women may prefer to go to facilities such as Planned Parenthood for birth control
to protect their confidentiality, such as if they are still on a parent’s health insurance plan and are
worried about privacy. This carries important implications for policy, as women who are insured
may still utilize public family planning centers for their birth control needs.
Socioeconomic status alone was not a significant predictor of the likelihood of making
either a birth control visit or annual gynecological visit. However, insurance status was a key
difference and driver of making visits. Uninsured women had lower odds of making a birth
control visit compared to privately insured women, despite having the highest pregnancy
avoidance attitudes. More research is needed to uncover the reasons behind this finding. It could
be due to the cross-tabulation analyses finding that uninsured women had three to four times
higher percentages of reporting that they did not have a regular place to go for medical care,
compared to other insurance types. Or it could be that uninsured women fall into a “coverage
gap”, where they make too much to qualify for Medicaid insurance but cannot afford
marketplace or private insurance. On the other hand, women with marketplace insurance had
over twice the odds of making an annual gynecological visit compared to privately insured
women. Marketplace insurance was significantly associated with preventative healthcare visits,
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but not birth control visits. Taken together, these findings carry important implications for
research on women’s health disparities and reproductive healthcare policy. Rather than
socioeconomic status, insurance type and status may be a stand-in and important driver of
reproductive healthcare disparities.
One final important finding to note is that pregnancy avoidance attitudes were largely the
same among all subgroups. There were no statistically significant differences in pregnancy
avoidance attitudes by race/ethnicity, socioeconomic status, or insurance status. Most women in
each subgroup expressed a strong pregnancy avoidance attitude, with percentages ranging from
53 percent to 63 percent. These findings illustrate that pregnancy avoidance is largely a shared
attitude among the majority of women, even by subgroup, and the importance of creating equal
reproductive healthcare access for all women. However, hormonal contraception use differed by
subgroup, with use varying by race/ethnicity, socioeconomic status, and insurance status.
Whether this reflects individual preferences or larger access issues is unknown. Previous
research has demonstrated a gap between women’s use and preference for certain contraceptive
methods, particularly for groups such as the uninsured (Potter et al. 2017).
Limitations
One limitation is that the survey question about obtaining information about birth control
and pregnancy prevention during the last women’s healthcare visit did not ask if the information
was requested or not, so it is unclear whether information was provided to the patient upon their
request or not. Previous research has shown racial differences in pressure to use contraceptives
by a clinician (Becker and Tsui 2008), raising questions about whether this information was
given by patient request or not. However, including these visit questions can yield valuable
information as to whether different levels matter equally or if some are more important than
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others in healthcare visits, so it is imperative that they are included in the analyses. Another
limitation to note is that the patterns and findings noted in this study may change drastically
given the current COVID-19 pandemic, with many out of work and either losing employersponsored health coverage or not being able to afford insurance, as well as the Trump
administration’s attempts to abolish the Affordable Care Act. Both factors raise questions about
insurance coverage and the future of healthcare, and could shift the findings and patterns found
in this study in a major way.
CONCLUSION
As Krieger (2012) has written in her discussion of ecosocial theory, there are many
different pathways of embodiment. In the words of Nancy Krieger, “no one is an individual one
day and a member of a population another. Each person is both, simultaneously” (Krieger
2012:939). This study examined individual attitudes, interpersonal variables, and institutional
policy factors to further untangle the web of reproductive health disparities, while recognizing
that these influences are dynamic, overlapping, and co-constitutive. Findings illustrate that the
relative importance of each level can depend on the context of the healthcare visit, such as
whether a woman is seeking preventative reproductive healthcare or birth control. The factors
that influence making a reproductive healthcare visit are different for birth control visits versus
preventative visits. Individual attitudes and interpersonal interactions played a larger role in
making a birth control visit than a preventative health care visit. Institutional variables such as
insurance status and facility type mattered in both cases. These findings demonstrate the
importance of looking at multiple levels, such as individual attitudes, doctor-patient interactions,
and institutional policy factors, because the importance of each factor depends on the type of
medical care involved. Considering the context in which services are received and the factors
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influencing making a particular type of healthcare visit is essential because this can influence
service uptake and shed light on where providers and policymakers can direct their efforts.

43

REFERENCES
Agénor, Madina, Zinzi Bailey, Nancy Krieger, S. Bryn Austin, and Barbara R. Gottlieb. 2015. "Exploring the
Cervical Cancer Screening Experiences of Black Lesbian, Bisexual, And Queer Women: The Role of
Patient-Provider Communication." Women & Health 55(6):717-736.
Allison, Paul D. 2000. "Multiple Imputation for Missing Data: A Cautionary Tale." Sociological Methods &
Research 28(3):301-309.
Antonisse, Larisa, Rachel Garfield, Robin Rudowitz, and Samantha Artiga. 2018. The Effects of Medicaid
Expansion Under the ACA: Updated Findings from a Literature Review (Washington, D.C.: Kaiser Family
Foundation, March 2018).
Ashton, Carol M., Paul Haidet, Debora A. Paterniti, Tracie C. Collins, Howard S. Gordon, Kimberly O’Malley,
Laura A. Petersen et al. 2003. "Racial and Ethnic Disparities in the Use of Health Services." Journal of
General Internal Medicine 18(2):146-152.
Baicker, Katherine, Sarah L. Taubman, Heidi L. Allen, Mira Bernstein, Jonathan H. Gruber, Joseph P. Newhouse,
Eric C. Schneider, Bill J. Wright, Alan M. Zaslavsky, and Amy N. Finkelstein. 2013. "The Oregon
Experiment—Effects of Medicaid on Clinical Outcomes." New England Journal of Medicine
368(18):1713-1722.
Becker, Davida, and Amy O. Tsui. 2008. "Reproductive Health Service Preferences and Perceptions of Quality
Among Low‐Income Women: Racial, Ethnic and Language Group Differences." Perspectives on Sexual
and Reproductive Health 40(4):202-211.
Benard, Vicki B., Cheryll C. Thomas, Jessica King, Greta M. Massetti, V. Paul Doria-Rose, and Mona Saraiya.
2014. "Vital Signs: Cervical Cancer Incidence, Mortality, And Screening—United States, 2007–2012."
Morbidity and Mortality Weekly Report 63(44):1004-1009.
Breslau, Joshua, Bing Han, Bradley D. Stein, Rachel M. Burns, and Hao Yu. 2018. "Did The Affordable Care Act's
Dependent Coverage Expansion Affect Race/Ethnic Disparities In Health Insurance Coverage?" Health
Services Research 53(2):1286-1298.

44

Campo, Shelly, Natoshia M. Askelson, Erica L. Spies, and Mary Losch. 2012. "Ambivalence, Communication and
Past Use: Understanding What Influences Women's Intentions to Use Contraceptives." Psychology, Health
& Medicine 17(3):356-365.
Collins, Sara R., Munira Gunja, Michelle M. Doty, and Sophie Beutel. 2016. "Americans' Experiences with ACA
Marketplace and Medicaid Coverage: Access to Care and Satisfaction: Findings from the Commonwealth
Fund Affordable Care Act Tracking Survey, February–April 2016." Issue Brief (Commonwealth Fund)
14:1-18. http://www.commonwealthfund.org/publications/issue-briefs/2016/may/aca-tracking-surveyaccess-to-care-and-satisfaction
Dehlendorf, Christine, Nora Anderson, Eric Vittinghoff, Kevin Grumbach, Kira Levy, and Jody Steinauer. 2017.
"Quality and Content of Patient–Provider Communication About Contraception: Differences By
Race/Ethnicity and Socioeconomic Status." Women's Health Issues 27(5):530-538.
Eliason, Erica. 2019. “The Effects of the Dependent Coverage Provision on Young Women's Utilization of Sexual
and Reproductive Health Services.” Preventive Medicine 129:1-6.
Emmers-Sommer, Tara M., Sarah Nebel, Mae-Li Allison, Michele L. Cannella, Desiree Cartmill, Sarah Ewing,
Daniel Horvath, Jonathan K. Osborne, and Brittney Wojtaszek. 2009. "Patient–Provider Communication
About Sexual Health: The Relationship with Gender, Age, Gender-Stereotypical Beliefs, and Perceptions
of Communication Inappropriateness." Sex Roles 60(9-10):669-681.
Everett, Bethany G., Jenny A. Higgins, Sadia Haider, and Emma Carpenter. 2019. "Do Sexual Minorities Receive
Appropriate Sexual And Reproductive Health Care And Counseling?" Journal of Women's Health
28(1):53-62.
Finer, Lawrence B., Adam Sonfield, and Rachel K. Jones. 2014. "Changes in Out-of-Pocket Payments for
Contraception by Privately Insured Women During Implementation of the Federal Contraceptive Coverage
Requirement." Contraception 89(2):97-102.
Finer, Lawrence B., and Mia R. Zolna. 2016. "Declines in Unintended Pregnancy in the United States, 2008–2011."
New England Journal of Medicine 374(9):843-852.
Finkelstein, Amy, Sarah Taubman, Bill Wright, Mira Bernstein, Jonathan Gruber, Joseph P. Newhouse, Heidi Allen,
Katherine Baicker, The Oregon Health Study Group. 2011. “The Oregon Health Insurance Experiment:

45

Evidence from the First Year” (National Bureau of Economic Research, July 2011, Working Paper 17190).
Retrieved from http://www.nber.org/papers/w17190
Garfield, Rachel, Kendal Orgera, and Anthony Damico. 2019. “The Uninsured and the ACA: A Primer – Key Facts
about Health Insurance and the Uninsured amidst Changes to the Affordable Care Act.” Retrieved from
https://www.kff.org/report-section/the-uninsured-and-the-aca-a-primer-key-facts-about-health-insuranceand-the-uninsured-amidst-changes-to-the-affordable-care-act-how-does-lack-of-insurance-affect-access-tocare/
Ghosh, Ausmita, Kosali Simon, and Benjamin D. Sommers. 2017. The Effect of State Medicaid Expansions on
Prescription Drug Use: Evidence From The Affordable Care Act. (Working Paper No. 23044. National
Bureau of Economic Research, January 2017). Retrieved from
http://www.nber.org/papers/w23044?utm_campaign=ntw&utm_medium=email&utm_source=ntw
Gomez, Anu Manchikanti, and Mikaela Wapman. 2017. "Under (Implicit) Pressure: Young Black and Latina
Women's Perceptions of Contraceptive Care." Contraception 96(4):221-226.
Hammond, Alexandra. 2019. "Disparities in Access to Contraception in the United States: An Intersectional
Analysis." Senior Thesis, Scripps College.
Hayford, Sarah R., And Karen Benjamin Guzzo. 2013. "Racial and Ethnic Variation in Unmarried Young Adults’
Motivation to Avoid Pregnancy." Perspectives on Sexual And Reproductive Health 45(1):41-51.
Health Resources & Services Administration. 2019. “Women’s Preventive Services Guidelines.” Retrieved from
https://www.hrsa.gov/womens-guidelines/index.html
Holt, Kelsey, Katrina Kimport, Miriam Kuppermann, Judith Fitzpatrick, Jody Steinauer, and Christine Dehlendorf.
2020. "Patient-Provider Communication Before and After Implementation of the Contraceptive Decision
Support Tool My Birth Control." Patient Education and Counseling 103(2):315-320.
Horton, Nicholas J., and Ken P. Kleinman. 2007. "Much Ado About Nothing: A Comparison of Missing Data
Methods and Software to Fit Incomplete Data Regression Models." The American Statistician 61(1):79-90.
Hosmer, David W. and Lemeshow, Stanley. 2000. Applied Logistic Regression, 2nd Edition. John Wiley & Sons,
Inc.
IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp.

46

Jones, Rachel K., Laura D. Lindberg, and Jenny A. Higgins. 2014. "Pull and Pray or Extra Protection?
Contraceptive Strategies Involving Withdrawal Among US Adult Women." Contraception 90(4):416-421.
Jones, Rachel K., Athena Tapales, Laura D. Lindberg, and Jennifer Frost. 2015. "Using Longitudinal Data to
Understand Changes in Consistent Contraceptive Use." Perspectives on Sexual and Reproductive Health
47(3):131-139.
Jones, Rachel K., and Adam Sonfield. 2016. "Health Insurance Coverage Among Women of Reproductive Age
Before And After Implementation Of The Affordable Care Act." Contraception 93(5):386-391.
Jones, Rachel K. 2017. "Are Uncertain Fertility Intentions A Temporary or Long-Term Outlook? Findings from a
Panel Study." Women's Health Issues 27(1):21-28.
Jones, Rachel K. 2017. "Change and Consistency in US Women's Pregnancy Attitudes and Associations with
Contraceptive Use." Contraception 95(5):485-490.
Jones, Rachel K. 2018. "Is Pregnancy Fatalism Normal? An Attitudinal Assessment Among Women Trying to Get
Pregnant and Those Not Using Contraception." Contraception 98(4):255-259.
Jones, Rachel. 2018. Continuity and Change in Contraceptive Use, United States, 2012-2014. Ann Arbor, MI: Interuniversity Consortium for Political and Social Research [distributor], 2018-05-09.
https://doi.org/10.3886/ICPSR37067.v1
Kaiser Family Foundation. 2021. “Women’s Health Insurance Coverage.” Retrieved
from https://www.kff.org/womens-health-policy/fact-sheet/womens-health-insurance-coverage/
Kendall, Carl, Aimee Afable-Munsuz, Ilene Speizer, Alexis Avery, Norine Schmidt, and John Santelli. 2005.
"Understanding Pregnancy in a Population of Inner-City Women in New Orleans—Results of Qualitative
Research." Social Science & Medicine 60(2):297-311.
Kim, Theresa Y., Rada K. Dagher, and Jie Chen. 2016. "Racial/Ethnic Differences In Unintended Pregnancy:
Evidence From A National Sample Of U.S. Women." American Journal Of Preventive Medicine
50(4):427-435.
Krieger, Nancy. 1994. "Epidemiology and the Web of Causation: Has Anyone Seen the Spider?." Social Science &
Medicine 39(7):887-903.
Krieger, Nancy. 2001. "Theories for Social Epidemiology in the 21st Century: An Ecosocial Perspective."
International Journal of Epidemiology 30(4):668-677.

47

Krieger, Nancy. 2012. "Methods For The Scientific Study Of Discrimination And Health: An Ecosocial Approach."
American Journal Of Public Health 102(5):936-944.
Krieger, Nancy. 2014. "Got Theory? On the 21st c. CE Rise of Explicit Use of Epidemiologic Theories of Disease
Distribution: A Review and Ecosocial Analysis." Current Epidemiology Reports 1(1):45-56.
Lindberg, Laura, Rachel Jones, and Jenny Higgins. 2014. "Use of Withdrawal Among Young Adults in the US:
Pulling Out All the Stops?" Journal of Adolescent Health 54(2):S61.
Little, Todd D., Terrence D. Jorgensen, Kyle M. Lang, and E. Whitney G. Moore. 2014. "On The Joys Of Missing
Data." Journal Of Pediatric Psychology 39(2):151-162.
Nardi, Christina, Prabjot Sandhu, and Nancy Selix. 2016. "Cervical Cancer Screening Among Minorities in the
United States." The Journal for Nurse Practitioners 12(10):675-682.
Oglesby, Willie H. 2014. "Perceptions Of And Preferences For Federally-Funded Family Planning Clinics."
Reproductive Health 11(1):50.
O'Hara, Brett, and Matthew W. Brault. 2013. "The Disparate Impact Of The ACA‐Dependent Expansion Across
Population Subgroups." Health Services Research 48(5):1581-1592.
Potter, Joseph E., Kate Coleman-Minahan, Kari White, Daniel A. Powers, Chloe Dillaway, Amanda J. Stevenson,
Kristine Hopkins, and Daniel Grossman. 2017. "Contraception after Delivery among Publicly Insured
Women in Texas: Use Compared With Preference." Obstetrics and Gynecology 130(2):393.
RamaRao, Saumya, Marlina Lacuesta, Marilou Costello, Blesilda Pangolibay, and Heidi Jones. 2003. "The Link
Between Quality Of Care And Contraceptive Use." International Family Planning Perspectives 29(2):7683.
Ranji, Usha, Ivette Gomez, and Alina Salganicoff. 2019. In Their Own Voices: Low-Income Women and Their
Health Providers in Three Communities Talk About Access to Care, Reproductive Health, and
Immigration. San Francisco, CA: Henry J. Kaiser Family Foundation. Retrieved from
https://www.kff.org/report-section/in-their-own-voices-low-income-women-and-their-health-providerstalk-about-access-to-care-reproductive-health-and-immigration-report/
Reed, Joanna, Paula England, Krystale Littlejohn, Brooke Conroy Bass, and Mónica L. Caudillo. 2014. "Consistent
and Inconsistent Contraception Among Young Women: Insights from Qualitative Interviews." Family
Relations 63(2):244-258.

48

Rimer, Barbara K., and Karen Glanz. 2005. Theory at a Glance: A Guide For Health Promotion Practice. U.S.
Department of Health and Human Services, National Institutes of Health, National Cancer Institute.
Roberts, Dorothy E. 1999. Killing The Black Body: Race, Reproduction, And The Meaning Of Liberty. New York:
Vintage Books.
Ross, Loretta, Elena Gutiérrez, Marlene Gerber, and Jael Silliman. 2016. Undivided Rights: Women of Color
Organizing for Reproductive Justice. Haymarket Books.
Schaeffer, Katherine. 2019. “The Most Common Age Among Whites in U.S. is 58 – More than Double That of
Racial and Ethnic Minorities.” Retrieved from https://www.pewresearch.org/fact-tank/2019/07/30/mostcommon-age-among-us-racial-ethnic-groups/
Shane, Dan M. and Padmaja Ayyagari. 2014. “Will Health Care Reform Reduce Disparities in Insurance Coverage?
Evidence from the Dependent Coverage Mandate.” Medical Care 52(6):528-534.
Shomo, Anisa. 2019. “Black Women in America and Cervical Cancer Prevention.” Retrieved from
https://www.theatlantavoice.com/articles/black-women-in-america-and-cervical-cancer-prevention/
Smith, Jessica C., and Carla Medalia. 2014. Health Insurance Coverage in the United States: 2013. Washington,
DC: US Department of Commerce, Economics and Statistics Administration, Bureau of the Census.
Smith, Ellie, Beth Sundstrom, and Andrea L. DeMaria. 2019. "“Nobody Ever Asks Me:” A Reproductive Justice
Approach to Rural Health Disparities." Analyses of Social Issues and Public Policy 19(1):78-103.
Social Science Computing Cooperative. 2013. “Multiple Imputation in Stata: Deciding to Impute.” University of
Wisconsin-Madison. Retrieved from https://www.ssc.wisc.edu/sscc/pubs/stata_mi_decide.htm
Social Science Computing Cooperative. 2015. “Multiple Imputation in Stata: Creating Imputation Models.”
University of Wisconsin-Madison. Retrieved from
https://www.ssc.wisc.edu/sscc/pubs/stata_mi_models.htm#ChoosingVariables
Sonfield, Adam, Athena Tapales, Rachel K. Jones, and Lawrence B. Finer. 2015. "Impact of the Federal
Contraceptive Coverage Guarantee on Out-of-Pocket Payments for Contraceptives: 2014 Update."
Contraception 91(1):44-48.
StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC.

49

Sugerman, Susan, Neal Halfon, Arleen Fink, Martin Anderson, Laurie Valle, and Robert H. Brook. 2000. "Family
Planning Clinic Patients: Their Usual Health Care Providers, Insurance Status, and Implications for
Managed Care." Journal of Adolescent Health 27(1):25-33.
United States Census Bureau. N.d. “QuickFacts United States. In Civilian Labor Force, Female, Percent of
Population Age 16 Years+, 2014-2018.” Retrieved from
https://www.census.gov/quickfacts/fact/table/US/LFE046218#qf-headnote-a
Väisänen, Heini, and Rachel K. Jones. 2015. "Using Panel Data to Examine Pregnancy Attitudes over Time."
International Journal of Population Studies 1(1):1-17.
Warren-Jeanpiere, Lari., 2006. From Mothers to Daughters: A Qualitative Examination of The Reproductive Health
Seeking Behaviour of African American Women. Women’s Health and Urban Life 5(2):42-61.
Young, Rebekah, and David R. Johnson. 2010. "Imputing the Missing Y’s: Implications for Survey Producers and
Survey Users." In Proceedings of The AAPOR Conference Abstracts:6242-6248.

50

Table 1. Aggregate Sample Characteristics (N=982)
N
Dependent Variables
Made a visit for birth control or contraception in the last six months
Yes
No
Made a visit for an annual gynecological visit or pap smear in the last six months
Yes
No
Individual Attitudes, Knowledge, & Contraception Use
Pregnancy avoidance attitude
1 Not at all important to avoid pregnancy
2
3
4
5
6 Very important to avoid pregnancy
N/A (currently pregnant)
Knowledge of birth control methods (scale of 1 to 6, from 1 “I know nothing” to 6 “I
know everything)
Used the pill at T1, T2, or T3
Yes
No
Used LARC method (IUD or implant) at T3
Yes
No
Interpersonal Variables
Last WHC Visit: Doctor or nurse talked about plans for children
Yes
No
Last WHC Visit: Got information about birth control and pregnancy prevention
Yes
No
Relationship status
Been together for 6 months or longer
Broken up but back together
Not together for 6 months or longer
N/A, not dating anyone
Institutional Policy Factors
Last WHC visit – Facility
Private doctor’s office or group practice
Planned Parenthood or other family planning clinic
Public health department or community health clinic
Student health clinic or some other type of health care facility
Last WHC visit - Payment
I paid some or all of the costs myself (including any insurance co-pays)
My insurance paid some or all of the costs
I received services at a reduced fee or the services were free
Regular place to go for medical care
Yes
No
Lives in a state that expanded Medicaid under ACA (as of December 2013)
Yes
No
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% or Mean
(S.D.)

982
497
485
982
748
234

100.00
50.61
49.39
100.00
76.17
23.83

982
128
36
71
109
98
447
93
982

100.00
13.03
3.67
7.23
11.10
9.98
45.52
9.47
4.24 (1.02)

982
463
519
982
98
884

100.00
47.15
52.85
100.00
9.98
90.02

982
480
502

100.00
48.88
51.12

403
579
982
801
27
53
101

41.04
58.96
100.00
81.57
2.75
5.40
10.29

982
819
62
67
34
982
136
733
113
982
857
125
982
639
343

100.00
83.40
6.31
6.82
3.46
100.00
13.85
74.64
11.51
100.00
87.27
12.73
100.00
65.07
34.93

Key Subgroups
Race and ethnicity
White, Non-Hispanic
Black, Non-Hispanic
Other, Non-Hispanic
Hispanic
2+ Races, Non-Hispanic
Socioeconomic status
Less than 100%
100-199%
200%+
Insurance status
Private health insurance that I get through my job, school, a family member or
that I pay for myself
Medicaid or some other government-sponsored health insurance
I don’t have health insurance
Insurance obtained through a health insurance marketplace or exchange, such
as www.healthcare.gov
Control Variables
Marital Status
Married
Never married
Living with partner
Divorced or separated
Education
Less than high school
High school
Some college, no degree
Associate’s degree
Bachelor’s degree
Master’s degree or professional or doctorate degree
Employment
Full-time
Part-time
Unemployed
Foreign-born
Yes
No
Age
18-26
27-30
31-36
37-39
Age, continuous (range: 18-39)
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982
679
84
42
139
38
982
149
195
638
982
705

100.00
69.14
8.55
4.28
14.15
3.87
100.00
15.17
19.86
64.97
100.00
71.79

158
62
57

16.09
6.31
5.80

982
478
303
162
39
982
38
107
226
96
348
167
982
544
121
317
982
98
884
982
389
254
258
81
982

100.00
48.68
30.86
16.50
3.97
100.00
3.87
10.90
23.01
9.78
35.44
17.01
100.00
55.40
12.32
32.28
100.00
9.98
90.02
100.00
39.61
25.87
26.27
8.25
28.61 (5.15)

Table 2. Individual Pregnancy Attitudes, Knowledge, and Contraception Use, by Key Subgroup

Pregnancy avoidance
attitude
1 Not at all important
to avoid pregnancy
2
3
4
5
6 Very important to
avoid pregnancy
Currently pregnant
Chi-square test of
independence
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Birth control methods
knowledge
Mean
Standard Deviation
N
One-way ANOVA
Used pill at T1, T2, or T3
Yes
No
Chi-square test of
independence
Used implant or IUD at
T3
Yes
No
Chi-square test of
independence

Race and Ethnicity
Other Multiracial

Hispanic

Socioeconomic Status
Less than
100-199%
200%+
100%

Private

Insurance
Medicaid Marketplace

White

Black

Uninsured

13.11

17.86

14.29

7.89

10.79

13.42

12.82

13.01

12.34

16.46

12.28

12.90

4.12
7.22
11.63
11.05
42.71

1.19
4.76
10.71
8.33
50.00

4.76
4.76
9.52
9.52
45.24

2.63
13.16
7.89
7.89
52.63

2.88
7.91
10.07
6.47
54.68

2.01
10.07
7.38
6.04
51.68

4.10
7.18
11.79
10.26
43.08

3.92
6.58
11.76
10.82
44.83

4.40
7.09
11.91
10.64
44.68

1.27
6.96
8.86
9.49
43.04

1.75
10.53
7.02
10.53
47.37

3.23
6.45
11.29
3.23
59.68

10.16

7.14
11.90
7.89
Χ2 (24, N=982)=18.26, p=.790

7.19

9.40
10.77
9.09
Χ2 (12, N=982)=10.35, p=.585

8.94

13.92
10.53
3.23
Χ2 (18, N=982)=21.19, p=.270

4.24
(.97)
679

4.42
4.31
4.39
(1.16) (1.07)
(1.08)
84
42
38
F(4,977)=2.01, p=.091

4.06
(1.14)
139

4.16
(1.16)
149

4.11
4.30
(1.13)
(.95)
195
638
F(2,979)=3.11, p=.045

4.24
(.97)
705

4.12
4.42
(1.16)
(1.24)
158
57
F(3,978)=1.46, p=.224

4.32
(1.02)
62

50.96
49.04

41.67
38.10
42.11
58.33
61.90
57.89
Χ2 (4, N=982)=13.70, p=.008

35.97
64.03

40.94
37.95
51.41
59.06
62.05
48.59
Χ2 (2, N=982)=13.58, p=.001

50.92
49.08

31.65
45.61
45.16
68.35
54.39
54.84
Χ2 (3, N=982)=19.42, p=.000

9.28
90.72

5.95
2.38
13.16
94.05
97.62
86.84
Χ2 (4, N=982)=13.23, p=.010

17.27
82.73

10.07
9.23
10.19
89.93
90.77
89.81
Χ2 (2, N=982)=0.15, p=.926

10.92
89.08

8.23
7.02
6.45
91.77
92.98
93.55
Χ2 (3, N=982)=2.65, p=.448

Table 3. Interpersonal Variables, by Key Subgroup
Doctor or nurse spent time talking
with you about your future plans
for having or not having children
(or more children) at last women's
health care visit
Yes
No
Chi-square test of independence
Got information about birth
control and pregnancy prevention
at last women's health care visit
Yes
No
Chi-square test of independence
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Been together with partner for six
months or longer
Yes
Yes, though we have broken up
and gotten back together during
that time
No
N/A, not dating anyone
Chi-square test of independence

Race and Ethnicity
Other
Multiracial

49.48
50.52

44.05
42.86
60.53
55.95
57.14
39.47
Χ2 (4, N=982)=3.67, p=.453

47.48
52.52

46.98
46.15
50.16
53.02
53.85
49.84
Χ2 (2, N=982)=1.21,
p=.546

48.94
51.06

50.00
52.63
41.94
50.00
47.37
58.06
Χ2 (3, N=982)=1.60, p=.660

39.03
60.97

47.62
50.00
50.00
52.38
50.00
50.00
Χ2 (4, N=982)=5.32, p=.256

41.73
58.27

53.02
36.92
39.50
46.98
63.08
60.50
Χ2 (2, N=982)=10.83,
p=.004

37.87
62.13

45.57
54.39
53.23
54.43
45.61
46.77
Χ2 (3, N=982)=12.26, p=.007

83.65
1.77

58.33
10.71

85.61
2.88

71.81
4.70

83.23
2.19

84.68
1.70

4.57
10.01

8.33
4.76
13.16
22.62
7.14
7.89
Χ2 (12, N=982)=52.89, p=.000

5.76
5.76

10.07
4.10
4.70
13.42
9.23
9.87
Χ2 (6, N=982)=13.84,
p=.031

3.83
9.79

73.68
5.26

83.59
3.08

Private

Insurance
Medicaid Marketplace

Black

88.10
0.00

Hispanic

Socioeconomic Status
Less
100- 200%+
than
199%
100%

White

72.78
6.33

68.42
5.26

Uninsured

80.65
3.23

9.49
10.53
8.06
11.39
15.79
8.06
Χ2 (9, N=982)=29.14, p=.001

Table 4. Reproductive Healthcare Institutional Policy Factors, by Key Subgroup
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Current insurance
Private
Medicaid
Marketplace
I don’t have health insurance
Chi-square test of
independence
Regular place to go for medical
care
Yes
No
Chi-square test of
independence
Place where you last received
women’s health care
Private doctor’s office or
group practice
Planned Parenthood or other
family planning clinic
Public health dept. or
community health clinic
Student health clinic or some
other type of health care
facility
Chi-square test of
independence
Made a visit in the last 6 months
Annual gyn visit or pap
smear
Yes
No
Chi-square test of
independence
Visit for birth control or
contraception
Yes
No

Race or Ethnicity
Other
Multiracial

Hispanic

Socioeconomic Status
Less
100200%+
than
199%
100%

Black

77.32
13.25
5.30
4.12

52.38
71.43
76.32
29.76
19.05
18.42
9.52
7.14
2.63
8.33
2.38
2.63
Χ2 (12, N=982)=68.27, p=.000

55.40
20.14
6.47
17.99

24.16
57.95
87.15
51.68
25.13
5.02
10.07
6.15
4.70
14.09
10.77
3.13
Χ2 (6, N=982)=285.73,
p=.000

-

88.07
11.93

84.52
88.10
86.84
15.48
11.90
13.16
Χ2 (4, N=982)=1.70, p=.790

84.89
15.11

82.55
82.56
89.81
17.45
17.44
10.19
Χ2 (2, N=982)=10.59,
p=.005

90.92
9.08

88.37

67.86

80.95

73.68

71.94

65.77

74.36

90.28

92.20

67.72

66.67

38.71

4.42

10.71

7.14

13.16

10.79

16.11

7.69

3.61

2.41

11.39

24.56

20.97

4.27

17.86

7.14

7.89

12.23

12.75

12.31

3.76

2.27

18.35

7.02

29.03

2.95

3.57

4.76

5.26

5.04

5.37

5.64

2.35

3.12

2.53

1.75

11.29

Χ2 (12, N=982)=50.39, p=.000

Private

Insurance
Medicaid
Marketplace

White

Χ2 (6, N=982)=73.27,
p=.000

85.71
83.33
68.42
14.29
16.67
31.58
Χ2 (4, N=982)=7.21, p=.125

76.26
23.74

73.83
73.33
77.59
26.17
26.67
22.41
Χ2 (2, N=982)=2.02,
p=.364

77.16
22.84

50.66
49.34

52.38
47.62

53.24
46.76

57.72
42.28

50.78
49.22

44.74
55.26

50.26
49.74

49.06
50.94

-

84.18
84.21
15.82
15.79
Χ2 (3, N=982)=63.31, p=.000

-

56.45
43.55

Χ2 (9, N=982)=211.70, p=.000

74.96
25.04

42.86
57.14

-

Uninsured

74.05
82.46
25.95
17.54
Χ2 (3, N=982)=6.65, p=.084

46.20
53.80

57.89
42.11

64.52
35.48

53.23
46.77

Chi-square test of
independence
Women’s health care visit
payment
Respondent paid
Insurance paid
Free or reduced fee
Chi-square test of
independence
Lives in a state that expanded
Medicaid
Yes
No
Chi-square test of
independence

Χ2 (4, N=982)=2.02, p=.731

Χ2 (2, N=982)=3.64,
p=.162

Χ2 (3, N=982)=2.62, p=.455

13.11
78.50
8.39

13.10
14.29
10.53
65.48
66.67
81.58
21.43
19.05
7.89
Χ2 (8, N=982)=31.90, p=.000

18.71
61.87
19.42

11.41
13.33
14.58
63.09
68.21
79.31
25.50
18.46
6.11
Χ2 (4, N=982)=56.23,
p=.000

14.04
81.84
4.11

4.43
14.04
69.62
63.16
25.95
22.81
Χ2 (6, N=982)=207.71, p=.000

35.48
16.13
48.39

65.83
34.17

47.62 78.57
73.68
52.38 21.43
26.32
Χ2 (4, N=982)=16.05, p=.003

65.47
34.53

65.77
69.23
63.64
34.23
30.77
36.36
Χ2 (2, N=982)=2.09,
p=.351

63.12
36.88

77.22
68.42
22.78
31.58
Χ2 (3, N=982)=15.54, p=.001

53.23
46.77
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Table 5. Nested Logistic Regression Models: Likelihood of Making a Visit for Birth Control or Contraception
Model 1
Health Disparities
Model
OR (95% CI)
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Individual Attitudes, Knowledge, &
Contraception Use
Pregnancy avoidance attitude
2
3
4
5
6 Very important to avoid pregnancy
Currently pregnant
Knowledge of birth control methods
Past use of the pill
LARC at last wave
Interpersonal Variables
Visit: Doctor or nurse talked about future plans for
children
Visit: Got info about birth control and pregnancy
prevention
Relationship status
Broken up but back together
Not together for six months or longer
Not dating anyone
Institutional Policy Factors
Visit: Facility type
Planned Parenthood or other family
planning clinic
Public health dept. or community health
clinic
Student health clinic or some other type
of healthcare facility
Visit: Payment
Insurance paid
Reduced fee or free services
Has a regular place to go for medical care
Lives in a state that expanded Medicaid under ACA

Model 2
Model 1+ Individual
Attitudes,
Knowledge, &
Contraception Use
OR (95% CI)

Model 3
Model 2 + Interpersonal Variables

Model 4
Model 3+Institutional
Policy Factors

OR (95% CI)

OR (95% CI)

2.39 (.95 - 6.00)
3.05** (1.43 - 6.51)
2.67** (1.37 - 5.23)
3.32** (1.64 - 6.70)
4.44*** (2.47 - 7.99)
.26** (.11 - .67)
1.06 (.90 - 1.25)
5.56*** (3.90 - 7.92)
.81 (.47 - 1.38)

2.46 (.97 - 6.24)
3.04** (1.41 - 6.52)
2.59** (1.31 - 5.11)
3.27** (1.61 - 6.63)
4.39*** (2.43 - 7.94)
.26** (.10 - .65)
1.08 (.91 - 1.28)
5.89*** (4.10 - 8.47)
.82 (.48 - 1.41)

2.73* (1.13 - 6.63)
3.45** (1.68 - 7.09)
3.62*** (1.91 - 6.85)
4.78*** (2.45 - 9.30)
6.22*** (3.60 - 10.75)
.23** (.10 - .58)
1.07 (.91 - 1.25)
5.71*** (4.07 - 8.00)
.71 (.43 - 1.19)

.69 (.47 - 1.03)

.71 (.47 - 1.06)

3.87*** (2.58 - 5.79)

3.79*** (2.52 - 5.71)

1.79 (.58 - 5.53)
.61 (.30 - 1.26)
.41** (.22 - .74)

1.59 (.52 - 4.85)
.54 (.26 - 1.15)
.38** (.21 - .69)

2.71* (1.16 - 6.30)
1.85 (.86 - 3.95)
1.03 (.41 - 2.57)

1.10 (.67 - 1.80)
1.36 (.65 - 2.86)
.69 (.39 - 1.19)
.89 (.63 - 1.27)
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Key Subgroups
Race and ethnicity
Black
Other
Hispanic
Multiracial
Socioeconomic status
100-199%
200%+
Insurance status
Medicaid
Uninsured
Marketplace
Control Variables
Marital status
Never married
Living with partner
Divorced or separated
Employment status
Part-time
Full-time
Educational attainment
High school
Some college, no degree
Associate’s degree
Bachelor’s degree
Master’s, professional, or doctorate
degree
Age
18-26
27-30
31-36
Foreign-born

.85 (.51 - 1.40)
.93 (.45 - 1.92)
1.21 (.79 - 1.86)
.63 (.31 - 1.27)

1.08 (.60 - 1.92)
1.20 (.51 - 2.83)
1.52 (.91 - 2.52)
.67 (.30 - 1.48)

.97 (.53 - 1.77)
1.01 (.41 - 2.48)
1.45 (.86 - 2.46)
.55 (.24 - 1.26)

.88 (.47 - 1.62)
1.05 (.43 - 2.61)
1.41 (.83 - 2.41)
.50 (.21 - 1.18)

.75 (.46 - 1.22)
.74 (.46 - 1.20)

.78 (.44 - 1.37)
.58 (.33 - 1.02)

.89 (.49 - 1.62)
.64 (.35 - 1.16)

.88 (.48 - 1.61)
.65 (.36 - 1.19)

.55* (.35 - .87)
.83 (.45 - 1.51)
1.03 (.57 - 1.88)

.88 (.52 - 1.49)
.69 (.34 - 1.39)
1.29 (.62 - 2.68)

.73 (.41 - 1.28)
.54 (.26 - 1.14)
1.09 (.50 - 2.35)

.61 (.34 - 1.11)
.32** (.14 - .75)
.81 (.36 - 1.81)

1.89*** (1.34 - 2.66)
1.67* (1.11 - 2.53)
1.45 (.73 - 2.88)

.87 (.57 - 1.31)
1.05 (.65 - 1.72)
.77 (.34 - 1.70)

1.28 (.79 - 2.07)
1.26 (.76 - 2.10)
.94 (.39 - 2.24)

1.35 (.83 - 2.20)
1.22 (.73 - 2.04)
.97 (.40 - 2.34)

1.94** (1.22 - 3.07)
1.40* (1.00 - 1.95)

1.58 (.93 - 2.68)
1.34 (.90 - 1.98)

1.71 (.98 - 2.98)
1.39 (.93 - 2.08)

1.64 (.93 - 2.88)
1.35 (.90 - 2.04)

.72 (.29 - 1.80)
1.12 (.47 - 2.65)
.82 (.31 - 2.15)
.75 (.31 - 1.81)
.72 (.28 - 1.86)

.49 (.19 - 1.29)
.72 (.29 - 1.80)
.58 (.21 - 1.58)
.49 (.19 - 1.26)
.45 (.16 - 1.21)

.60 (.23 - 1.60)
.85 (.34 - 2.14)
.65 (.24 - 1.81)
.57 (.22 - 1.47)
.51 (.18 - 1.39)

.70 (.31 - 1.57)
.89 (.42 - 1.90)
.80 (.34 - 1.87)
.71 (.33 - 1.55)
.61 (.26 - 1.39)

4.02*** (2.29 - 7.04)
2.17** (1.24 - 3.83)
1.87* (1.06 - 3.29)
.89 (.53 - 1.50)

3.61*** (1.90 - 6.84)
2.26* (1.18 - 4.31)
1.81 (.96 - 3.44)
.66 (.36 - 1.20)

3.13** (1.60 - 6.12)
2.19* (1.11 - 4.29)
1.76 (.90 - 3.42)
.59 (.32 - 1.10)

3.01** (1.53 - 5.93)
2.17* (1.10 - 4.30)
1.79 (.91 - 3.52)
.57 (.31 - 1.07)

Constant
.46 (.18 - 1.20)
.07*** (.02 - .27)
.09** (.02 - .38)
.10** (.02 - .53)
Observations
982
982
982
982
Log-likelihood
-624.81
-493.29
-461.89
-455.02
Log-likelihood ratio test p-value
.000
.000
.056
Note. *** p<.001, ** p<.01, * p<.05. Reference categories are respectively: White; Less than 100% FPL; Private insurance; Married; Unemployed; Less than High School; Age
37-39; Not foreign-born; Pregnancy avoidance attitude of 1; No past use of the pill; No LARC at last wave; Doctor didn’t talk about future plans for children; Didn’t get
information about birth control; Together for six months or longer; Private doctor’s office; Respondent paid; No regular place for medical care; Lives in a state that did not expand
Medicaid under ACA.

Table 6. Nested Logistic Regression Models: Likelihood of Making an Annual Gynecological Visit
Model 1
Health Disparities Model

OR (95% CI)
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Individual Attitudes, Knowledge, &
Contraception Use
Pregnancy avoidance attitude
2
3
4
5
6 Very important to avoid pregnancy
Currently pregnant
Knowledge of birth control methods
Past use of the pill
LARC at last wave
Interpersonal Variables
Visit: Doctor or nurse talked about future plans
for children
Visit: Got info about birth control and
pregnancy prevention
Relationship status
Broken up but back together
Not together for six months or longer
Not dating anyone
Institutional Policy Factors
Visit: Facility type
Planned Parenthood or other family
planning clinic
Public health dept. or community
health clinic
Student health clinic or some other
type of healthcare facility
Visit: Payment
Insurance paid
Reduced fee or free services
Has a regular place to go for medical care
Lives in a state that expanded Medicaid under
ACA

Model 2
Model 1+ Individual
Attitudes,
Knowledge, & Contraception
Use
OR (95% CI)

.98 (.34 - 2.81)
.97 (.41 - 2.27)
.73 (.36 - 1.48)
.54 (.27 - 1.10)
.46* (.26 - .83)
.29*** (.15 - .57)
1.01 (.87 - 1.19)
1.25 (.89 - 1.75)
1.86* (1.01 - 3.40)

Model 3
Model 2 + Interpersonal
Variables

Model 4
Model 3+Institutional
Policy Factors

OR (95% CI)

OR (95% CI)

1.04 (.36 - 3.00)
1.05 (.45 - 2.48)
.80 (.39 - 1.65)
.62 (.30 - 1.28)
.54* (.30 - .99)
.30** (.15 - .60)
1.02 (.87 - 1.20)
1.30 (.92 - 1.83)
1.80 (.98 - 3.32)

1.003 (.35 - 2.88)
1.06 (.44 - 2.53)
.84 (.41 - 1.74)
.64 (.31 - 1.33)
.56 (.31 - 1.04)
.31** (.16 - .61)
1.01 (.86 - 1.19)
1.25 (.88 - 1.78)
1.82 (.98 - 3.37)

1.50* (1.04 - 2.16)

1.45 (1.00 - 2.10)

.76 (.52 - 1.11)

.84 (.56 - 1.24)

1.18 (.40 - 3.51)
1.27 (.58 - 2.74)
.76 (.42 - 1.35)

1.17 (.39 - 3.51)
1.39 (.63 - 3.07)
.78 (.43 - 1.41)

.29*** (.14 - .56)
.56 (.28 - 1.10)
.44* (.20 - .98)

1.01 (.62 - 1.63)
.80 (.40 - 1.58)
1.00 (.62 - 1.64)
.98 (.69 - 1.38)
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Key Subgroups
Race and ethnicity
Black
Other
Hispanic
Multiracial
Socioeconomic status
100-199%
200%+
Insurance status
Medicaid
Uninsured
Marketplace
Control Variables
Marital status
Never married
Living with partner
Divorced or separated
Employment status
Part-time
Full-time
Educational attainment
High school
Some college, no degree
Associate’s degree
Bachelor’s degree
Master’s, professional, or doctorate
degree
Age
18-26
27-30
31-36
Foreign-born

2.01* (1.02 - 3.95)
1.09 (.44 - 2.71)
1.02 (.63 - 1.66)
.75 (.36 - 1.56)

2.10* (1.05 - 4.18)
1.24 (.49 - 3.14)
1.02 (.62 - 1.67)
.74 (.35 - 1.58)

2.11* (1.05 - 4.23)
1.33 (.52 - 3.39)
1.00 (.61 - 1.64)
.69 (.32 - 1.47)

2.44* (1.18 - 5.04)
1.46 (.55 - 3.87)
1.06 (.64 - 1.77)
.81 (.37 - 1.76)

.92 (.54 - 1.56)
.96 (.56 - 1.62)

.97 (.57 - 1.66)
.99 (.58 - 1.70)

.95 (.55 - 1.64)
.98 (.57 - 1.68)

.92 (.52 - 1.60)
.88 (.50 - 1.53)

1.00 (.61 - 1.66)
.57 (.30 - 1.06)
1.66 (.79 - 3.48)

1.05 (.63 - 1.77)
.56 (.29 - 1.06)
1.77 (.83 - 3.74)

1.04 (.61 - 1.75)
.57 (.30 - 1.09)
1.76 (.82 - 3.75)

1.23 (.70 - 2.14)
.93 (.44 - 1.97)
2.43* (1.09 - 5.40)

1.29 (.87 - 1.91)
1.29 (.81 - 2.06)
1.68 (.66 - 4.29)

1.38 (.90 - 2.12)
1.35 (.83 - 2.19)
1.68 (.64 - 4.37)

1.55 (.96 - 2.50)
1.38 (.85 - 2.25)
1.72 (.64 - 4.63)

1.53 (.94 - 2.49)
1.46 (.89 - 2.41)
1.66 (.61 - 4.51)

.71 (.44 - 1.15)
1.36 (.94 - 1.99)

.65 (.39 - 1.06)
1.27 (.87 - 1.86)

.64 (.39 - 1.06)
1.26 (.86 - 1.85)

.69 (.41 - 1.15)
1.29 (.87 - 1.92)

2.25 (.94 - 5.39)
1.55 (.70 - 3.47)
1.43 (.58 - 3.51)
2.05 (.89 - 4.71)
2.15 (.86 - 5.32)

2.63* (1.08 - 6.40)
1.60 (.70 - 3.63)
1.63 (.65 - 4.09)
2.22 (.95 - 5.18)
2.21 (.88 - 5.59)

2.57* (1.04 - 6.33)
1.62 (.70 - 3.72)
1.54 (.61 - 3.91)
2.14 (.91 - 5.06)
2.20 (.86 - 5.62)

2.10 (.83 - 5.31)
1.37 (.58 - 3.25)
1.35 (.52 - 3.51)
1.87 (.77 - 4.54)
1.94 (.74 - 5.09)

.24** (.10 - .54)
.23** (.10 - .54)
.44 (.19 - 1.02)
1.81 (.93 - 3.50)

.24** (.10 - .57)
.25** (.11 - .59)
.46 (.19 - 1.09)
1.80 (.92 - 3.53)

.23** (.10 - .56)
.24** (.10 - .57)
.44 (.18 - 1.04)
1.84 (.94 - 3.63)

.23** (.10 - .56)
.23** (.10 - .55)
.40* (.17 - .97)
1.98 (.98 - 3.99)

Constant
4.43* (1.38 - 14.24)
5.62* (1.36 - 23.27)
4.69* (1.11 - 19.81)
6.50* (1.29 - 32.78)
Observations
982
982
982
982
Log-likelihood
-508.80
-495.28
-491.88
-480.93
Log-likelihood ratio test p-value
.001
.237
.003
Note. *** p<.001, ** p<.01, * p<.05. Reference categories are respectively: White; Less than 100% FPL; Private insurance; Married; Unemployed; Less than High School; Age
37-39; Not foreign-born; Pregnancy avoidance attitude of 1; No past use of the pill; No LARC at last wave; Doctor didn’t talk about future plans for children; Didn’t get
information about birth control; Together for six months or longer; Private doctor’s office; Respondent paid; No regular place for medical care; Lives in a state that did not expand
Medicaid under ACA.

AIM #2: Controlling Birth Control? State-Level Conditions Influencing Availability of
Telecontraception Platforms
Telemedicine is a growing area of healthcare with the potential to cut costs and increase
access, particularly for underserved and rural populations (Centers for Disease Control and
Prevention 2020). The current COVID-19 crisis is raising many questions about health care
delivery and the use of telemedicine. One emerging segment of telemedicine is the rise of
telecontraception platforms, such as Nurx, Planned Parenthood Direct, and Pill Club, which
deliver birth control directly to consumers through the mail or pharmacy pickup. These platforms
represent a growing market and innovative approach that aims to address barriers in obtaining
contraception in the United States. On-demand birth control services can help meet the needs of
women who reside far from clinics or in contraceptive deserts, who lack the time or resources to
go to a doctor to obtain or refill a birth control prescription, or who face long wait times for an
appointment (Sundstrom et al. 2019; Grindlay and Grossman 2016; Chuck 2017). Research has
demonstrated women’s positive attitudes toward telecontraception, such as the potential to
reduce wait times and increase knowledge of birth control methods (Sundstrom et al. 2019).
However, currently it is not known whether telecontraception platforms increase
accessibility to contraception for those who face barriers or whether they simply make it more
convenient for those who already have access (Dorland, Fowler, and Morain 2019; Zuniga et al.
2020). Recent studies have begun to look at issues of access by mapping out characteristics
across telecontraception platforms, such as cost, age requirements, and state availability (Zuniga
et al. 2020; Dorland, Fowler, and Morain 2019). As access to the internet and apps increase,
online platforms increasingly employ a rhetoric of “choice” and “empowerment” (Lupton 2016;
Lupton 2018). However, consumers are still subject to laws and policies regarding the dispensing
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and prescribing of birth control. One study found that 39 percent of requests did not get filled
from Nurx (Wollum et al. 2018). Barriers due to policy, legislation, cost, or insurance may all be
possible explanations for why these requests were not filled. Policy and legislation can affect the
reach of telecontraception platforms across states by dictating a platform’s ability to prescribe
and/or dispense medications, limiting the ability of patients to access these services, yet less is
known about what affects these factors. Technological innovations are subject to the social
context from which they emerge (MacKenzie and Wajcman 1999). Political, social, economic,
and legislative factors all combine to influence state climates. Therefore, theoretical and
sociological issues are at stake in an investigation of what influences states to provide access and
availability to telecontraception.
This research addresses this knowledge gap by using fuzzy-set qualitative comparative
analysis (fsQCA; Ragin 2000; Ragin 2008a; Ragin 2008b) to investigate state-level conditions
found in states with high availability of telecontraception platforms. This method provides an
opportunity for new insights on the social, economic, political, and legislative influences on
technological innovations such as telecontraception because it focuses on the combinations of
these multiple influences associated with telecontraception availability in a state. Reproductive
rights activism often focuses on political factors, but other state-level conditions can also
influence policy in combination with other conditions. Using fsQCA can provide a more realistic
picture of the influences on telecontraception availability because it investigates how state-level
conditions combine and operate with one another to pattern access. Telemedicine
implementation is affected by various stakeholders with competing interests and visions
(Greenhalgh et al. 2012). Despite their powerful influence on decision-making, research
examining the role of political and cultural characteristics of telemedicine play in controlling
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access to telemedicine are understudied (Wade, Gray, and Carati 2017). What combination of
state-level conditions influence telecontraception platform availability? Investigating the statelevel conditions that pattern availability of telecontraception platform services is critical to
illuminate the ability of these platforms to offer equitable access to telecontraception, or whether
reproductive healthcare disparities remain despite these emerging technologies. Providing an
analysis of state-level conditions affecting telecontraception platform access and availability can
also help inform broader telehealth measures, interventions, and policy, areas of increasing
importance during the current COVID-19 pandemic.
LITERATURE REVIEW
Overview of Telecontraception Platforms
Nurx, Planned Parenthood Direct, and Pill Club are all examples of telecontraception
platforms which provide birth control and other reproductive healthcare services via an app or
website. Telecontraception platforms deliver birth control directly to customers or provide a
prescription that a customer can pick up at a pharmacy. Customers download the app or go to the
company website, create a profile with their contact information, and answer health history
questions. Platforms differ on the degree of interaction between patients and providers, such as
messaging versus video consultations (Dorland, Fowler, and Morain 2019). Users have the
option to use an existing prescription or request a new prescription. They also have the option to
use insurance or pay out of pocket. While billing through insurance for contraception costs
nothing to the customer under the Affordable Care Act (with the exception of religious
employers who may choose not to cover contraception (U.S. Centers for Medicare & Medicaid
Services 2020)), the cost of paying for birth control without a prescription varies depending on
the platform and whether the drug is a brand name or a generic equivalent. A licensed member of
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the medical team in the user’s state (either a doctor, nurse practitioner, or physician assistant)
then reviews, fills, and sends the prescription directly to the customer.
Telecontraception platforms are growing in number and reach. Previous research has
identified more than eight telecontraception platforms providing birth control prescriptions by
mail or pharmacy pickup (Dorland, Fowler, and Morain 2019; Zuniga et al. 2020), with
additional platforms available outside of the U.S. only (Ibis Reproductive Health 2020). Nurx, a
startup telecontraception company, provides care to over 300,000 patients monthly (Shieber
2020; Landi 2020). Less is known about who utilizes telecontraception platforms, although
limited research has been conducted on Nurx users and attitudes toward telecontraception in
general (Wollum et al. 2018; Sundstrom et al. 2019). One study found that contraception
requests on the Nurx platform jumped from 3 per day in 2015 to 127 per day in 2017 (Wollum et
al. 2018). According to Nurx’s founder, the largest amount of sign-ups comes from Texas, a state
with the highest number of contraceptive deserts in the United States (Chuck 2017).
The Social Shaping of Technology
The social shaping of technology (SST) is a theoretical framework arguing that
technological design and advances are inseparable from the social context in which they emerge
(MacKenzie and Wajcman 1999). Social, economic, and political factors influence technology at
all stages, from design to implementation. Many different choices, decisions, and actors are
involved with technology so that technology and society cannot be considered distinct entities;
rather, they are intertwined and mutually shape one another (Kitchin 2014; Latour 1987; Winner
1986; O’Neil 2016; Devlin 2018; Eubanks 2018; Cowen 1983). Despite these mutually
reinforcing factors, rhetoric around technology still often portrays technological innovations and
inventions as a “techno-utopia” where technology is viewed as the solution to all of humanity’s
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problems (Rogers 1995; Winner 1986; Wajcman 2004; Nakamura 2009; boyd & Crawford 2012;
Mosco 2014; Devlin 2018; Zuboff 2019). This rhetoric ignores the power, control, and tools that
certain groups hold over others at all stages of technological innovation.
Prescription birth control is a prime example of SST. Many different political and social
decisions, factors, and stakeholders shape and are shaped by this technology. Even as technology
advances to produce online platforms that can aid in the delivery of healthcare through a tap on a
smartphone, legislation affects access to prescriptions and birth control. Mort and Finch
(2005:68) argue that the telemedicine literature paints telemedicine as a neutral, “value free”
technology but that it cannot be separated from place-based political contexts. Stakeholders with
competing interests and visions can affect the implementation of telemedicine initiatives
(Greenhalgh et al. 2012), and legislation is one area in which this plays out. States dictate
whether a telecontraception platform can prescribe and dispense prescription birth control. Thus,
although these platforms aim to meet the reproductive healthcare needs of women across the
United States through technological innovation, the ability of women everywhere to access these
services is not patterned equally due to on-the-ground as well as policy factors. These competing
forces illustrate that technological innovations are not a value-free, neutral occurrence but are
heavily influenced by the social, economic, and political conditions present as they emerge.
Political and Legislative Influences on Contraception
By design, internet platforms of all kinds aim to disrupt the restrictions of place, allowing
individuals around the globe access to information, goods, and services that may not be available
where they live. However, platforms can be subject to place-based regulation, and regulation is
influenced by regional stakeholders. Although platforms are portrayed as technology without
borders, platforms are still very much shaped by on-the-ground forces such as gatekeepers and
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local decision-makers (Zuboff 2019; Srnicek 2017). Regulations can affect the reach of
telecontraception platforms across states by dictating a platform’s ability to prescribe and/or
dispense medications. Thus, regulatory forces shaped by local political and social contexts can
expand or limit the power of telecontraception platforms to reach the individuals that demand
their services.
For example, in the United States, access to telecontraception platform services differs by
state: Nurx provides telecontraception services to 30 states and Pill Club prescribes to 42 states
(Nurx Inc. 2020; Pill Club 2020). These lists frequently change as telecontraception platforms
gain authority and access to more and more states. Furthermore, regulatory practices can produce
discrepancies in what a platform can provide even within a single state. As one example, Pill
Club can dispense to customers in North Dakota but cannot write prescriptions for these
residents (Pill Club 2020). States differ on their telemedicine policies such as reimbursement, yet
research has not examined the causes of these differences (Trout et al. 2017). Research
investigating telemedicine implementation has found that policy and legislation is a determinant
and prerequisite for successful telemedicine initiatives (Broens et al. 2007).
Legal barriers are replacing technological barriers in telemedicine implementation (Daley
2000). For example, Nurx has cited anti-abortion groups and conservative lawmakers as two
sources of resistance to telecontraception platforms (Chuck 2017). Conflicting stakeholders and
interests place different values on particular aspects of telemedicine, such as clinical quality
versus return on investment, and these competing visions and priorities can affect telemedicine
implementation (Greenhalgh et al. 2012). Debates and tensions among these stakeholders, such
as physicians, pharmacists, pharmaceutical and insurance companies, may also play a role in
lobbying in ways that influence legislation in specific states. Despite the influential role politics
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play in telemedicine initiatives, limited research has been conducted on the political and cultural
characteristics of telemedicine (Wade, Gray, and Carati 2017; Greenhalgh et al. 2012; Bareiss
2001).
States are a major player in this process because they determine where telecontraception
platforms can prescribe and dispense contraception to customers. The ability of a platform to
provide its services to customers is thus not solely up the platform and the technology but is
dictated by regulations which act as a gatekeeper. Therefore, although platforms are in the
process of adding more states to their lists, customers in different states may not have equal
access to these services. Less is known about which specific state-level factors influence the
availability and access of telecontraception platforms across states. For example, Nurx’s cofounder cited wait times for doctor licensing approval as the main obstacle to gaining access in
each state (Klabusich 2017). Other political, economic, and social factors beyond licensing may
also influence state policy on telecontraception platform access and availability.
The proportion of women to men in state legislative roles. One important factor which
could influence state-level policy on telecontraception platform access and availability is the
proportion of women to men in state-level policymaking roles. These positions of power create
and influence policy, so it is possible that having greater proportions of women with interest in
women’s issues, such as reproductive healthcare access, could result in increased availability of
telecontraception platforms. Rising numbers of women in the legislature means that women’s
representation in policymaking positions is increasing, along with the potential to push for
legislation representing women’s issues. States with higher proportions of women
representatives propose more bills pertaining to women, children, and families compared to men
and also compared to states with lower proportions of women representatives (Volden, Wiseman
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& Wittmer 2018; Thomas 1991; Saint-Germain 1989), regardless of political party (Volden,
Wiseman and Wittmer 2018). International research has also found that women legislators were
more likely to represent and advance women’s rights and interests compared to male legislators
(Tam 2020; Tam 2017). The organizational environment, in terms of support through increased
representation and proportions of women in these roles, is hypothesized to play a role in these
findings (Thomas 1991; Saint-Germain 1989). However, one study found that while women
legislators introduced more bills on women’s issues, they have lower success rates of becoming
law (Volden, Wiseman and Wittmer 2018).
State-level political party dominance. Another important factor to consider in
telecontraception platform policy and legislation is the political control of a state. States can be
categorized as Democrat, Republican, split, or nonpartisan depending on the partisan
composition of the state legislature and governor (National Conference of State Legislatures
2020). Divergent values and viewpoints of each political party are linked with reproductive
healthcare issues such as women’s access to birth control and abortion, which are then translated
into policy, restrictions, and legislation. These beliefs largely coincide with political party
affiliation: a survey by Pew Research Center (2019) found that 82 percent of Democrats support
legal abortion, compared to 36 percent of Republicans. At the state level, actions to overturn Roe
vs. Wade largely consist of Republican lawmakers and anti-abortion groups (Sonmez 2020).
Anti-abortion groups and social conservatives support Republican administrations and
pressure these political administrations for restrictive policies on birth control and abortion
(Bryson, Légier, and Ribieras 2018; Dreweke 2018). For example, legislation by the Trump
administration allows employers to decline contraception coverage for their employees based on
personal religious or moral reasons (U.S. Centers for Medicare & Medicaid Services 2020;
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Adamczyk 2020). Nearly half of the states in the U.S. have some type of law dictating actions
surrounding moral or religious objections to filling certain prescriptions, such as oral
contraceptives or emergency contraception (Chiarello 2011). Some states have a “conscience
clause” for medical providers that allows them to opt out of medical processes or procedures for
moral or religious reasons, while other states have “duty-to-dispense” laws or “refuse-and-refer”
laws which entail stricter enforcement of filling prescriptions (Chiarello 2011; Berlinger 2008;
Harrington 2006).
Given this link between state political party control and reproductive healthcare policy
and legislation, it is logical that this connection would extend to telecontraception. Platforms
which aim to increase the accessibility and availability of birth control may be at odds with the
ideology and beliefs of certain political groups and parties who hold the power to write the rules
and policies dictating their use. On the other hand, similar viewpoints which align with the
philosophy of accessible, available birth control could accelerate policies and legislation granting
the authority of telecontraception platforms to dispense and prescribe birth control in a state.
Research is needed to illuminate whether the connection between state-level political party and
access to contraception extends to telecontraception.
Economic Factors Shaping Telecontraception Platform Availability
State conditions affecting the access and availability of telecontraception platforms may
also be driven by economic considerations, such as the impact of federal policies that influence
state funding for reproductive health, the proportion of uninsured women in a state, and the
proportion of rural to urban residents, which can also shape state-level health care delivery costs.
Telemedicine is often discussed in terms of cutting costs and increasing healthcare access,
particularly for underserved and rural populations (Centers for Disease Control and Prevention
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2020). States have their own economic and financial constraints which may shape the availability
of telecontraception platforms. For example, some states have had to make financial decisions
regarding their budgets for family planning clinics in response to the Trump administration’s
“gag rule” barring clinics from providing abortion referrals if they receive federal funds under
Title X (Modern Healthcare 2020). The gag rule has diminished the capacity of family planning
clinics to provide services to their patients, with some states more impacted than others (Dawson
2020). These political decisions and changes at the federal level have effects at the state level,
typically by restricting access to federal funds, which can then affect state-level policy. States
that face funding constraints on family planning services such as contraception may be more
open to telecontraception platforms to mitigate the financial pressures as well as provide services
to patients in need.
The proportion of uninsured women in a state. Related to this issue are the economic and
financial pressures of states to meet the needs of their uninsured populations. Just over 11
percent of women aged 19 to 64, or 11.1 million women, in the United States were uninsured in
2019 (Kaiser Family Foundation 2021). Family planning clinics provide free or reduced fee
services but given the increased economic and financial pressures faced by states regarding
family planning clinic funding, patients may face increasing barriers to accessing the care they
need. Although the Affordable Care Act (ACA) has increased insurance coverage rates,
disparities persist by race and ethnicity (Shane and Ayyagari 2014; Breslau et al. 2018; Smith
and Medalia 2014; O’Hara and Brault 2013). Rates of uninsurance are not patterned equally and
can exacerbate existing economic disparities. States with higher numbers of uninsured women
may thus look to other, market-based options such as telecontraception platforms in attempt to
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alleviate some of the financial and economic pressure to ensure reproductive healthcare access to
their uninsured populations.
The proportion of a state population that is rural. Telecontraception platforms also have
the potential to overcome geographic restrictions and barriers to accessing in-person
reproductive healthcare, provided that women have access to the internet. States with larger rural
populations may have limited resources for family planning clinics and services. Geographical
barriers and smaller populations can pose issues of access and service availability for patients in
need of reproductive healthcare services, such as long wait or travel times (Sundstrom et al.
2019). There may be fewer clinics in rural areas which could place greater pressure on existing
clinics. States with higher numbers of rural residents may thus turn to telehealth initiatives to
better serve the needs of their populations. A qualitative interview study of women living in rural
South Carolina found that women discussed the potential of telehealth contraception to fill an
existing gap by reducing cost, wait, and travel times and also providing knowledge and
information about different contraception options (Sundstrom et al. 2019).
Rural areas may also have a smaller variety of contraception options. For example, a
nationwide survey of community health centers showed that rural and suburban community
health centers provide less options for contraception compared to urban health centers, such as
long-acting reversible contraception options like IUDs and implants as well as emergency
contraception such as Plan B (Packtor 2018). Less access to long-acting reversible contraception
methods and emergency contraception can raise the risk of unintended pregnancy (Packtor
2018). One study found higher adolescent birth rates for women living in rural areas with health
professional shortages compared to women living in urban counties (Orimaye et al. 2020).
States with rural populations may grant greater prescribing and dispensing authority to
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telecontraception platforms since they can provide an array of contraception options and
information, while also reducing access issues such as long wait or travel times.
METHODS
Data
This study draws from an original dataset constructed from a variety of public-use
websites of state-level factors for all fifty states hypothesized to influence telecontraception
platform access and availability. The method of fsQCA is well-suited for this research question
because it allows for an investigation of multiple factors such as the social, economic, political,
and legislative conditions across states and how they combine to pattern telecontraception
availability. The total sample size of 50 fits the characteristics of fsQCA, which is suitable when
analyzing small samples like this one (Fainshmidt et al. 2020). As an analytical tool, fsQCA is
used to analyze samples that are larger than case studies but smaller than those needed to support
multiple regression analyses (Fainshmidt et al. 2020). Missing data was minimal; one variable
had three missing values and another variable had one missing value, so the final sample size
was 46 states. This study was approved by the University of Wisconsin-Milwaukee Institutional
Review Board (IRB #20.339).
Measures
Outcome variable. The outcome variable for this study is the availability of
telecontraception platforms in each state as of 2019. This is operationalized as the number of
companies providing telecontraception services that are available to residents in a state.
Information about telecontraception platform availability across states comes from previous
research that mapped out characteristics across telecontraception platforms, such as cost, age
requirements, and state availability (Zuniga et al. 2020; Dorland, Fowler, and Morain 2019). The
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number of telecontraception platforms available in each state as of February 2019 was obtained
from Dorland, Fowler, and Morain’s (2019) research and compiled into a dataset. This outcome
variable serves as a proxy for policy regarding the dispensing and prescribing authority of a
telecontraception company in a state, since it measures the number of companies available to
provide telecontraception services to residents within a given state. The number of platforms
ranged from two to five or more services. Telecontraception platform availability was coded as
“high” if the number of services were three or more, and “low” if a state had two services. This
was coded as a dichotomous variable (1 = high availability; 0 = low availability). Sensitivity
analyses were conducted using alternative categorizations of all variables used in this study (see
Appendix B).
Condition variables. Four condition variables were hypothesized to pattern
telecontraception platform availability: state political control, proportion of women legislators in
each state, proportion of a state population that is rural, and proportion of uninsured women.
Data for state political control and proportion of women legislators are from 2019 and were
obtained from the National Conference of State Legislatures (NCSL) website (National
Conference of State Legislatures 2019; National Conference of State Legislatures 2020). State
political control examines the party control of each state legislature and governorship. Values
consisted of 1 = Democrat control, 0 = Republican control, and 0.5 = divided state control. There
was one missing value for this state control variable (Nebraska, which has a nonpartisan
unicameral state legislature). This variable groups together state legislature control (Democrat,
Republican, or divided) and governor (Democrat or Republican). Sensitivity analyses separated
out this single variable into two separate variables. Since fsQCA software does not count cases
with values of 0.5 on any of the causal conditions, states with divided state control needed to be
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coded as values of 0.4 or 0.6 (Charles Ragin, personal communication, March 4, 2021). This is
because a value of 0.5 represents an exact middle ground and needs to be categorized “into” or
“out of” a condition. States with divided state control were categorized as 0.4 (more Republican)
or 0.6 (more Democrat) based on results of the last four presidential elections (“Red States and
Blue States,” n.d.).
Coding for proportion of women legislators took into consideration the degree of
membership (Ragin 2008a). Degree of membership can be calibrated into various qualitative
breakpoints to indicate membership in a set; this is referred to as “fuzzy set” data (Ragin 2008a).
Qualitative comparative analysis uses either fuzzy set or crisp set data. With fuzzy set data like
this, variables can be coded either as 0 (non-membership) to 1 (full membership), but thresholds
and breakpoints can be set to delineate the level of membership in that condition (Devers et al.
2013). Researchers must determine these various cut points (Devers et al. 2013), first by drawing
on substantive and theoretical knowledge if possible, but in the absence of this guidance,
technical criteria like distribution of cases can be used (Devers et al. 2013). Values for percent
women legislators in each state ranged from 14% to 52%, and were coded into four categories
reflecting the degree of membership in this variable: “fully in”, “more in than out”, “more out
than in”, and “fully out” (Ragin 2008). Small percentages of women legislators in a state were
coded as either “fully out” or “more out than in” of the category. For example, if a state had a
small proportion of women legislators, such as 14 percent, it would be coded as “fully out”.
Proportions of women legislators that were 33% and above were classified as 1 (fully in), less
than 20% as 0 (fully out), 20-25% as 0.33 (more out than in), and anything from 26 to 32 was
0.67 (more in than out).
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Proportion of a state population that is rural was obtained from the United States
Department of Agriculture Economic Research Service (2020) website. Data from 2019 was
collected and calculated by dividing the rural (nonmetro) population by the total population each
state. Three states were missing this information (Delaware, New Jersey, and Rhode Island).
Values for percent rural population ranged from 1% to 69% and were coded into three
categories. Proportions of a state population that is rural that were less than 20% were classified
as 0 (“fully out” using the language of fsQCA), 20-26% as 0.5 (“neither fully in nor fully out”),
and anything above 26% as 1 (“fully in”). Since fsQCA software does not allow values of 0.5 as
mentioned earlier (Charles Ragin, personal communication, March 4, 2021), states with values of
0.5 were coded as 0.4 if they had values of 20-22% rural population (less rural) and coded as 0.6
if they had values of 23-26% rural population (more rural).
Proportion of uninsured women were obtained from the Guttmacher Institute Data Center
website and represent the percentage of women aged 15 to 44 who were uninsured as of 2017
(Guttmacher Institute 2020). Percent uninsured women ranged from 3% to 24%. Values that
were 10% and above were coded as 1 (fully in), 8-9% were coded as 0.67 (more in than out), 7%
as 0.33 (more out than in), and anything 6% or less as 0 (fully out).
Analytic Plan
Qualitative comparative analysis (Ragin 2000; Ragin 2008a; Ragin 2008b) is often used
to analyze small samples like this one and can be particularly helpful for health services
researchers because it can illuminate characteristics of interventions which produce a given
outcome (Kane et al. 2014). This method also acts as a link between quantitative and qualitative
analytical camps because it allows researchers to use both precision and substantive knowledge
in their construction of membership scores (Ragin 2008a). Similar methods that examine
combinations of variables acting together, such as latent class analysis (LCA), require large
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sample sizes (Park and Yu 2018). Other similar methods such as discriminant class analysis
requires a minimum sample size of 20 for four or five predictor variables, but researchers are
strongly urged against using this method with low sample sizes (Poulsen and French 2008), and
cluster analysis requires multiplying the number of variables by 70 to generate the appropriate
sample size (Dolnicar et al. 2014). Given current knowledge about sample size and various
analytical approaches, fsQCA is the best approach here (Ragin 2008b).
Qualitative comparative analysis differs from standard methods such as multiple
regression because it focuses on configurations of cases as packages, or sets, of relations (Ragin
2000; Ragin 2008a). It preserves the complexity and variation across both conditions and cases,
allowing for an analysis of multiple combinatory factors leading to an outcome. As a method,
fsQCA is well-suited to the analyses conducted in this study because it examines specific
combinations of state-level conditions associated with availability of telecontraception platforms.
States are not a homogenous group; they have unique characteristics that can reflect competing
interests. Therefore, fsQCA can capture this variation and examine patterns in telecontraception
platform availability across states. There can be many different combinations of state-level
conditions leading to an outcome, and fsQCA allows researchers to examine each of these
possible combinations (Ragin 2008a). Once the variables are correctly constructed, different
possible combinations of state-level conditions can be identified. Researchers can then conduct
additional analyses to examine the coverage and consistency of various combinations leading to
a particular outcome (Ragin 2008a).
The analysis proceeds in three steps. First, state-level factors hypothesized to pattern
telecontraception platform availability were collected and compiled into a raw data table and
variables were constructed to reflect degree of membership in a set. Second, fsQCA software
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was used to identify all possible combinations of causal conditions patterning telecontraception
platform availability (Ragin and Davey 2016; Ragin 2018). Third, the algorithm in fsQCA was
used to evaluate solution consistency and coverage measures (Ragin and Davey 2016; Ragin
2018). Sensitivity analyses were conducted and used different categorical constructions of key
variables to examine how robust solutions, consistency, and coverage measures were to different
operationalizations of key condition variables (see Appendix B).
RESULTS
Table 7 documents the values for both the outcome and condition measures for all fifty
states. This table shows descriptively the number of telecontraception platforms available in a
state, the proportion of women legislators, state political party control, the proportion of
uninsured women, and the proportion of a state population that is rural. Since fsQCA software
eliminates cases with missing values, the four states with missing values (Delaware, Nebraska,
New Jersey, and Rhode Island) were dropped from all subsequent analyses.
Table 8 documents all possible combinations of condition variables generated from the
dataset. The number of combinations is based on the number of condition variables, so in this
analysis using four condition variables there are 16 possible combinations of state-level
conditions (24 = 16) (Ragin 2008a; Ragin 2018). The number column represents the number of
states that are sorted into a particular combination (Ragin 2008a, p. 131; Ragin 2018). The next
set of columns in Table 8 document consistency scores generated from the fsQCA analysis
(Ragin 2008a). These scores are used to help identify viable combinations linking specific
conditions to the outcome from combinations that are less likely to result in the outcome, given
these conditions (Ragin 2008a). Raw scores document the degree of membership in the outcome,
while PRI (proportional reduction in inconsistency) and SYM (symmetric version of PRI) scores
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document alternative ways of measuring consistency (Ragin 2018; Ragin 2015). All scores range
from a low of 0 (indicating no consistency) to a high of 1 (indicating perfect consistency). Table
8 shows that consistency scores across the different measures (raw, PRI, and SYM) were
identical in all combinations. Values for consistency should be at least 0.80 or higher to be
considered viable combinations of state-level conditions linking specific conditions to the
outcome, although researchers can test different consistency cutoff values to see their effect on
the results (Ragin 2018). Here, the general cutoff of 0.80 was used, resulting in eight out of the
eleven configurations coded as substantially consistent. Robustness analyses were also
conducted using an alternative cutoff value; see Appendix B. Each configuration was assigned a
1 if it met or exceeded the cutoff value or “0” if it was less than the consistency cutoff value. The
last column of Table 8 illustrates all combinations that were identified as exhibiting the outcome
based on the consistency cutoff score of 0.80.
Combinations of State-Level Conditions Linked to Telecontraception Platform Availability
Table 9 documents the identification of three key combinations of state-level conditions
associated with telecontraception platform availability. First, the conditions associated with each
combination are delineated by either “Yes” or “No” to indicate high or low presence of a
condition in a particular combination (“N/A” indicates that the condition was neither present nor
absent). Thus, two combinations (#2, #3) identify the proportion of women legislators in a state
as a key factor, in combination with other conditions, associated with telecontraception platform
availability. Similarly, having Republican state political control is important in producing
telecontraception platform availability in two combinations (#1, #3) in combination with other
conditions. The states associated with each combination are listed next, followed by the
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consistency and coverage scores for each combination. Maps illustrating the combinations of
states found in each combination are shown in Figure 2.
Solution consistency and coverage scores represent the scores for the entire solution;
specifically, the entire body or combination of combinations taken together. Consistency
indicates the percentage of cases with a combination of conditions which also exhibit the
outcome; they range from a low of zero (no consistency) to a high of one (perfect consistency),
with values of at least 0.75 interpreted as identifying meaningful combinations (Ragin 2008a;
Legewie 2013). The individual consistency scores associated with each of the three identified
combinations exhibit high consistency (0.85 – 1.0 > 0.75) with an overall solution consistency of
0.91. Thus, the results in Table 9 demonstrate that all three combinations of state-level factors,
both individually and taken together as a whole, represent meaningful conditions that are
associated with telecontraception platform availability.
Coverage indicates how well a combination of state-level conditions accounts for the
outcome instance by measuring if the combination is empirically relevant or important to the
outcome (Ragin 2008a; Legewie 2013). Coverage scores range from a low of zero (no coverage)
to a high of one (high coverage). Raw coverage measures the percentage of cases exhibiting the
outcome that are explained by the combinations of conditions in a combination, while unique
coverage measures the percentage of cases in the outcome explained by each individual
condition in a combination (Ragin 2018). Although there are no formal guidelines on cutoffs for
coverage scores, its values have been compared to R2 ranging from zero to one (Legewie 2013;
Thiem 2010). Table 9 documents both coverage scores for each combination (ranging from 0.24
to 0.32) and the solution as a whole (0.62). Combinations can have high consistency but low
coverage, or vice versa, but this information can still be meaningful from either an empirical or
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theoretical standpoint (Ragin 2008a). Ragin (2008a) explains how consistency is similar to the
idea of “significance” and coverage is similar to the idea of “strength” in correlation statistical
analyses. These two measures of consistency and coverage analyze how well the combinations
display the outcome and which conditions are most relevant or important for exhibiting the
outcome.
The results in Table 9 document that all four state-level conditions are relevant for
evaluating the outcome of telecontraception platform availability. Put differently, there is not a
single condition variable that was not utilized in these analyses, indicating that these state-level
conditions are necessary if cultivating greater telecontraception access is a policy goal. Some
combinations may not contain a condition, but others do, which indicates that there is more than
one combination of conditions that coexist with telecontraception platform availability in a state.
Ten states exhibit the first combination of state-level conditions, fifteen states display the second
combination of conditions, and seven states show the third combination of conditions associated
with telecontraception platform availability.
Combination #1. The first combination documents cases in which telecontraception
platform availability is present when there is Republican state political control, a presence of
uninsured women, and the absence of a rural population (consistency = .85; coverage = .24). Ten
states exhibited this combination (Arizona, Florida, Georgia, Indiana, Louisiana, North Carolina,
South Carolina, Tennessee, Texas, and Utah). Figure 2 shows that these states are mostly
clustered in the southwestern and southeastern regions of the United States. Two states
(Louisiana and Utah) exhibit this combinations of conditions but lead to low telecontraception
platform availability (2 services available in their states). The goal of fsQCA is to identify
configurations of conditions linked to an outcome with high consistency, meaning that there will
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be few or no cases with an outcome value of zero (Charles Ragin, personal communication,
March 5 and 10, 2021). Although this combination of conditions contains two cases which lead
to low telecontraception platform availability, it yields a high consistency score of .85 which
illustrates that this combination is a strong subset of the outcome. Percent women legislators was
not a necessary condition to telecontraception platform availability for this combination.
Combination #2. The second combination illustrates that telecontraception platform
availability is present when there is a presence of women legislators, Democratic state political
control, and an absence of a rural population (consistency = 1.0, coverage = .32). Fifteen states
exhibited this combination (California, Colorado, Connecticut, Hawaii, Illinois, Massachusetts,
Maryland, Michigan, Minnesota, Nevada, New York, Oregon, Pennsylvania, Virginia, and
Washington). Looking at Figure 2, these states are grouped into regions within the northern half
of the United States; there are no southern states in this combination of conditions. The
consistency score of 1.0 represents perfect consistency, indicating strong identification of a
combination of conditions to the outcome. Raw coverage is .32, illustrating that this combination
of conditions is relevant or important to the outcome. The percentage of uninsured women in a
state was not a necessary condition to telecontraception platform availability for this
combination.
Combination #3. The third combination consists of a presence of women legislators,
Republican state political control, and a presence of uninsured women. Seven states exhibit this
combination of conditions (Alaska, Arizona, Florida, Georgia, Idaho, Kansas, and Montana). As
Figure 2 shows, these states are concentrated in the western and southeastern regions of the
United States. Three states in this third combination (Arizona, Florida, and Georgia) also
appeared in the first combination. The finding that these three states belonged to multiple
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combinations illustrates how there are multiple pathways to telecontraception platform
availability. Specifically, the focus of fsQCA is on the combinations of conditions across each
grouping of states rather than the individual states themselves. States can be in more than one
combination because each combination illustrates the shared pertinent combination of conditions
linked to an outcome across these specific cases. This third combination exhibited high
consistency (.91) and coverage (.25), indicating this is a meaningful and relevant combination of
conditions to the outcome.
Finally, the overall solution consistency and coverage scores for all three combinations
are high (solution consistency = .91, solution coverage = .62), indicating that these three total
combinations are meaningful and relevant combinations to the outcome of telecontraception
platform availability. In total, the three combinations contain 29 states which indicates that most
states in the U.S. are represented in this analysis. States that did not appear in any of the three
combinations may have some other, unmeasured state-level conditions that are also important to
telecontraception access but have yet to be investigated.
DISCUSSION
This study utilized fsQCA to analyze combinations of state-level factors linked to
telecontraception platform availability. Although telecontraception platforms are growing in
number and scope, access to their services is not patterned equally across the United States.
Thus, despite arguments about the “disruptive” nature of emerging platforms and technologies,
where a woman lives can determine whether she can access telecontraception. Despite the
growing number and scope of healthcare platforms, research has yet to examine the state-level
conditions that have important effects on the on-the-ground experiences of women attempting to
access these services. This study serves as a first step to help better understand how key state-
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level features, alone or in combination with others, might be important for access to
telecontraception. Although there are sixteen possible combinations that could occur, it is
noteworthy that the analyses uncovered three combinations of state-level conditions linked to
telecontraception platform availability with very high consistency.
One major finding from this study is that having a large presence of women in state
policymaking roles alongside other political and economic state-level conditions is an important
ingredient for availability of telecontraception platforms, aligning with previous research that
points to the importance of higher proportions of women legislators proposing bills related to
women’s rights and issues (Tam 2020; Tam 2017; Volden, Wiseman & Wittmer 2018; Thomas
1991; Saint-Germain 1989). Importantly, the presence of women legislators in combination with
other state-level conditions was linked to telecontraception platform availability in both
Republican and Democrat politically controlled states. This is interesting since many public and
policy discussions surrounding birth control and reproductive rights often focus solely on
political party. Robustness analyses examined whether this condition variable of women
legislators is an indicator of larger Democratic political party control, since there are greater
numbers of women legislators in the Democratic party compared to the Republican party
(Blazina and Desilver 2021; National Conference of State Legislatures 2019). Results of this
robustness analysis produced similar findings but lower coverage scores (see Appendix B),
indicating that the partisan composition of women legislators in combination with other social,
economic, and political conditions is less relevant in leading to telecontraception platform
availability than the percentage of women legislators in combination with other factors.
The gender makeup of legislative bodies may operate as a force in and of itself in
influencing policies affecting women, as seen in previous work which found that states with
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higher proportions of women representatives propose more bills pertaining to women, children,
and families compared to men and also compared to states with lower proportions of women
representatives, regardless of political party (Volden, Wiseman & Wittmer 2018; Thomas 1991;
Saint-Germain 1989). It may be that women legislators have firsthand, personal experience with
hurdles or barriers to accessing birth control and reproductive healthcare services, which could
drive their decisions and actions. Future research is needed on how women legislators prioritize
and make decisions about telecontraception policy and legislation.
The number of women in political positions of power is growing. In earlier research on
the proportion of women in state legislatures, percentages ranged from 3 to 30% in 1988
(Thomas 1991). Now, women in the legislature range from 14 to 52%, and 2019 yielded the
largest number of women elected at a single time (National Conference of State Legislatures
2019). As more women move into policymaking roles, their ability to push issues and influence
decisions may increase. Many discussions surrounding birth control and reproductive rights often
focus on political party. Findings from this study suggest that gender and having women in
positions of power, in combination with other political and economic state-level factors, is
another growing and important factor to consider in legislation and policy related to women’s
issues such as reproductive health rights and policy. This also carries implications for broader
policy issues related to women, suggesting another channel through which advocacy groups can
push for change.
Another important combination of state-level factors leading to high telecontraception
platform availability was Republican state political control and the economic pressures of a state.
Two out of the three combinations require Republican state political control but also have a high
percentage of uninsured women. This suggests that states may take into consideration the needs
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of their populations or respond to pressures regarding these populations, despite political party
ideology towards contraception. Republican-controlled states may also endorse telecontraception
platform services as a market-based solution to the needs of their population because they align
with their ideology of business model market solutions to healthcare. It also may be that states
are facing greater pressures on public family planning clinics due to the Trump administration’s
gag rule, causing states to turn to market-based solutions such as telecontraception platforms that
can grant these options to women living in these states. Looking at the set of these states, some
have large populations and thus may have larger uninsured populations and metropolitan areas
(such as Florida and Texas). This may also contribute to the finding of why the absence of a
rural population was linked to telecontraception platform availability because states with nonrural populations may have larger metropolitan areas with greater numbers of uninsured
residents. On the other hand, it could also be that states with large rural populations may be less
likely to deviate from socially conservative policies.
One last important pattern to note is the geographical clustering of states in the different
combinations. Overall, the combinations illustrate distinct groupings of geographical regions.
For example, the first combination is concentrated among states in the southwest and southeast
regions of the United States. Neighboring states may share similarities not just in their
geographical location but also in their attitudes, ideologies, and demographics. These regions can
be viewed as “cultural groups” with their own set of political cultures and values (Elazar 1984).
Even the names of these groupings are conceptualized as mini-regions: “New England” is one
such example of a geographical region of a group of states “bound by the tightest of social and
historical ties” despite differences among these states (Elazar 1984:138). Previous research has
classified these regions into three political cultures: individualistic, moralistic, and traditionalistic
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(Elazar 1984). Thus, states may share similar norms from which they operate to address new
technological innovations such as telecontraception. States may also look to each nearby states
for guidance when passing legislation, such as through the processes of diffusion, isomorphism,
or legitimacy (Scott 2014; Rogers 1995). Communication and social networks across these
clusters of states may be a key factor operating in the availability of telecontraception platforms.
As these platforms are a new, innovative technology, states may look to nearby neighbors for
guidance or tap into their communication networks in the face of uncertainty. These findings
suggest that adoption of new technological innovations may first occur across geographical
regions rather than nationwide.
Technologies shape and are shaped by their social context. This study illustrates how
political, economic, and social factors pattern the accessibility and availability of
telecontraception platforms across the United States. Technologies “are the products of social
processes and social choices” (Saetnan 2000, p. 3), and telecontraception platforms are one
example that illustrates how on-the-ground decisions affect technological designs and use, and
vice versa. Findings from this study demonstrate how the path to telecontraception availability is
not one-size-fits-all. Rather, there are many different decisions, choices, and possibilities to
arrive at this outcome. Some states, such as Arizona, Florida, and Georgia, belonged to more
than one combination linked with telecontraception platform availability. This illustrates the
configurational nature of fsQCA which emphasizes the combinations of conditions linked to an
outcome, rather than “independent variables” having separate effects on an outcome used in
other forms of quantitative analyses (Ragin 2008a). Rather than viewing the states as separate
entities operating independently, fsQCA considers the whole package of states that share a
common pattern of conditions linked to an outcome. Thus, states can be in more than one
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combination because they have multiple possible relevant configurational conditions linked with
telecontraception platform availability.
Limitations
These results should be interpreted with a few limitations in mind. First, it is important to
remember that telecontraception platform availability as the outcome variable in this study
served as a proxy for policy regarding the dispensing and prescribing authority of a
telecontraception company in a state. There may be other, missing factors not accounted for
which influence the availability of telecontraception platforms in a state such as administrative
policies or hurdles to telecontraception implementation. Another limitation to note is that this
study uncovered four condition variables important to telecontraception policy, but there are
undoubtedly many other important conditions that pattern telecontraception platform availability
across states. One of the strengths of fsQCA is its ability to delineate the many different
combinations that lead to an outcome. However, there are other possible conditions or factors
that could pattern telecontraception access that have not been investigated yet, such as state laws
allowing pharmacists to prescribe and provide contraceptives or states that expanded Medicaid
under the Affordable Care Act. This may explain why 17 out of the 46 states in this sample did
not fit the combinations of conditions linked to telecontraception platform availability in this
study because they may have other unmeasured state-level conditions that are also important to
telecontraception access.
CONCLUSION
The case of telecontraception platforms is a prime example of the social shaping of
technology because it illustrates that social, economic, and political conditions influence the
design, implementation, and use of new innovations like telemedicine. Previous generations of
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women have attempted to use the technology of their day to gain access to health information
and products that were not available in their local area. In 1873, a federal law made it illegal to
send contraception information and devices through the U.S. mail (May 2010). Today, many
women are turning to telecontraception platforms to access birth control. Yet reproductive health
products are still not available to all women because political climates regulate the ability of a
platform to prescribe or dispense contraception, just as we regulated the mail—another “placedisrupting” technology—in the nineteenth century. This study demonstrates that conditions at the
state level are an essential and important area of study when looking at telecontraception access,
as well as telemedicine and telehealth policy broadly. Technological innovations alone are not
enough. They require the right social conditions to work as intended. Qualitative comparative
analysis provides an innovative and informative approach for policymakers, stakeholders, and
researchers to examine the state-level factors that pattern access to telecontraception,
illuminating opportunities for intervention and improvement of reproductive healthcare across
the United States.
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Table 7. Descriptive Table of Outcome and Condition Variables
State

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Number of
Telecontraception
Platforms
3
4
5
3
5
5
5
2
5
5
3
3
5
5
5
3
4
2
3
3
5
5
5
2
5
5
5
3
2
5
2
5
4
4
5
2
4
5
5
4
4
5
5
2
3
5
5
2
5
5

Women
Legislators
(%)
16
38
39
24
31
47
33
24
30
31
32
31
36
24
29
28
23
16
39
39
29
36
32
14
25
30
29
52
34
31
36
32
25
21
27
22
40
27
38
16
24
16
24
24
40
26
42
14
27
16

Political Party
Control
Republican
Republican
Republican
Republican
Democrat
Democrat
Democrat
Democrat
Republican
Republican
Democrat
Republican
Democrat
Republican
Republican
Split
Republican
Split
Democrat
Split
Split
Split
Split
Republican
Republican
Split
--Democrat
Split
Democrat
Democrat
Democrat
Split
Republican
Republican
Republican
Democrat
Split
Democrat
Republican
Republican
Republican
Republican
Republican
Split
Split
Democrat
Republican
Split
Republican
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Uninsured
Women
(%)
14
15
13
11
9
10
7
7
18
19
5
16
9
11
5
11
7
10
11
8
3
6
6
17
13
11
12
15
7
11
12
7
15
10
7
20
9
7
6
16
12
11
24
11
5
12
8
8
7
17

Rural
Population
(%)
23
33
5
37
2
12
5
--3
17
19
32
11
22
40
31
41
16
41
3
1
18
22
53
25
65
34
9
37
--33
7
21
50
20
34
16
11
--14
51
22
11
10
65
12
10
38
26
69

Table 8. All Combinations of State-Level Conditions Linked to Telecontraception Platform
Availability
Combination
Women
Legislators

Condition Variables
State
Uninsured
Political
Women
Control

Number

State

Rural
Population

1

0

0

1

1

9

2

1

1

1

0

8

3

1

1

0

0

7

4

0

0

1

0

7

5

1

0

1

1

4

6

1

0

1

0

3

7

1

1

0

1

3

8

1

1

1

1

2

9
10
11
12
13
14
15
16

1
0
1
0
0
0
0
0

0
0
0
0
1
1
1
1

0
0
0
0
0
1
0
1

0
1
1
0
0
0
1
1

1
1
1
0
0
0
0
0

97

AL,
AR,
MS,
MO,
ND,
OK,
SD,
WV,
WY
CA,
CO,
IL,
MD,
NV,
OR,
VA,
WA
CT,
HI,
MA,
MI,
MN,
NY,
PA
IN,
LA,
NC,
SC,
TN,
TX,
UT
AK,
ID,
KS,
MT
AZ,
FL,
GA
NH,
VT,
WI
ME,
NM
OH
KY
IA

Consistency
Raw PRI SYM

.76

.76

.76

Meets or
Exceeds
Consistency
Cutoff of
.80
0

1.0

1.0

1.0

1

1.0

1.0

1.0

1

.83

.83

.83

1

.90

.90

.90

1

.94

.94

.94

1

.73

.73

.73

0

.65

.65

.65

0

1.0
.86
.87

1.0
.86
.87

1.0
.86
.87

1
1
1

Table 9. Key Combinations of State-Level Conditions Linked to Telecontraception Platform
Availability
Conditions
Women Legislators
State Political Control (Dem)
Uninsured Women
Rural Population
States with this combination of
conditions

Consistency
Raw coverage
Unique coverage

Combination #1

Combination #2

Combination #3

N/A
No
Yes
No

Yes
Yes
N/A
No

Yes
No
Yes
N/A

AZ, FL, GA, IN, LA, NC, SC,
TN, TX, UT

CA, CO, CT, HI, IL,
MA, MD, MI, MN, NV,
NY, OR, PA, VA, WA

AK, AZ, FL, GA, ID,
KS, MT

.85
.24
.10

1.0
.32
.27

.91
.25
.11

Solution consistency
.91
Solution coverage
.62
Note. “Yes” = high presence of a condition; “No” = low presence of a condition.
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COMBINATION #1

COMBINATION #2

COMBINATION #3

Figure 2. Maps Showing States Associated with Each Combination of State-Level Conditions
Linked to Telecontraception Platform Availability
(Source: Mapchart.net 2020).
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AIM #3: An Analysis of User Reviews from Nurx and Planned Parenthood Direct: What
User Experiences Reveal About Mobile Apps for Reproductive Health
Health apps and telemedicine are growing in numbers and demand, particularly with the
current COVID-19 crisis (Lupton 2018; Carroll et al. 2017; Payne et al. 2015). One growing
segment is the rise of telecontraception platforms that aim to provide accessible birth control and
reproductive healthcare services via an app or website. Telemedicine can save time and money
and is linked with high patient and provider satisfaction (Hanson et al. 2019), yet it is not known
whether these same findings carry over to telecontraception. Given that nearly one-third of
women reported difficulties obtaining prescription birth control or refills (Grindlay and
Grossman 2016), telecontraception serves as a potential solution to address important existing
access barriers such as geography (Chuck 2017; Sundstrom et al. 2019), time (Rodler et al. 2020;
Jain and Mehrotra 2020), and cost (Weigel et al. 2019; Grindlay and Grossman 2016).
Despite recent media coverage of telecontraception platforms (Stengel 2020; Basu 2019;
Chuck 2017), research examining women’s experiences and evaluations of telecontraception
platforms is lacking. Nurx, a startup telecontraception company, provides care to over 300,000
patients monthly (Shieber 2020; Landi 2020). While there has been research on health app users,
such as their demographic characteristics and health behaviors (Carroll et al. 2017), little
research exists on telecontraception platform users and their experiences using these platforms.
Existing research has looked at telecontraception requests (Wollum et al. 2018; Martinez et al.
2020), experiences of those who requested PrEP (pre-exposure prophylaxis) (Hughes and
Koester 2019), and rural women’s perceptions of the idea of telecontraception (Sundstrom et al.
2019). There are also studies on the users of online informational reproductive health apps
(Whitfield, Welti, and Manlove 2019; Gressel et al. 2014; Akinola et al. 2019).
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Research has shown that women value accessible contraception. One study found that
over two-thirds of women in the United States would use contraception available directly from
pharmacists, with higher interest among low-income and uninsured women (Landau, Tapias, and
McGhee 2006). Another study found that 39 percent of U.S. women would be likely to use a
progestin-only birth control pill if it was available over the counter, particularly if they are
insured or tried to get a birth control prescription in the last year (Grindlay and Grossman 2018).
However, it is unknown whether these same patterns and attitudes carry over to telecontraception
platforms, nor the main reasons why women seek contraception outside of an in-person doctor
visit. Highlighting user evaluations of telecontraception platforms can uncover motivations for
using the platform, delineate the pros and cons of using the platforms, and illuminate needs gaps
in the traditional in-person healthcare system, an area of growing importance during the current
COVID-19 pandemic. Doing so can help inform reproductive health policy and services both in
telemedicine and traditional in-person healthcare systems.
To address this gap in knowledge, this study analyzed user reviews for two major
telecontraception platforms: Nurx and Planned Parenthood Direct. These platforms represent two
contrasting entities in terms of their size, stage of development, and user orientation. While Nurx
is an online startup company operating completely in the virtual sphere, Planned Parenthood has
been around for over 100 years and has local, physical locations where users can go for in-person
appointments (Planned Parenthood Federation of America Inc. 2021). Therefore, these two
telecontraception platforms offer varying degrees of telehealth services, name recognition, and
user orientations to their platform. Findings from this study illustrate that while there are
similarities in user evaluations of telecontraception services, there are important differences by
platform. These insights indicate that while similar factors underlie women’s motivations for
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accessing telecontraception, their experiences can differ across telecontraception platforms. Most
importantly, user reviews of both platforms illuminate areas in which telecontraception is
addressing existing barriers to contraception as well as identify areas for improvement.
LITERATURE REVIEW
User Reviews and Health Care Experiences
Mobile apps have been used in many different types of health interventions, ranging from
diet and physical activity to mental health, and there are now over 31,000 health-related apps
(Payne et al. 2015). Analysis of user reviews is a growing way of studying apps because they can
yield valuable insights about user experiences. “User experience” is a term originally used in the
human-computer interaction field but is now a growing term applied to various other contexts
and settings (Araz 2018). Studies of user experience examine the interaction between a user and
an artifact in a certain context (Araz 2018). App designers have a goal in mind about what they
would like users to experience when they create an app (Araz 2018). Thus, analyzing user
experiences can uncover whether these apps are producing the desired experience for users.
User experience is also important from a sociological standpoint since it incorporates and
relies upon context. When looking at user experience, there is more than just the “user” and the
“app”: the user and app interact in a certain context or situation (Araz 2018). All three factors are
necessary when studying user experience. Studying user reviews of health apps can yield
valuable insights about these three factors: the user, the object, and the context. User reviews can
illuminate what users find valuable about an app, how and why they use an app, and requests for
desired features (Stawarz et al. 2018; Genc-Nayebi and Abran 2017; Caldeira et al. 2017). This
information can provide a greater understanding of social life and the broader social context,
since it can uncover motivations and reasons for using an app. Technology can provide solutions
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that purport to make life easier and solve existing problems. Apps are an example of this, in that
users may turn to an app for a problem or a need (Light, Burgess, and Duguay 2018).
Technological innovations such as apps arise from a particular social context (MacKenzie
and Wajcman 1999). Studying apps can thus reveal information about societal dynamics and
areas of sociocultural and economic transformation (Light, Burgess, and Duguay 2018). From a
sociological standpoint, analysis of apps can move beyond simply the functionality of apps to
reveal deeper insights about its users, its intentions, and its cultural meanings – what researchers
have termed “the walkthrough method” (Light, Burgess, and Duguay 2018). This method fuses
science, technology, and cultural studies into one to provide a framework for critically analyzing
an app (Light, Burgess, and Duguay 2018). At its core, this method recognizes that culture and
technology shape one another and users experience a technology in a particular social context or
culture (Light, Burgess, and Duguay 2018). In practice, it highlights the cultural discourses
embedded in an app’s interface and how this might influence user interactions with an app
(Light, Burgess, and Duguay 2018). The walkthrough method examines an app’s vision,
operating model, and governance, then moves to features and functions such as registration and
entry, everyday use/activities, and app suspension or closure (Light, Burgess, and Duguay 2018).
Using this method can yield insights about the vision and the larger context in which these apps
are developed and can be combined with interviews or content analysis of user reviews or
discussions to provide a fuller picture of how users adapt and apply the app in their life.
Overview of Telecontraception Platforms
Nurx, LemonAid, Pill Club, and Planned Parenthood Direct are all examples of online
platforms which provide birth control via an app or website. Known colloquially as “the Uber for
birth control” (Brown 2016; Chuck 2017), these platforms aim to increase access to a variety of
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reproductive healthcare services such as birth control, sexually transmitted infection (STI) testing
and treatment, urinary tract infection (UTI) treatment, and emergency contraception by providing
access to on-demand providers for consultations and shipping prescriptions directly to customers
or to their pharmacy. Users download the app or go to the company website, create a profile with
their contact information, and answer health history questions. Costs for birth control vary
depending on the platform, insurance status or type, and whether a drug is a brand name or a
generic equivalent. Some platforms charge a consultation fee.
During consultations, patients are provided access to on-demand providers who can
discuss needs, concerns, and provide information and education about different options. Patients
can interact directly with a provider and ask questions on their schedule when it is convenient for
them. The degree of interaction can vary depending on the platform, such as messaging versus a
video consultation. Once a patient has selected an option, a licensed member of the medical team
in the user’s state (either a doctor, nurse practitioner, or physician assistant) reviews, fills, and
sends the prescription directly to the customer. However, policy and legislation affect the reach
of a platform by dictating its ability to prescribe and/or dispense medication. Therefore,
customers may not have equal access to these services simply due to the state they live in.
In-Person Reproductive Health Care Interactions vs. Telecontraception
In-person visits. Obtaining prescription contraception or reproductive health care
typically requires an in-person visit to a healthcare provider in a medical setting such as a
doctor’s office or clinic (Hariton and Tracy 2019). Visits for contraception are considered
preventive care and are covered under the Affordable Care Act (ACA) by most insurance plans,
although religious employers may choose not to cover contraception (U.S. Centers for Medicare
& Medicaid Services 2020). Patients who do not have insurance or are not eligible for Medicaid
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pay out-of-pocket for a visit, although some clinics offer discounted rates or free services under
certain programs which can vary by state. This preventive care is called a “well-woman visit”
and consists of obtaining health history, screenings, and counseling depending on the patient’s
age and family history (The American College of Obstetricians and Gynecologists 2020). The
well-woman visit provides an opportunity for a provider to assess a woman’s overall health,
although taking a blood pressure reading is the only test that is medically necessary for starting
hormonal contraceptive use (Centers for Disease Control and Prevention 2017).
Ideally, an in-person visit for contraception consists of a dialogue between the patient and
provider regarding information and options. There are mixed findings regarding how these
interactions play out and these can vary depending on different factors. Research has found that
black women were more likely than white women to report pressure to use contraceptives by a
provider (Becker and Tsui 2008), pressure that can be implicit such as through provider tone of
voice or imbalanced information favoring certain methods (Gomez and Wapman 2017). Other
research did not find differences in contraceptive counseling by race or ethnicity or
socioeconomic status of the patient but found that providers largely did not assess patient
pregnancy intention, birth control preferences, or allow patients an opportunity to ask questions
(Dehlendorf et al. 2017). Educational, interactive decision tools for patients to choose birth
control and a printout given to the provider about their preferences prior to a healthcare visit
have been effective in patient-provider communication by allowing patient concerns and
preferences to enter the discussion rather than being dictated by the provider’s presumptive
expertise (Holt et al. 2020).
There are both benefits and drawbacks to requiring an in-person visit to obtain
prescription birth control. Benefits include speaking with a provider one-on-one to get
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information and ask questions about different birth control options, assessing overall health and
vital signs, and zero cost under ACA (if a patient has insurance). There are also certain birth
control methods that must be physically carried out in person, such as insertion of an implant or
intrauterine device (IUD). Drawbacks include time, transportation, cost (if uninsured), and a nonindicated invasive pelvic exam, which research has shown is not necessary for prescribing birth
control (Ellison et al. 2021; Stormo et al. 2011). Other drawbacks can influence the quality of
care such as limited time to cover all the information, answer patient questions, or complete
additional tasks such as screenings, as well as other provider interaction issues such as pressure,
imbalanced information, or lack of patient input (Becker and Tsui 2008; Gomez and Wapman
2017; Dehlendorf et al. 2017).
Telecontraception “visits”. Research on telemedicine illustrates that it reduces or
eliminates many barriers associated with in-person visits. Convenience is a major factor in
telemedicine studies because patients can access healthcare providers and services outside of
normal business hours (Jain and Mehrotra 2020; Rodler et al. 2020). Patients also receive access
to on-demand providers who can provide information and education about different options,
discuss concerns, and answer questions, in comparison to an in-person visit where a provider
may be pressed for time due to juggling multiple tasks such as assessing a woman’s whole health
history or conducting other screenings. The ability to discuss options with a provider was
mentioned as a benefit of telecontraception, as rural women indicated that this could provide
knowledge and information about different contraception options (Sundstrom et al. 2019). In
contrast, research on in-person visits found that providers largely did not assess a patient’s
pregnancy intention, birth control preferences, or allow patients an opportunity to ask questions
(Dehlendorf et al. 2017). Barriers such as long wait times for an appointment, time taken off
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work to go to an appointment, transportation issues, and an invasive, non-indicated pelvic exam
are all eliminated through telecontraception.
Research has demonstrated both family planning provider and patient support for
telecontraception services (Stifani, Avila, and Levi 2021; Sundstrom et al. 2019). Despite this
support, uptake of its services varies. A recent report found that contraceptive management
represented 65 percent of all reproductive health telemedicine claims for those with employersponsored health insurance plans (Weigel et al. 2019). Rates of telemedicine use are higher for
those with private insurance, higher income, and living in suburban and urban areas (Weigel et
al. 2019; Jain and Mehrotra 2020). One explanation for this finding is that most telecontraception
platforms do not accept Medicaid, and there can be cost issues if a platform provider is not
considered in-network (Weigel et al. 2019). In contrast, users visiting an in-network provider for
birth control in a traditional healthcare setting can have those reproductive healthcare services
covered at no cost under ACA. Depending on insurance, patients may end up paying more using
these platforms than visiting a healthcare provider in person (Weigel et al. 2019). Cost and
coverage are two important potential explanations for low uptake rates of telecontraception
services, despite patient and provider support for these platforms (Stifani, Avila, and Levi 2021;
Sundstrom et al. 2019).
Barriers to Accessing Contraception
Nearly one-third of women reported difficulties obtaining prescription birth control or
refills (Grindlay and Grossman 2016). The most common barriers related to the in-person visit
include long appointment wait times, requirements of in-person exam or pap smears,
transportation issues, not having a regular place to go for health care, and cost or insurance
concerns, with uninsured and Spanish-speaking women more likely to report barriers to
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accessing contraception (Grindlay and Grossman 2016). Barriers are such a large factor in
obtaining contraception that The American College of Obstetricians and Gynecologists (2019)
published a committee opinion expressing their support and recommendation of over-the-counter
hormonal contraception.
Geography. By removing the in-person visit requirement, telecontraception can help meet
the needs of women in contraceptive deserts or rural areas who reside far from clinics (Chuck
2017; Sundstrom et al. 2019). Elimination of geographical barriers is a frequently cited benefit of
telemedicine, but the research is mixed. One study found that rural women discussed the
potential of telecontraception to fill an existing gap by reducing cost, wait, and travel times
(Sundstrom et al. 2019). However, another study found that patients using telemedicine lived in
urban areas with higher income and most did not live in a primary care health professional
shortage area (Jain and Mehrotra 2020). This suggests that the idea of telemedicine might
operate differently than its implementation, since in practice it may not address geographical
barriers due to lack of awareness of telemedicine services, internet access, or cost (Jain and
Mehrotra 2020). State-level legislation and policy can also affect the reach of telemedicine
across states by dictating a platform’s ability to prescribe and/or dispense medications. Thus,
although telecontraception platforms are designed to increase access to contraception, access can
still be limited depending on place-based regulation.
Medical gatekeeping. Another important barrier to obtain contraception is medical
gatekeeping. Although not medically necessary, many women report that their doctor requires
pelvic exams prior to prescribing hormonal contraception (Mencimer 2012; Ellison et al. 2021).
For example, one study found that 71.6 percent of obstetrician-gynecologists and 67.7 percent of
family/general practitioners reported routine use of pelvic examinations as a requirement for
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hormonal contraception (Stormo et al. 2011). However, blood pressure is the only test that is
medically necessary for starting hormonal contraceptive use (Centers for Disease Control and
Prevention 2017). Pelvic exams are “not necessary before initiation of combined hormonal
contraceptives because it does not facilitate detection of conditions for which hormonal
contraceptives would be unsafe” (CDC 2017; Westhoff, Jones, and Guiaha 2011; Stewart et al.
2001; The American College of Obstetricians and Gynecologists 2015). These exams carry the
risk of over-testing and false positives, anxiety, pain, and distress due to their invasiveness, and
women may avoid the doctor altogether due to pelvic exams (Rabin 2014; Stormo et al. 2011). In
contrast, telecontraception platforms only require blood pressure or a brief health overview,
complying more with scientific findings regarding birth control prescriptions than in-person
providers. Consequently, telecontraception platforms provide a direct challenge to the traditional
healthcare system linking birth control prescriptions with exams by eliminating the need to see a
provider in person and undergo an invasive, non-indicated exam to receive birth control.
Policy and legislation. Access to birth control is heavily influenced by policy and
legislation. Nearly half of the states in the U.S. have some type of law dictating actions
surrounding moral or religious objections to filling certain prescriptions, such as oral
contraceptives or emergency contraception (Chiarello 2011). Some states have a “conscience
clause” for medical providers, which allows them to opt out of medical processes or procedures
due to moral or religious reasons (Chiarello 2011; Berlinger 2008; Harrington 2006). Other states
have “duty-to-dispense” laws or “refuse-and-refer” laws which entail stricter enforcement of
filling prescriptions (Chiarello 2011). Legislation by the Trump administration allows employers
to decline contraception coverage for their employees based on personal religious or moral
reasons (U.S. Centers for Medicare & Medicaid Services 2020; Adamczyk 2020).
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Telecontraception platforms aim to reduce these barriers by facilitating women’s access to
doctors and pharmacists who believe in accessible birth control.
Overall, existing research highlights how barriers to obtaining contraception are linked
with the requirement of an in-person visit. Telecontraception aims to alleviate many of these
barriers through its technology, but no studies to date have examined these claims through an
analysis of users’ experiences, as revealed by reviews. Research is needed to illuminate whether
telecontraception platforms provide a viable alternative to in-person birth control visits by
addressing barriers related to obtaining contraception, such as those related to geography and
medical gatekeeping, as well as how and why users use these apps. Qualitative research using
analysis of user reviews allows for an in-depth study of the meanings and experiences of
telecontraception platform users, an advantage that cannot be captured through experimental
design or survey questionnaires (Atieno 2009). Furthermore, user reviews represent a source of
information and insights from many people (Frie et al. 2017) and thus can illuminate why
women are using telecontraception platforms and their evaluations of these services on a larger
scale. Illuminating motivations, reasons, and experiences using telecontraception can shed light
on the potential of telecontraception to address existing barriers as well as identify unmet needs
and areas for improvement related to obtaining contraception in the traditional healthcare system.
METHODS
Sample
There are currently 17 telecontraception platforms that provide reproductive health
services in the United States (Ibis Reproductive Health 2021). Telecontraception platforms that
did not write birth control prescriptions, did not contain any user reviews, or only offered
services to one or a few states were excluded. Telecontraception platforms that provided user
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reviews only on their company website or a specialty review website were also excluded due to
concerns about company control of this content. Telehealth platforms which offered birth control
as one of a myriad of health services were also excluded because user reviews contained
information on unrelated issues (e.g., ordering contacts). After these exclusions, two strictly
telecontraception platforms (Nurx and Planned Parenthood Direct) remained which cover the
largest number of states, contain the largest number of user reviews, and represent two
contrasting stages of development in the emerging field of telecontraception platforms.
While Nurx is an online startup company founded in 2015 and currently has over 16,000
user reviews (Crunchbase Inc. 2021; Nurx Inc. 2021), Planned Parenthood Direct began as a
pilot program in six states and has over 200 user reviews (Lovett 2019; Google Play 2021). Nurx
and Planned Parenthood Direct are opposites of the telecontraception platform spectrum,
representing contrasts in size, development stage, and user orientation. While Nurx operates
completely in the virtual sphere, Planned Parenthood Direct also lets users request in-person
appointments at their local Planned Parenthood location (Lovett 2019). Planned Parenthood has
also been around for over 100 years and so may have greater name recognition and familiarity,
which could make the transition to telemedicine easier for some patients who have visited its inperson locations (Planned Parenthood Federation of America Inc. 2021).
Data
User reviews were collected using AppFollow, an open-source tool specializing in app
analytics, to compile all user reviews for Nurx and Planned Parenthood Direct. AppFollow
contained reviews for these two platforms beginning in 2017, so data for this study contains user
reviews posted on either platform between 2017 through January 2021. The data for user reviews
is publicly available on either the website or app of the telecontraception platform. Publicly
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available data of user reviews in app stores represents an opportunity to naturally investigate
consumer perspectives (Nicholas et al. 2017). Thus, a qualitative analysis of a convenience
sample of user reviews is the best method for this exploratory research question because it serves
as a way to unobtrusively garner user evaluations and experiences with using this emerging
service of telecontraception platforms. This study was approved by the University of WisconsinMilwaukee Institutional Review Board (IRB #20.339).
Due to concerns about companies controlling the content of reviews, reviews were
collected from the Google Play Store and Apple App Store rather than the company websites.
Nurx had 269 reviews on the Google Play Store and 1,055 reviews on the Apple App Store.
Nurx was initially only available through the Apple App Store, which could explain why the
number of reviews are so much higher for that platform. In addition, although the majority of
smartphone users around the world use the Android system, iOS is the most popular mobile
operating system in North America (Afilias Technologies Limited 2019; Chadha 2018). The
length of user reviews varied from a few sentences to a couple paragraphs. Since a user could
theoretically post a review on both platforms, duplicate usernames were checked using SPSS
27.0 (IBM Corp. 2020). Nurx had one duplicate user review and username, which brought that
sample size down to 1,323 reviews. Planned Parenthood Direct had 283 reviews on the Google
Play Store and 239 reviews on the Apple App Store, resulting in a total of 522 reviews. There
were no duplicate reviews or usernames for Planned Parenthood Direct.
Analytic Plan
Qualitative data analysis was used to conduct a thematic analysis of user reviews from
these two telecontraception platforms. Thematic analysis is conducted in several steps, starting
with generating initial codes, grouping codes into themes, and defining and refining the themes
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(Braun and Clarke 2006). In this study, several codes were expected to capture themes
hypothesized to emerge from the data based on the previous literature review illustrating
research on barriers to obtaining contraception, such as medical gatekeeping and issues
pertaining to policy and legislation. Additional themes, such as those capturing interactions with
online clinicians or the ease of use of the app itself emerged from the data during the coding
process. Codes were combined, refined, or added in an iterative process, going back and forth
between the user reviews and the codes. This approach followed previous research conducting a
qualitative analysis of user reviews which utilized thematic analysis (Stawarz et al. 2018). All
user reviews were coded and analyzed using Dedoose software (Dedoose 2020). Appendix C
provides further detail on the codes developed for this study and their frequency in both the Nurx
and Planned Parenthood Direct User reviews. User reviews were analyzed separately for each
platform, then compared to analyze similarities and differences.
RESULTS
A Brief Walkthrough of Telecontraception App Visions
I first draw on the walkthrough method to provide a brief overview of the vision and
claims made by the two telecontraception apps as a way to examine cultural and social meanings
embedded within these apps (Light, Burgess, and Duguay 2018). This can yield insights about
the purpose, vision, and larger context in which these apps are created and used. Combined with
user reviews, this provides a fuller picture of user experience of telecontraception apps. Nurx and
Planned Parenthood Direct both have different philosophies and motives regarding their rationale
for providing telecontraception. While Nurx aims to transform and disrupt the existing healthcare
system, Planned Parenthood Direct focuses more on providing access, autonomy, and education.
These different philosophies are illustrated in the company mission statements and websites. For
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example, the mission statement of Nurx is “Our mission is putting you in control of your own
health!” (Comparably 2021). The Nurx homepage uses large, attention-grabbing headlines in all
capital letters such as “Expert care from your home” and “We’re on a mission to transform
healthcare” (Nurx Inc. 2021). Overall, the Nurx homepage conveys the message that they value
the patient and have a vision of transforming healthcare yet still draws on traditional language of
medicine and healthcare to emphasize the legitimacy of their services through references to
“expert care” and “your medical team” (Nurx Inc. 2021).
In contrast, the Planned Parenthood Direct homepage does not make claims about
changing healthcare but instead provides brief, clear information on obtaining reproductive
healthcare services virtually. Their focus is not on “transforming” healthcare because they have
been providing in-person reproductive healthcare services within the healthcare sphere for over
100 years (Planned Parenthood Federation of America Inc. 2021) but rather on providing and
fighting for affordable reproductive healthcare. Their mission statement focuses on access,
affordability, autonomy, advocacy, and education (Planned Parenthood Federation of America
Inc. 2021). This is reflected on their homepage through its straightforward approach to providing
clear, concise information and education about reproductive healthcare access and cost. For
example, the homepage contains practical aspects such as a step-by-step explanation of how their
services work and a map of the U.S. where users can select their state and are given a short,
bulleted list of the costs and services available to them (Planned Parenthood Direct 2020). Both
telecontraception homepages also have a woman of color prominently featured at the top of the
homepage, possibly to convey inclusiveness. This is especially important in the reproductive
healthcare sphere, where historical abuses and systemic control, surveillance, and sterilization of
women of color (Salas 2019; Roberts 1999) may impact their trust and experiences of
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reproductive healthcare interactions, and also during a time period in the United States where
racial injustice and discrimination is at the forefront of national and global attention.
Overview of Themes
User reviews for both Nurx and Planned Parenthood Direct largely yielded the same
major themes. Codes for each platform were analyzed, grouped, and categorized into five
themes: 1) access and timeliness of apps, 2) clinician interaction, 3) cost and affordability, 4)
support for the idea of telecontraception, and 5) platform development. Although the user
reviews for both platforms yielded similar themes, the codes within each theme could have
different meanings depending on the platform. This is discussed in the cost and affordability and
platform development subsections.
Access and Timeliness of Apps
Approximately one in five user reviews across both platforms (N=243 Nurx reviews;
N=101 Planned Parenthood Direct reviews) cited problems with in-person healthcare visits to
obtain birth control which were alleviated by using telecontraception. Not having to take time off
work, having a busy schedule, and waiting months to wait for an appointment with a booked inperson provider were the most common codes under this theme. This is particularly important in
the case of birth control, where time is of the essence:
I couldn’t find an appointment for birth control before when I’m supposed to put a new ring,
when I downloaded the app I got my prescription in less than 5 hours! (PP Direct user)
This app is amazing and saved my skin when I needed birth control asap. My employer provided
health insurance was cancelled, my prescription then void, and I wasn’t able to have access to
BC through my hospital. I logged on to the app, in literally less than an hour I talked to a Dr,
verified my identity, and had BC pills sent directly to my home. I received them in 2 days! This
app and Planned Parenthood are life savers and I wish I could give them 10 stars! (PP Direct
user)
I found myself unemployed and without health insurance, and my healthcare provider cut off my
birth control prescription. With only a week to try and find a new prescription, I was freaking out
for sure. (Nurx user).
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My obgyn was refusing to fill my birth control prescription unless I went in to see them, but
wouldn’t give me an appointment for a couple months, so I decided to try out the app to see if I
could my prescription before then. I use birth control for menstrual/hormonal regulation so for
me it’s very stressful not having it. I signed up for the app on a Sunday and the Monday
immediately afterwards they had given me a prescription… (Nurx user).

This theme of access and timeliness of apps illustrates the drawbacks of certain
characteristics of the in-person healthcare system and how telecontraception alleviates many of
these barriers. In the current in-person system, obtaining contraception is tied to an in-person
visit with a provider. This presents barriers, such as not being able to get a timely appointment
or insurance tied to employment. The above quotes illustrate how timeliness is an integral
component of birth control which can present a major barrier if women cannot get a timely
appointment with a provider or lost insurance tied to their job. Obtaining a refill of an existing
prescription in a traditional healthcare setting still requires an in-person visit from a provider, so
telecontraception platforms represent a way for women to access birth control on their schedule
when they need it. The words “lifesaver” and “game changer” were commonly used to describe
these platforms: references to these terms were mentioned in 112 of 1,845 total reviews (6% of
all reviews).
Another code connected to this theme was the medical need for birth control, which was
mentioned by approximately ten percent of users across both platforms (N=143 Nurx reviews;
N=50 Planned Parenthood Direct reviews). For these users, being on birth control was
medically necessary to alleviate medical conditions like endometriosis, painful periods, or
hormonal regulation. Not having timely access to an in-person provider combined with medical
needs results in a major barrier to obtaining the reproductive healthcare a user needs.
Eliminating wait times for visits and facilitating on-demand contact with a clinician is one way
in which telecontraception platforms purport to break down this barrier. Additional codes under
this theme of access and timeliness of apps consisted of speed/quick service, easy to use,
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convenience, and shipping. Only four reviews across both platforms explicitly mentioned living
in a rural area.
Clinician Interaction
Interactions with telecontraception clinicians was another major theme mentioned by
approximately one in four user reviews across both platforms (N=331 Nurx reviews; N=141
Planned Parenthood Direct reviews). Users indicated that providers answered their questions and
concerns and were supportive and knowledgeable:
I’ve had nothing but fantastic experiences using Nurx. It’s such a contrast to the care I’ve
received at a doctors office or clinic (judgmental, flippant, and I’ve had doctors flat out tell me
my birth control side effects were “impossible” and all in my head... What could I possibly gain
from making it up?). Nurx is completely different. Their staff and doctors treat me with respect,
and they treat me like an intelligent person…When I told them I was having side effects, they took
my concerns seriously and made recommendations for a different pill. (Nurx user)
I’ve used this app several times and always feel listened to and helped. The doctors are extremely
nice and it’s easy to get help. (PP Direct user).

Friendly, informative, and helpful clinicians were largely mentioned in the Planned
Parenthood Direct reviews. Users often described their clinicians as “sweet” or “nice”. User
reviews of Nurx expressed more negative experiences regarding their requests than users of
Planned Parenthood Direct, although the line between provider and customer service is blurred in
these reviews. For example, it is impossible to discern who the user is referring to when they
discuss sending a request since this could be a question to a clinician or a question to the
customer service department (for example, about a billing issue). In addition, Planned
Parenthood Direct conducts video visits with patients while Nurx reviews requests and fills a
prescription so contact is made through messages rather than face-to-face virtual visits. The
mode of interaction then may influence user experiences with a clinician, such as if they are
viewing and interacting with them in real time versus messaging through an online portal.
Whether a user interacts with a provider via messaging or a video visit may also reflect the
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design choices of the platform itself. For example, Nurx does not require a video visit and
presents this is a positive aspect of their service by stating that users can access services on their
schedule (Nurx Inc. 2021). On the other hand, Planned Parenthood Direct mentions that video
chats may be necessary (Planned Parenthood Direct 2020), and most Planned Parenthood Direct
users who mentioned clinician interactions referred to a video visit. Telecontraception platforms
may operate from different standpoints and perspectives regarding what is required to provide
quality reproductive healthcare, and their design choices reflect these philosophies.
Related to this theme are the additional codes of birth control options, information and
education, and discreet/privacy characteristics of telecontraception. Birth control options was a
code that was specific to Nurx. One in five user reviews (N=260) mentioned different birth
control options offered by Nurx, which was often related to clinician interaction and
information/education about the various options. Some users expressed their need for a specific
brand of birth control, which was often associated with a higher cost versus a generic version.
Users were often upset about this, citing a medical need to be on a name-brand contraception.
Other users expressed gratitude for “finally” finding a birth control that was right for them, and
how it was the first time experiencing this despite visiting providers in-person for birth control.
Information and education was related to this theme, as users expressed how they learned about
birth control options through informational resources or through their provider:
I’ve had so many struggles finding the right pill for me and this app got it right on the first try.
The papers with all the informations they send is so helpful and makes me feel so comfortable.
(Nurx user).
I ended up trying a few birth controls through this app. I once used the doctor’s recommendation
function, but I also found their listing of all the birth controls available to be one of the most
comprehensive and easy-to-read guides on the internet. At the OBGYN, I never felt empowered to
do my own research and make my own choices. In years of using birth control, I never felt like I
was on the right thing until now (Nurx user).
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I got a notification from a doctor hours after submitting my request with lots of very useful
information. (Planned Parenthood Direct user).
I was sent a ton of helpful information. (Planned Parenthood Direct user).

The above quotes illustrate the increased information and educational resources available
to patients through telecontraception platforms. Patients can review these informational materials
and ask questions. This stands in contrast to in-person visits, where a provider often selects a
brand of birth control. Here, in telecontraception apps, patients can choose based on many
different options. The second quote references the doctor recommendation function available in
the Nurx app, which selects an option for the patient based on what the provider would
recommend if the patient is unsure about making a decision. This is similar to in-person visits.
However, these quotes also illustrate the potential of telecontraception to address existing
barriers in the in-person healthcare system such as not having enough time to discuss options or
providing a comprehensive guide to choosing contraception which would be the best fit. Finally,
the last code categorized under this theme relates to the discreet and private nature of
telecontraception. Some patients mentioned not wanting others to find out about their use of
contraception, such as a religious parent, and appreciated the discreet packaging.
Cost and Affordability
User reviews discussing the cost or affordability of telecontraception was mentioned by
approximately one in five users across both platforms (N=292 Nurx reviews; N=104 Planned
Parenthood Direct reviews). Users were divided on this issue, illustrating how telecontraception
has yet to alleviate barriers of cost and affordability. Just like the current in-person healthcare
system, accessing and paying for care is dictated by insurance and socioeconomic status. Thus
overall, the platforms largely mirror existing dynamics in in-person healthcare. On one hand,
users lamented that the platform did not accept their insurance or complained that the cost was

119

too high. Prices seemed to vary widely. Some users mentioned paying $20, while others
complained of inflated prices such as $150. Another major difference was that Nurx charged a
$15 nonrefundable consultation fee, even if the user later found out that the platform did not
accept their insurance. They were drawn in by the idea of the platform but were charged before
finding out they could not use it. Users felt that this was a deceptive practice, since this felt to
them like a “bait and switch.” Lack of transparency about pricing was a common complaint
among Nurx users. However, Planned Parenthood Direct provides a clear guide to how much
users will pay for using its services. This reflected in its user reviews: while billing complaints
were mentioned in 14% of Nurx user reviews, this issue only represented 2% of Planned
Parenthood Direct reviews. Issues of cost represent the operating model and design choices of
each company on its website or app, and also whether it is a for-profit or non-profit company.
Providing direct, explicit information about reproductive healthcare costs was a clear focus on
the Planned Parenthood Direct homepage, while this information was harder to find on the Nurx
website. This might reflect the different philosophies of the two companies regarding how they
view the purposes of their services, whether that is rooted in affordability and access (Planned
Parenthood Direct) or financial interests and running a business to compete with in-person
healthcare (Nurx).
On the other hand, users praised the platforms for being an “affordable” option. Some
users even mentioned that there was no cost. Cost was also often mentioned alongside
convenience:
I feel that they are reasonably priced for how convenient it was. (PP Direct user).
So convenient and cheaper than seeing my own doctor! (PP Direct user).
I pay $15 a month without my insurance but I don’t mind because they’ve made this so easy!
(Nurx user).
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Absolute easiest and most cost effective way to be in control of your reproductive health (Nurx
user).
I’ve never had to pay anything out of pocket since my insurance covers my BC, until this year.
This year, Nurx decided to charge people $15 (which I believe is for the year). Though it’s
annoying, it’s less than the copay I would need to pay to see my doctor AND they don’t charge
for shipping (Nurx user).

Users mentioned convenience alongside cost to justify or rationalize paying for
contraception. Getting birth control shipped directly to them or not having to go to a doctor’s
office or pharmacy were mentioned by many users in terms of cost and convenience. Many
women who indicated that they did not have health insurance said that the services were a
“lifesaver” for them. Affordable birth control may mean different things to different users.
Others complained that their insurance was not accepted by the platform, despite paying nothing
for birth control with their insurance if they went through their in-person provider. Having
insurance did not necessarily guarantee a cost-effective, affordable experience since the
platforms did not work with all types of insurance. For example, users with Medicaid insurance
lamented the fact that Nurx did not accept their insurance. Planned Parenthood Direct users
mentioned that even though they had insurance, the platform would not accept it but that they did
not mind paying the cost because it was supporting an organization they believed in. Overall, the
platforms contained mixed reviews of cost and affordability, suggesting that telecontraception
platforms have not yet fully addressed barriers to affordable contraception.
Support for the Idea of Telecontraception
Another major theme across both platforms was support for the idea of telecontraception
(N=263 Nurx reviews; N=73 Planned Parenthood Direct reviews). Many user reviews expressed
gratitude directly to the platform for providing its services, indicating a long-time need for their
services. Others expressed their support for the idea even if they had less than positive
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experiences, indicating that these platforms are tapping into an unmet need. Reviews frequently
used the words “game changer” to describe telecontraception platforms.
Thank you!!! This app is easy to use, well-designed, and you really can have birth control
ordered in mere hours. That’s absolutely incredible. (PP Direct user).
Honestly, I love everything about Nurx. This system is a complete game changer. (Nurx user).
I’ve never written an App Store review before, but this was worth the effort. This is truly a game
changer for how we treat birth control. (Nurx user).
I’m telling every girl I know about this. (Nurx user).
I was getting increasingly frustrated with how much effort it took to obtain birth control,
something that is over the counter in other countries, when I found Nurx and it changed my life. I
recommend it to everyone searching for a simple solution! (Nurx user).
I cannot stress enough how great this service is….It’s just been such a huge relief and I cannot
imagine going back to life without it. (Nurx user).
I am so glad this app exists. (PP Direct user).
This was the best invention! Love this app and the services provided to me. (Nurx user).
PPDirect is revolutionary! (PP Direct user).
What women and menstruating persons have needed forever. (PP Direct user).
Love the idea of this and it should be more of a thing!!!! Thank you guys for creating something
like this. (PP Direct user).
Thank you Planned Parenthood for creating this app. It is wonderful! (PP Direct user).

Related to this theme was that many users of Planned Parenthood Direct had a history
with the organization. Ten percent of reviews for PP Direct (N=50) mentioned being a patient or
supporter of Planned Parenthood. Name recognition and having a prior history with the
organization seemed to influence users, as they were grateful for its services both in-person and
through the platform:
I’m a huge supporter of Planned Parenthood and have been for 25 years. This is the first time in
20 years I have not had health insurance so I was DELIGHTED to find this app and I’m literally
no time at all I had a prescription filled and at such a low cost. (PP Direct user).
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Thank you Planned Parenthood for all that you do. Have been going there for years ever since I
started my birth control and will always go there. (PP Direct user).
This is where I first started getting birth control because I could get it without insurance and
without my dad finding out (religious) I was 19. (PP Direct user).
I was interested when I saw an ad for another company that offered the same service but I didn’t
really feel comfortable with it until I saw that Planned Parenthood also offered the service. I
decided to go with Planned Parenthood. (PP Direct user).

Having an established orientation to the company or platform made users feel more
comfortable using telecontraception services, since they could trust it as a legitimate service
based on the recognition of the company name. In contrast, many user reviews of the Nurx
platform mentioned being “skeptical” ordering birth control through an app. They were not sure
if it was legitimate or not. Having the history and name recognition of an established
organization like Planned Parenthood seemed to eliminate any concerns about legitimacy, as no
user reviews mentioned being skeptical of their telecontraception services.
Another code related to this theme of support for the telecontraception idea is state
(un)availability. While the number of user reviews mentioning this was small (3 percent of
reviews for Nurx and 8 percent of reviews for Planned Parenthood Direct), it is an important to
mention because it illustrates the policy and legislative influences on telecontraception platform
availability. These users mentioned how the platform was not available to them because they
lived in a certain state, often linking their statement about the lack of access to needing access:
I downloaded this app getting very excited to find something like this. I cannot express how much
these service(s) are needed. Then I notice that pretty much every state is on the app except
Nevada. What a huge deflate I had immediately…(Nurx user).
Need this in GA and every other state they don’t offer it in!!! Thanks!!! (Nurx user).
I’m assuming it’s great so I’ll give you a high rating for just existing as an option for women! But
please expand to Maryland!!! It seems as though you’re everywhere else but where I am…and
quite honestly, it would be an INBELIEVABLE help to the community if you guys ever were to
expand to Maryland. When young girls living in the socioeconomic nightmare that is the inner
city-a pregnancy can ruin not only the life of the mother, but that of the child as well! Smart girls
get stuck here! HELP!. (Nurx user).
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Thus, users would express a need for obtaining contraception in this virtual sphere while
simultaneously expressing their support for the idea of telecontraception. This illustrates the need
for women in all states to be provided with the opportunity to access the services. Lack of access
does not mean lack of interest for these users. Quite the contrary, they expressed a desire for the
platform to expand services to include their state.
Platform Development
The final theme was platform development, which drew on statements coded to reflect
comments about app rollout, technological complaints about the app, and customer service. This
largely represented “growing pains” of a new business, such as how Nurx began as a startup
company and Planned Parenthood Direct began with a select number of pilot states to test its
app. It also reflected the different backgrounds and experiences the two companies have in the
reproductive healthcare sphere. Planned Parenthood’s wealth of historical, institutional
knowledge and experience may have helped with rolling out their virtual services compared to
Nurx which is a startup company and new to the healthcare services arena.
Technological complaints about the app were mentioned in over one-third of reviews for
Planned Parenthood Direct and 13% of reviews for Nurx. However, Nurx had a large amount of
reviews (33%) mentioning customer service, which overlapped with these codes. For example,
as Nurx grew and rolled out their app to the Google Play Store, their customer service was
seemingly bombarded by requests. Users mentioned how the Nurx app contained a banner
expressing the long hold or wait times to speak with a representative. Users complained about
slow response times, citing how they often waited on hold for over an hour on the phone to reach
customer service. Some reviews also mentioned that as Nurx grew over time, this became more
of an issue compared to when they had accessed its services at the beginning of its creation.
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However, it is worth mentioning that some users praised the customer service department. The
trajectory to establish a telecontraception app seems to be a bit rocky regardless of the company
model. Both platforms experienced “bugs”, crashes, slow loading times, and problems with app
functionality. However, Nurx contained many more reviews related to slow service than Planned
Parenthood Direct.
DISCUSSION
This qualitative analysis of user experience of telecontraception platforms allows for an
on-the-ground perspective of what users experience both in the virtual and non-virtual spheres.
Findings illustrate how areas where telecontraception both alleviates and falls short of addressing
barriers to obtaining contraception in the current in-person healthcare system. Specifically, the
user reviews demonstrate that telecontraception platforms address important accessibility issues
inherent in the current traditional healthcare system but findings are more mixed regarding
affordability and equitability. This demonstrates how technological innovations often make
broad claims to “solve” existing issues, yet they must still grapple with real-world, on-theground forces such as insurance systems. Telecontraception is no exception, though it does
address many problems women face in obtaining contraception in the current in-person
healthcare system.
Overall, users express how telecontraception platforms do alleviate some barriers
associated with an in-person provider visit. Not having to take time off work, having a busy
schedule, and waiting months to wait for an appointment with a booked in-person provider
reflect the advantages of these platforms and how they can reduce geographical and time barriers
associated with in-person healthcare. These findings reflect earlier research on telemedicine and
convenience, particularly how patients can access health care providers and services outside of
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normal business hours (Jain and Mehrotra 2020; Rodler et al. 2020). This allows patients to
request what they need when they need it, rather than having to conform to a 9-to-5 clinic
schedule. Users express these new telecontraception systems as “game changers” or “life
savers”, illustrating how these platforms are literally changing the “game” of in-person
healthcare visits. Related to this is user support for the idea of telecontraception. Many users
expressed effusive gratitude for this service, which suggests unmet reproductive health needs in
the current in-person healthcare system.
Clinician and patient interactions in telecontraception platforms were brought up by
approximately one in four women across both platforms. Users mentioned the friendliness and
knowledge of their clinician and expressing how they valued that they could ask questions and
were not judged. This stands in contrast to previous research illustrating how providers largely
did not assess patient pregnancy intention, birth control preferences, or allow patients an
opportunity to ask questions during an in-person visit for birth control (Dehlendorf et al. 2017).
This study’s finding illustrates that these platforms are meeting the visions of women about
telecontraception, such as the ability to discuss options with a provider and provided with
knowledge and information about different contraception options (Sundstrom et al. 2019).
Although clinician and patient interaction is characteristic of both in-person and virtual
reproductive healthcare services, the positive experiences of patients with their telecontraception
providers illustrates that there may be other factors influencing the quality of care of these visits.
It may be that telecontraception interactions are less subject to time restrictions since
patients can access providers on their schedule rather than vice versa and in a relaxed setting
such as their home. Online visits also place patient concerns and needs at the forefront (Basu
2019). There may be more time to discuss options and concerns, answer questions, and build
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rapport since the sole focus of the interaction is reproductive healthcare, as opposed to a wellwoman visit where there are many different competing tasks to accomplish. In-person visits may
have more restrictions such as short appointment time slots or competing tasks to complete
during the visit which could affect the quality of the patient-provider interaction or amount of
information and discussion conducted during the visit. This may explain previous research
findings about in-person providers failing to assess patient pregnancy intention, birth control
preferences, or allow patients an opportunity to ask questions (Dehlendorf et al. 2017).
Telecontraception platforms may also provide greater information, education, and resources
about different options which patients can read about and discuss with a provider in their own
time. Providing educational decision tools about birth control choices and preferences are
effective in patient-provider communication by allowing patient concerns and preferences to
enter the discussion rather than provider choice (Holt et al. 2020).
One important finding to note was that the mode of interaction seemed to make a
difference in a user’s experience of telecontraception. Nurx and Planned Parenthood Direct
contained differing perspectives of the clinician interaction. This could be due to the way
patients and providers interact on these platforms. While Planned Parenthood Direct providers
conduct video visits with patients, Nurx providers review requests made through the app and
interact with patients through messages rather than face-to-face virtual visits. Planned
Parenthood Direct users praised their clinicians, while Nurx users had more mixed reviews. The
mode of interaction may influence user experiences with a provider because they are viewing
and interacting with them in real time, versus back-and-forth messages. It could also be the
growing pains associated with Nurx, if clinicians are bombarded with messages and not able to
provide the best care because of these pressures. Yet another explanation is the philosophy and
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operating model behind the telecontraception platforms. Planned Parenthood has advocated and
provided reproductive healthcare for over 100 years, so they may value transferring aspects of
their quality of care such as face-to-face interactions to the virtual sphere. On the other hand,
Nurx is a startup company aiming to gain more users for its business so they may value
messaging as a way to handle a larger volume of users. Overall, users expressed clinician
interactions in a largely positive way, especially when tying it to finding the right birth control
for them, obtaining information, and the discreet, private, non-judgmental manner of getting
contraception.
However, this analysis also showed that telecontraception platforms fall short in
addressing some barriers in obtaining contraception. The theme of cost and affordability largely
reflects the current dynamics of in-person healthcare, where the ability to access affordable care
is tied to existing insurance and employment patterns and state-level policy (U.S. Centers for
Medicare & Medicaid Services 2020; Adamczyk 2020; Jones and Sonfield 2016), factors that
limit the scope of “disruption” that platform designers can realize. Technological design and
advances are inseparable from the social context in which they emerge (MacKenzie and
Wajcman 1999). Telecontraception platforms must still operate within existing economic and
political environments, such as insurance systems or legislative policy. This limits the ability of
technological innovations to “solve” existing problems because they are still subject to and must
grapple with prevailing institutional forces. Rhetoric around technology often portrays
technological innovations as a “techno-utopia” where technology is portrayed as a cure-all for
the current problems of the day, yet this mythology ignores the power, control, and tools that
certain groups hold over others at all stages of technological innovation (Rogers 1995; Winner
1986; Wajcman 2004; boyd & Crawford 2012; Zuboff 2019). Telecontraception platforms
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provide an example of this through their limits of addressing barriers tied to insurance systems
and state-level policy on prescribing and dispensing authority because they still exist within
these institutional contexts and constraints.
Limitations
There are limitations to using data such as user reviews from publicly available websites.
It raises questions about the validity and reliability of the data, as well as who it represents (boyd
& Crawford 2012). User reviews can represent sample selection bias since users are not required
to write reviews (Caldeira et al. 2017) so the reviews may represent atypical experiences. They
may not be representative of all telecontraception users. Another problem in mining user reviews
is that is difficult to detect spam or fake reviews (Genc-Bayebi and Abran 2017). This sample is
also restricted to users who have internet access. Research has demonstrated a digital divide in
internet access, skills, and information, and these are patterned by existing social inequalities
such as income (DiMaggio et al. 2004; Hargittai 2002). A recent study found that racial and
ethnic minorities had higher odds of telehealth use during the COVID-19 pandemic and
illustrates the need for continued expanded access and coverage of telehealth services (CamposCastillo and Anthony 2021). In addition, research has documented disparities among health
platform users and non-users (Carroll et al. 2017; Mesch 2016; Bidmon and Terlutter 2015;
Anthony, Campos-Castillo, and Lim 2018), although studies have not yet looked at
telecontraception platform users. Telecontraception platform users may differ in ways from other
non-users, such as having internet access, use, skills, and knowledge to navigate the internet.
However, given the dearth of data on telecontraception platforms, analyzing user reviews on a
large scale serves as an exploratory first step toward uncovering more about these platforms and
how users experience them. It allows for a preliminary exploration into why some women are
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using these platforms as well as their experiences and evaluations of the platform services. This
research also identifies areas for further research that can examine representative samples of
women across the United States, such as the potential of telecontraception to empower women
by providing more information and education about different options.
CONCLUSION
Telecontraception platforms represent a novel way to approach contraception access and
availability. These apps are growing and expanding, and are particularly helpful during the
current COVID-19 pandemic as many users mentioned how they do not want to visit an inperson provider to obtain birth control due to concerns about contracting the virus or they have
lost insurance through losing a job. Nurx and Planned Parenthood Direct are two platforms
which represent opposites in terms of size, development stage, and user orientation. Yet user
reviews of the two platforms yielded similar themes, suggesting that widely experienced
motivations and intentions drive use of telecontraception. However, the way telecontraception
platforms deliver these services can vary depending on their characteristics, underlying
philosophies, and business operating models, which can serve to either alleviate or reinforce
current in-person healthcare system dynamics associated with obtaining contraception. Severing
the tie between in-person visits and contraception can improve women’s experiences obtaining
birth control in that they are not limited to geographical and time barriers present in the in-person
system (Grindlay and Grossman 2016; Jain and Mehrotra 2020; Rodler et al. 2020), and they
also enjoy patient-centered interactions with their provider and increased information and
education about their options and preferences, which are all important factors in improving
patient-provider communication in reproductive healthcare services (Holt et al. 2020; Dehlendorf
et al. 2017; Becker and Tsui 2008; Gomez and Wapman 2017). While telecontraception
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platforms are “game changers” and “life savers” in many ways, this study indicates that
overcoming the barriers faced by women who need reproductive healthcare is less about
technological innovation, and more about disrupting entrenched social forces that shape
insurance systems and policymaking.
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CONCLUSION
This research set out to investigate the current landscape of reproductive healthcare and
telecontraception with an eye toward accessibility, affordability, and equitability. In the
introduction, three aims were discussed. Aim #1 sought to better understand sources of
reproductive healthcare access, affordability, and equity issues by providing a current picture of
the in-person, traditional reproductive healthcare system. The goal of aim #2 was to investigate
the state-level conditions that pattern accessibility and availability of telecontraception platforms
to uncover the combinatory political, economic, or social conditions linked to availability of
these platforms across the United States. Aim #3 analyzed user reviews of two telecontraception
platforms to gain insight into user experiences and evaluations of these emerging platforms.
These three aims used mixed methods that informed one another to examine the relationships
between gender, health, and technology. Using a national survey of women, state-level data
about social, economic, and political climates of states, and user reviews of telecontraception
platforms all provide different lenses for looking at the accessibility, affordability, and
equitability of telecontraception platforms. These different data sources and findings inform one
another to provide a fuller picture of this fast-growing phenomenon. Taken together, findings
illustrate both the promises and pitfalls of how technological innovations currently address
reproductive health needs and disparities. The remainder of this dissertation will discuss the
major themes and implications of these findings.
PROMISES OF TELECONTRACEPTION
This research uncovered many areas in which telecontraception is disrupting entrenched
institutional forces and conditions. Telecontraception addresses issues of accessibility and
equitability by breaking down barriers related to the time pressures of current in-person
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traditional healthcare environments. User reviews in Aim #3 revealed that these platforms do
alleviate many of the existing in-person barriers to obtain contraception, such as waiting months
for a booked provider and having to take time off work for a visit in order to fit into the nine to
five healthcare office hours. As many user reviews mentioned, birth control is a time-sensitive
medical need. Telecontraception addresses the issue of time because it provides on-demand
access to providers and birth control quickly. Many users expressed support and gratitude for
telecontraception, illustrating that these services are tapping into unaddressed issues and needs in
obtaining contraception. Furthermore, states with high proportions of women legislators in
combination with other state-level conditions were linked to telecontraception platform
availability. This was true regardless of the political party of the women legislators in each state.
Having women in positions of power alongside other state conditions may be an important factor
moving forward for advocates of reproductive rights and policy, regardless of whether a state is
controlled by Democrats or Republicans.
Another area where telecontraception has the potential to improve reproductive health
care for women is through how they may affect the quality of reproductive healthcare visits.
Using a mixed methods approach illustrated the different aspects of this theme and how each aim
informs one another. As revealed in Aim #3, telecontraception platforms provide on-demand
access to knowledgeable, supportive clinicians as well as information and education about
different birth control options. This aligns with previous qualitative research on rural women’s
perceptions of telecontraception, such as the ability to discuss options with a provider and obtain
information and knowledge about different contraception options (Sundstrom et al. 2019). Aim
#1 revealed that individual attitudes and interpersonal interactions were important factors in
making a birth control visit, indicating that patient-provider communications and interactions are
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especially salient in efforts to access birth control. It also illustrated that only half of women
reported that they got information about birth control at their last visit or that their doctor spent
time talking to them about future plans for having or not having children. Telecontraception may
therefore be addressing an unmet need in the current traditional healthcare system which may be
pressed for time and competing priorities by giving patients more time to discuss options and
obtain information about birth control from on-demand providers. Since telecontraception visits
are initiated by the patient, their concerns are the main focus of the visit instead of a well-woman
visit where competing priorities take time and attention away from more substantial discussions
about options. Online visits place patient concerns and agenda at the forefront of the visit (Basu
2019), so telecontraception visits may represent a potential channel for achieving improved
quality of visits and patient-provider interactions about birth control.
This carries important implications for racial and ethnic minority women who are more
likely to experience racism through healthcare provider interactions, such as through pressure,
imbalanced information, lack of patient input, and exclusion (Becker and Tsui 2008; Gomez and
Wapman 2017; Dehlendorf et al. 2017; Gary et al. 2015). Having more time during a visit may
help alleviate some of these barriers related to racism and time pressures because patients are
provided with access to supportive, knowledge providers and information about all the birth
control options. The focus of the visit is also solely on contraception, so not having other
competing priorities such as exams and questionnaires taking up precious time during a visit can
also allow for improved discussions and interactions between patients and providers. Previous
research has shown that providing educational decision tools about birth control choices and
preferences are effective in patient-provider communication by allowing patient concerns and
preferences to enter the discussion (Holt et al. 2020). Telecontraception platforms have the
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potential to improve dialogue and interactions between patients and providers because their focus
is concentrated solely on birth control and patient concerns.
Telecontraception is a rapidly growing segment of telemedicine. As the number of users
and services continue to expand, it is important to identify how platforms focused on
reproductive health fit within the larger landscape of telemedicine. Findings from this research
illustrate that the promises of telecontraception have the potential to extend to other telehealth
initiatives and health apps more broadly. Specifically, telecontraception platforms disrupt the
accessibility barriers of the traditional healthcare system by providing on-demand contact with
providers and information. Patients do not have to mold their lives around a schedule of nine to
five appointments, booked medical providers, and rushed visits where they might not have time
to discuss all their questions, concerns, and options. The online visit is driven by the concerns
and agenda of the patient which has the potential to improve the quality of visits and interactions
between patients and providers. This is of the utmost importance in reproductive healthcare
visits, where information and choice are essential for women to make choices about their bodies
and lives.
PITFALLS OF TELECONTRACEPTION
All three aims illustrate that emerging innovations shape and are shaped by existing
social conditions and arrangements. Technological innovations such as telecontraception
platforms do not exist outside of their social, political, and economic contexts. Although in
theory this technology allows for greater access to more people, the ability of consumers to
utilize the services provided by these platforms is still limited by long-standing inequalities in
institutional systems. Institutional factors permeate every finding from each aim of this
dissertation. Making a reproductive healthcare visit, the ability to access telecontraception
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platforms in a certain state, and the experiences of telecontraception platform users are all shaped
by institutional influences. The pitfalls of telecontraception are related to issues of affordability
and equitability and largely mirror existing, on-the-ground systemic inequalities such as
insurance and socioeconomic status.
The Mythology of Technological Determinism
Technological determinism and the mythology of a techno-utopia permeate the language
and rhetoric surrounding technological innovation (Rogers 1995; Winner 1986; Wajcman 2004;
Nakamura 2009; boyd & Crawford 2012; Mosco 2014; Devlin 2018; Zuboff 2019). This
discourse focuses on the idea that any kind of technological advancement or innovation is
beneficial for humanity, along with a noticeable absence of questioning its meaning or costs and
ignorance of physical, social realities (Winner 1986; Nakamura 2009). In contrast, the social
shaping of technology theoretical framework recognizes that technological design and innovation
are inseparable from the contexts in which they emerge (MacKenzie and Wajcman 1999). There
is nothing inherent or deterministic about technology itself, and technology can operate
differently depending on time and place (Wajcman 2004). The social contexts, relationships, and
hierarchies which shape and are shaped by technology are important to study because they are
inextricably bound up in the concept of technological innovation; technology and society are not
separate factors (Latour 1987).
All three aims illustrate the social shaping of technology, whether that is accessing the
technology of contraception itself or using online platforms to access contraception. Individual,
interpersonal, and institutional factors all play a role in the decision to make a visit (virtual or
non-virtual) for contraception and the experience of doing so. State-level conditions influence
availability of telecontraception platforms across the United States. Insurance and socioeconomic
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status impact the experience of telecontraception users. In the case of telecontraception, this
technological innovation in theory grants access to anyone with a smartphone, but in reality
access is often limited along the lines of existing social, political, and economic inequalities.
Previous research questioned whether telecontraception platforms increase accessibility to
contraception for those who face barriers or whether they simply make it more convenient for
those who already have access (Dorland, Fowler, and Morain 2019; Zuniga et al. 2020). This
research demonstrates that these platforms do represent a novel way of addressing barriers but
are still limited by entrenched institutions and forces. They must still grapple with insurance
coverage and networks, as well as policy and legislation dictating their ability to prescribe and
dispense medication. Uninsured women still face barriers with these new innovations, despite the
finding in Aim #1 that this group shows the strongest pregnancy avoidance attitudes.
As access to the internet and apps increase, online platforms increasingly employ a
rhetoric of “choice” and “empowerment” (Lupton 2016; Lupton 2018). However, the ability of
users to access these services is patterned by existing inequalities such as insurance and
socioeconomic status. It is critical that health app designers, stakeholders, and policymakers
consider how their decisions and choices fit into existing contexts, otherwise they will fail to
address barriers that they are aiming to tear down. These choices affect who these apps reach and
as a result may fail to reach everyone who needs their services. Not doing so also risks
perpetuating existing inequalities (O’Neil 2016). The digital and material are linked (Mosco
2014). Many times with technology, social factors only appear when something goes wrong
(Latour 1987). With the rapid pace and adoption of technology and “big data”, health app
designers need to consider how their decisions and choices may affect and be affected by
existing social forces before they roll out a technology.
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One last important point to note about technological innovation and apps is the role of
privacy in the use of personal data. Many telecontraception platform users lamented that there
was no way to “delete” their profiles if they no longer wanted to use the app. Apps are an
emerging area of society in which legislation is slow to catch up in the United States (Zuboff
2019; Martínez-Pérez, De La Torre-Díez, & López-Coronado 2015). The General Data
Protection Regulation (GDPR) was implemented by the European Union (EU) as recently as
2018 and outlines privacy and security standards for organizations using personal data (Wolford
2021). As much as health apps such as telecontraception aim to provide access to needed
services, it is also important to consider what they are taking away from users in terms of
personal information and “digital breadcrumbs” which can be sold, combined, and used by other
organizations (Zuboff 2019:90).
Overall, the pitfalls of telecontraception illustrate many of the same drawbacks of
telemedicine and health apps more broadly. Findings from this research indicate that issues of
affordability and equitability do not have the same disruptive effect on the healthcare system as
the accessibility of telecontraception. User reviews revealed that cost and insurance were major
influences on the experiences of telecontraception platform users and largely mirrored the
frustrations of navigating insurance coverage and high prescription costs in the traditional inperson healthcare system. Furthermore, telecontraception experiences differed depending on the
platform itself. While Nurx is a for-profit company, Planned Parenthood Direct is a non-profit
organization. This carries implications for users because it affects their experiences of the
platform and whether they can afford to use it. Platform medicine designers make decisions
about who they want to reach through their business and operating models. Choices and
decisions about insurance, cost, and affordability all affect the experiences of platform users and
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in turn the equitability of these platforms. Although findings from this research illustrate that
telecontraception does alleviate many of the existing access barriers, findings also show that
users may still encounter roadblocks through affordability barriers. Breaking down the barriers
related to affordability and equitability requires innovation not only through the decisions and
choices of the platforms themselves, but also knowledge of how to achieve these goals within an
entrenched system of insurance and payment networks.
REPRODUCTIVE HEALTHCARE COMMONALITIES AND DISPARITIES
Commonalities
While findings from this research illustrate disparities in reproductive healthcare access
and affordability, it is also important to make note of the commonalities and similarities
uncovered among women in terms of their shared attitudes and experiences. The majority of
women in Aim #1 indicated a strong pregnancy avoidance attitude, with no statistically
significant differences by race or ethnicity, socioeconomic status, or insurance status. With most
women in each subgroup of this national survey expressing this shared attitude, this finding
illustrates that pregnancy avoidance is largely a shared attitude among women even by subgroup.
Similarly, user reviews in Aim #3 indicated support and gratitude for the idea of
telecontraception. This suggests a long-standing need for these services and their goal of
addressing existing barriers to obtaining contraception. While women may of course differ on
their individual views or modes of contraception, both findings illustrate that pregnancy
avoidance and accessible birth control are important to women. This is an important finding to
note because it demonstrates the importance of creating accessible reproductive healthcare
services for all women. It also aligns with previous research findings that women value and
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support accessible contraception, such as pharmacist-provided birth control or over-the-counter
birth control (Landau, Tapias, and McGhee 2006; Grindlay and Grossman 2018).
Another commonality among women are the many shared barriers they face in obtaining
contraception. Many user reviews of the telecontraception platforms mentioned barriers
associated with obtaining birth control in the in-person healthcare system. This mirrors findings
that nearly one-third of women report difficulties obtaining prescription birth control or refills
(Grindlay and Grossman 2016). Users expressed their gratitude for having a service that allowed
them to access contraception without having to take time off work, waiting months for an inperson appointment with a booked provider, or losing employer-sponsored health insurance with
the loss of a job. These are all features of the in-person, traditional healthcare system which
creates barriers to obtaining contraception. Telecontraception platforms have the potential to
address these barriers by providing convenient access to contraception and providers.
Clinician and patient interactions are also an important commonality shared by women in
accessing reproductive healthcare. Many users of telecontraception platforms mentioned
friendly, knowledgeable, nonjudgmental providers with whom they could ask questions. While
this is a factor that could arguably be present in the in-person healthcare system too, it is possible
that telecontraception platforms provide something that is missing in the in-person context such
as more time to discuss options, answer questions, and build rapport. Similarly, Aim #1 found
that women who went to Planned Parenthood or another family planning clinic for their last
women’s healthcare visit had nearly three times higher odds of making a birth control visit
compared to women who went to a private doctor’s office, while the opposite was true for
preventative annual gynecological healthcare visits. The context of the environments that provide
birth control, whether that is through increased time or a feeling of understanding, is important.
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Previous research has found that teens and other groups of women may prefer to utilize Planned
Parenthood for not only cost and confidentiality, but also for additional dimensions of care such
as ease of getting care and medical staff treatment (Sugerman et al. 2000; Oglesby 2014). There
may be other factors associated with family planning providers or telecontraception platforms
that influence women’s experiences of accessing contraception. Perhaps having the focus of the
visit being on contraception, rather than a “well-woman visit” that aims to cover many facets of
health, plays an important role in these dynamics. Previous research has found that in-person
providers largely fail to assess patient birth control preferences or allow patients an opportunity
to ask questions (Dehlendorf et al. 2017). Whether that it is due to time or other factors is
unknown, but a virtual or non-virtual visit for birth control arguably places the focus squarely on
birth control rather than other competing demands.
Women have firsthand experience with shared barriers to obtaining contraception, and
having women in positions of political power could be an important factor in translating these
barriers to solutions. Aim #2 demonstrated that the percentage of women legislatures in
combination with other political, social, and economic state-level factors was linked to
availability of telecontraception platforms across the United States. These findings did not
change even when considering the political orientation of these women legislatures, indicating
that gender may play a potentially important role in shaping access to these platforms. While I
cannot make claims that women legislators passed these policies, their higher percentages are
associated with the availability of these platforms in combination with other state-level factors
and this finding occurred in both environments of Democrat and Republican state political
control. This is consistent with previous research which found that states with higher proportions
of women representatives propose more bills pertaining to women, children, and families
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compared to men and also compared to states with lower proportions of women representatives,
regardless of political party (Volden, Wiseman & Wittmer 2018; Thomas 1991; Saint-Germain
1989). Overall, this indicates a potentially optimistic avenue for women, as having women in
positions of power can help introduce issues important to women regardless of the political
environment in which they operate.
Disparities
Findings from this research also illustrate reproductive healthcare disparities among
women that largely reflect long-standing inequalities in institutional systems. Insurance is a main
driver behind access and affordability of reproductive healthcare both in in-person and virtual
environments, as demonstrated by both Aim #1 and Aim #3. Uninsured women had lower odds
of making a birth control visit compared to privately-insured women, despite having the highest
pregnancy avoidance attitudes compared to women with other types of insurance. Institutional
variables such as insurance status and facility type were associated with making a birth control
visit and making an annual gynecological preventive visit.
User evaluations of telecontraception platforms uncovered major cost differences
depending on insurance status and coverage. This illustrates that regardless of the mode of
delivery, existing social institutions such as insurance still play a major role in influencing access
to healthcare. Over ten percent of women in the U.S. are uninsured, and there are still significant
racial and ethnic disparities in insurance coverage despite passage of the Affordable Care Act
(Kaiser Family Foundation 2021; Shane and Ayyagari 2014; Breslau et al. 2018; Smith and
Medalia 2014; O’Hara and Brault 2013). This was reflected in the Aim #1 findings that black
and Hispanic women had higher percentages of being uninsured compared to white women.
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Taken together, these findings illustrate that factors such as insurance intersect with race and
ethnicity to produce disparities rooted in access and affordability.
Where a woman lives dictates her access to telecontraception platforms. The mixed
methods approach used in this research yields findings that inform one another, especially
regarding this issue. Findings from Aim #2 showed that political, social, and economic statelevel factors all combine to pattern availability of these platforms across the United States. But as
Aim #3 shows, the availability of these platforms is not based upon demand or desire for the
platforms within these states. Many user reviews mentioning that the telecontraception platform
was unavailable in their state also pleaded to expand the services to their state. However, it is
important to note that the number of states serviced by a platform rapidly changed even during
the course of conducting this research. Since user reviews dated back to 2017, many of these
pleas have been answered as telecontraception platforms expand access to a greater number of
states. This illustrates the importance of making sure technological innovations such as
telecontraception are accessible, affordable, and equitable. Telecontraception platforms arose out
of a specific social, political, and economic context. They are clearly meeting an unaddressed
need for women across the United States. However, without considering how they affect and are
affected by existing institutions they will fail to address all of the barriers women currently face
in the traditional in-person healthcare system.
Conclusion
As platform medicine continues to emerge and innovate, what are telecontraception
platforms adding to the landscape of reproductive healthcare services? What problems are they
solving and where do they fall short? This research identified key research questions which
informed one another to uncover both the promises and pitfalls of current systems of accessing
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contraception. Overall, the findings illuminated areas for improvement in both the virtual and
traditional healthcare spaces. Results show that telecontraception addresses many of the
accessibility barriers associated with obtaining contraception in the United States. User reviews
expressed support and gratitude for telecontraception, indicating a need for these services that is
not being adequately addressed by the traditional healthcare system. However, existing social
forces such as insurance and legislation limit the affordability and equitability of
telecontraception. This carries important implications because this research also found that most
women across the United States expressed strong pregnancy avoidance attitudes, regardless of
subgroup. While telecontraception platforms disrupt issues of accessibility in the traditional
healthcare system, affordability and equitability still have room for improvement which carries
implications for who can use these platforms and their experiences of doing so. Harnessing the
potential of these apps, as well as health apps and telemedicine in general, requires knowledge
about the material, on-the-ground conditions and circumstances women operate in as they access
these platforms. Knowing more about these factors in both the traditional and virtual
environments can help tailor better approaches to ensure that all women across the United States
have equitable, affordable access to the care they request and deserve to make decisions about
their own bodies and lives.
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Appendix A: Supplementary Analyses for Aim #1
Table 1a. Logistic Regression Comparing Estimation Sample, Sample without Pregnant Women, and Imputed Data
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Individual Attitudes, Knowledge, & Contraception Use
Pregnancy avoidance attitude
2
3
4
5
6 Very important to avoid pregnancy
Currently pregnant
Knowledge of birth control methods
Past use of the pill
LARC at last wave
Interpersonal Variables
Visit: Doctor or nurse talked about future plans for children
Visit: Got info about birth control and pregnancy prevention
Relationship status
Broken up but back together
Not together for six months or longer
Not dating anyone
Institutional Policy Factors
Visit: Facility type
Planned Parenthood or other family planning clinic
Public health dept. or community health clinic
Student health clinic or some other type of h.c. facility
Visit: Payment
Insurance paid
Reduced fee or free services
Has a regular place to go for medical care
Lives in a state that expanded Medicaid under ACA
Key Subgroups
Race and ethnicity
Black

Birth Control
Visit
Estimation
Sample

Birth Control
Visit
Dropped
Pregnant Women

Birth
Control
Visit
Imputed
Data

Annual
Gynecological
Visit
Estimation
Sample

Annual
Gynecological
Visit
Dropped
Pregnant Women

Annual
Gynecological
Visit
Imputed
Data

OR

OR

OR

OR

OR

OR

1.00
1.06
.84
.64
.56
.31**
1.01
1.25
1.82

1.05
1.20
1.73

.97
1.05
.82
.66
.56
.29***
.99
1.26
1.69

2.46
3.04**
2.59**
3.27**
4.39***
.26**
1.08
5.89***
.82

2.52
3.10**
2.65**
3.38**
4.49***
1.09
5.75***
.75

2.25
2.88**
2.39*
2.87**
3.98***
.26**
1.08
5.65***
.88

.71
3.79**

.68
3.61***

.70
3.90***

1.45
.84

1.29
.81

1.46*
.83

1.59
.54
.38**

1.55
.53
.37**

1.48
.56
.40**

1.17
1.39
.78

1.20
1.35
.75

1.20
1.38
.81

2.71*
1.85
1.03

2.92*
1.88
.94

2.67*
1.77
1.03

1.10
1.36
.69
.89

1.24
1.39
.72
.88

1.10
1.36
.65
.88

1.01
.80
1.00
.98

1.07
.82
1.01
1.01

.97
.79
1.06
.998

.88

.84

.81

2.44*

2.13*

2.65**

.29***
.56
.44*

.94
1.04
.83
.64
.57

.25***
.51
.38*

.30***
.56
.43*
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Other
Hispanic
Multiracial
Socioeconomic status
100-199%
200%+
Insurance status
Medicaid
Uninsured
Marketplace
Control Variables
Marital status
Never married
Living with partner
Divorced or separated
Employment status
Part-time
Full-time
Educational attainment
High school
Some college, no degree
Associate’s degree
Bachelor’s degree
Master’s, professional, or doctorate degree
Age
18-26
27-30
31-36
Foreign-born

1.05
1.41
.50

1.14
1.39
.52

.98
1.35
.50

1.46
1.06
.81

1.90
.98
.91

1.56
1.07
.81

.88
.65

.96
.70

.87
.65

.92
.88

1.05
.91

.96
.95

.61
.32**
.81

.67
.36*
.91

.62
.31**
.82

1.23
.93
2.43*

.98
1.01
2.84*

1.23
.93
2.31*

1.35
1.22
.97

1.34
1.22
1.01

1.29
1.20
.95

1.53
1.46
1.66

1.48
1.57
1.56

1.46
1.41
1.63

1.64
1.35

1.53
1.35

1.70
1.35

.69
1.29

.73
1.35

.70
1.28

.60
.85
.65
.57
.51

.60
.85
.65
.54
.50

.58
.86
.66
.58
.52

2.10
1.37
1.35
1.87
1.94

2.10
1.30
1.26
1.76
2.05

1.97
1.34
1.25
1.73
1.84

3.01**
2.17*
1.79
.57

3.05**
2.04*
1.83
.55

2.95**
2.12*
1.79
.61

.23**
.23**
.40*
1.97

.24**
.25**
.46
1.92

.29**
.28**
.48
1.96

Constant
.10**
.09**
.12*
6.50*
5.40
5.93*
Observations
982
889
1,008
982
889
1,008
Note. *** p<.001, ** p<.01, * p<.05. Reference categories are respectively: White; Less than 100% FPL; Private insurance; Married; Unemployed; Less than High School; Age
37-39; Not foreign-born; Pregnancy avoidance attitude of 1; No past use of the pill; No LARC at last wave; Doctor didn’t talk about future plans for children; Didn’t get
information about birth control; Together for six months or longer; Private doctor’s office; Respondent paid; No regular place for medical care; Lives in a state that did not expand
Medicaid under ACA.

Appendix B: Supplementary Analyses for Aim #2
Table 1b. Sensitivity Analyses Conducted with Alternate Coding Schemes for Outcome and Condition Variables

Outcome Variable
Number of telecontraception
platform services
Range: 2, 3, 4, or 5 or more
services
Condition Variables
State political control
Democrat, Republican, or split
Proportion of women legislators
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Range: 14% – 52%

Coding Used in Original
Analysis

Coding Used in Sensitivity
Analyses

High availability = 3 or
more services

High availability = 4 or
more services

Low availability = 2
services
Groups together state
legislature (D, R, or split)
& state governor (D or R)
Four-value fuzzy set:
33% or higher = 1 (fully
in)
26% to 32% = 0.67 (more
in than out)

Result of Sensitivity
Analysis

Final Decision

Low availability = 2 or 3
services

Lower consistency scores
Lower coverage scores
Solution coverage dropped in
half (.33); solution
consistency was similar

Retained the original coding
scheme for greater
information about patterns to
the outcome, and greater
consistency and coverage.

Separated out state
legislature and state
governor into two separate
variables
Crisp set:

Similar consistency and
coverage scores
Similar combinations of
conditions
Lower coverage scores

Retained the original
combined variable of
legislature plus governor for
easier interpretation.
Retained the original coding
scheme because it provided
greater coverage and thus
more information about the
pathways.

Similar findings
Slightly lower coverage
scores

Retained the original coding
scheme because it provided
greater coverage.

30% or higher = 1 (fully in)
Less than 30% = 0 (fully
out)

20-25% = 0.33 (more out
than in)

Uninsured women
Range: 3% - 24%

Less than 20% = 0 (fully
out)
Four-value fuzzy set:
10% or higher = 1 (fully
in)
8% to 9% = 0.67 (more in
than out)

Crisp set:
10% or higher = 1 (fully in)
Less than 10% = 0 (fully
out)

7% = 0.33 (more out than
in)

Rural population
Range: 1% to 69%

6% or less = 0 (fully out)
Three-value fuzzy set:
27% or higher = 1 (fully
in)
20% - 26% = 0.5 (neither
fully in nor fully out)

Final robustness check using all
recalibrated variables from each
sensitivity analysis listed above
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---

Robustness check using a
variable representing the
percentage of women legislators
who are Democrat

---

Lower solution coverage
Fewer pathways (2 pathways)
with large groupings of states
in each pathway

Retained the original coding
scheme because it provided
greater solution coverage and
diverse information about the
pathways.

---

Very low coverage scores
Lower solution coverage and
consistency scores

---

Lower consistency scores
Fewer pathways with large
groupings of states in each
pathway
Similar findings
One of the pathways had low
raw and unique coverage
scores (.16 and .05,
respectively).

Retained original coding
decisions because this
provided greater coverage
and preserved the rich
variation and information
about the different pathways.
Retained original cutoff
value of 0.80 to preserve the
diversity of information
present in these pathways.
Retained original women
legislators variable due to
higher consistency and
coverage scores.

40% or higher = 1 (fully in)
Less than 40% = 0 (fully
out)

Less than 20% = 0 (fully
out)
---

Robustness check using
consistency cutoff value of 0.75

Range: 24% to 93%

Crisp set:

Crisp set:
51% or higher = 1 (fully in)
Less than 51% = 0 (fully
out)

Appendix C: Supplementary Coding Information for Aim #3
Table 1c. Descriptions of Codes and their Frequency in Nurx User Reviews
Themes and Codes

Number of
Reviews

Percentage of Total
Reviews (N=1,323)

Access and Timeliness of Apps
Speed/quick service
Easy to use
Convenience

207
235
108

16%
18%
8%

Medical need

143

11%

Shipping
In-person visit problems or barriers

143
243

11%
18%

331
260
45

25%
20%
3%

24

2%

292

22%

339

26%

Billing complaints
Support for the Idea of Telecontraception
Supports telecontraception idea

183

14%

263

20%

State (un)availability
Platform Development
Technology complaints about app

46

3%

167

13%

Clinician Interaction
Provider
Birth control options
Information/education
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Discreet/privacy
Cost and Affordability
Cost/affordability
Insurance

Code Description

Fast process to order birth control
App itself is easy to use (functionality), ordering process is easy
Mentions that the service is convenient, doesn’t have to leave home or go to
doctor or pharmacy
Requires contraception to deal with medical side effects and symptoms, need for
specific brands, existing medical conditions
Shipping orders out – fast or slow, never received or shipped
References to any barriers associated with in-person visits: long appointment wait
times, scheduling, time, cost, exams
Answering questions, medical consultation, team, messaging
Requests for a specific brands, different options offered for birth control
Provided information and education about birth control options, educational
resources, choice tailored to individual and their preferences
Mentions how the service is discreet, private, confidential; not wanting others to
find out, discreet packaging
Explicit dollar amounts patients pay, thoughts about the cost-effectiveness and
price of these services
Having or not having insurance and whether it is accepted by the app, whether
certain insurance plans cover costs
Problems with incorrect amounts or charges, need a reversal
References to support or love the idea of this service, company, believes in
expanding women’s health access
Mentions services not available in a certain state; need the services there

Technological issues with app functionality, bugs, loading times, notifications,
crashes, cannot add insurance, signs out
App rollout
12
1%
Conversion from the website to an app; experiences using the newly added app to
the Google Play Store
Customer service
437
33%
Mentions customer service department, contact with them, resolving issues
related to orders
Note: Percentage of total reviews do not add up to 100% since user reviews can contain multiple, overlapping codes.

Table 2c. Descriptions of Codes and their Frequency in Planned Parenthood Direct User Reviews
Themes and Codes

Number of
Reviews

Percentage of
Total Reviews
(N=522)

Access and Timeliness of Apps
Speed/quick service
Easy to use

158
129

30%
25%

Convenience

80

15%

Medical need

50

10%

In-person visit problems or barriers

101

19%

Provider

141

27%

Information/education

15

3%

Discreet/privacy

14

3%

Cost/affordability

104

20%

Insurance

56

11%

10

2%

73

14%

44
50

8%
10%

Code Description

Fast process to order birth control
App itself is easy to use (functionality), ordering process is easy
Mentions that the service is convenient, doesn’t have to leave home or go to doctor
or pharmacy
Requires contraception to deal with medical side effects and symptoms, need for
specific brands, existing medical conditions
References to any barriers associated with in-person visits: long appointment wait
times, scheduling, time, cost, exams

Clinician Interaction
Answering questions, medical consultation, video consultation, video chat, demeanor
of physician, speak to a physician
Provided information and education about different birth control options, educational
resources, choice is tailored to the individual and their preferences
Mentions how the service is discreet, private, confidential; not wanting others to find
out, discreet packaging
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Cost and Affordability

Billing complaints
Support for the Idea of Telecontraception
Supports telecontraception idea
State (un)availability
Planned Parenthood patient/history
Platform Development

Explicit dollar amounts patients pay, thoughts about the cost-effectiveness and price
of these services
Having or not having insurance and whether it is accepted by the app, whether
certain insurance plans cover costs
Problems with incorrect amounts or charges, need a reversal
References to support or love the idea of this service, company, believes in
expanding women’s health access
Mentions services not available in a certain state; need the services there
Planned Parenthood supporter, in-person patient, grateful for the organization

Technological issues with app functionality, bugs, loading times, notifications,
crashes, cannot add insurance, signs out
Note: Percentage of total reviews do not add up to 100% since user reviews can contain multiple, overlapping codes.
Technology complaints about app

178

34%
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